submitter_primary_diagnosis_id,treatment_type,is_primary_treatment,treatment_start_date,treatment_end_date,treatment_setting,treatment_intent,days_per_cycle,number_of_cycles,response_to_treatment_criteria_method,response_to_treatment,line_of_treatment,status_of_treatment,submitter_treatment_id,submitter_donor_id,program_id
PRIMARY_DIAGNOSIS_1,Immunotherapy|Bone marrow transplant|Other targeting molecular therapy,Unknown,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 72, 'day_interval': 2160}",Maintenance,Guidance,1.0,3.0,Response Assessment in Neuro-Oncology (RANO),Immune confirmed progressive disease (iCPD),4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_1,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_2,,No,"{'month_interval': 5, 'day_interval': 150}",,Conditioning,,4.0,4.0,iRECIST,Partial remission,3.0,Treatment stopped due to acute toxicity,TREATMENT_2,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_3,Bone marrow transplant|Hormonal therapy,Unknown,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 99, 'day_interval': 2970}",Salvage,Supportive,7.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Morphologic leukemia-free state,,Other,TREATMENT_3,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_4,,No,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 92, 'day_interval': 2760}",Radiosensitization,,1.0,5.0,RECIST 1.1,Partial response,4.0,Physician decision (stopped or interrupted treatment),TREATMENT_4,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_5,,No,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 51, 'day_interval': 1530}",Radiosensitization,Forensic,,3.0,AML Response Criteria,,4.0,Other,TREATMENT_5,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_6,Radiation therapy,Unknown,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 56, 'day_interval': 1680}",Salvage,Palliative,4.0,3.0,iRECIST,Minor response,,Treatment stopped due to acute toxicity,TREATMENT_6,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_7,,Unknown,,"{'month_interval': 86, 'day_interval': 2580}",Neoadjuvant,Guidance,3.0,,Response Assessment in Neuro-Oncology (RANO),,5.0,Not applicable,TREATMENT_7,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_8,,Unknown,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 81, 'day_interval': 2430}",Maintenance,Supportive,3.0,5.0,,Partial remission,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_8,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_9,Radiation therapy|Immunotherapy|Chemotherapy,Unknown,"{'month_interval': 18, 'day_interval': 540}",,Maintenance,Forensic,1.0,3.0,AML Response Criteria,Minor response,3.0,Treatment completed as prescribed,TREATMENT_9,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_10,,Unknown,"{'month_interval': 9, 'day_interval': 270}","{'month_interval': 67, 'day_interval': 2010}",Conditioning,Supportive,6.0,4.0,,Complete remission,2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_10,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_11,,Yes,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 51, 'day_interval': 1530}",,Screening,1.0,5.0,,No evidence of disease (NED),2.0,Treatment completed as prescribed,TREATMENT_11,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_12,Other targeting molecular therapy,,"{'month_interval': 9, 'day_interval': 270}",,Maintenance,Screening,2.0,5.0,Response Assessment in Neuro-Oncology (RANO),Molecular relapse (after CR MRD-),3.0,Treatment stopped due to acute toxicity,TREATMENT_12,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_13,Other targeting molecular therapy|Radiation therapy|Bone marrow transplant,Unknown,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 55, 'day_interval': 1650}",Locally advanced,Palliative,7.0,,,Complete response,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_13,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_14,,,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 98, 'day_interval': 2940}",Preventative,Forensic,7.0,5.0,Response Assessment in Neuro-Oncology (RANO),Molecular relapse (after CR MRD-),2.0,Treatment stopped due to acute toxicity,TREATMENT_14,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_15,No treatment|Stem cell transplant|Radiation therapy,Unknown,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 79, 'day_interval': 2370}",Preventative,Forensic,5.0,3.0,Response Assessment in Neuro-Oncology (RANO),Morphologic leukemia-free state,2.0,,TREATMENT_15,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_16,Immunotherapy,No,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 54, 'day_interval': 1620}",,Palliative,6.0,3.0,RECIST 1.1,Partial remission,,Patient choice (stopped or interrupted treatment),TREATMENT_16,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_17,,Yes,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 58, 'day_interval': 1740}",Advanced/Metastatic,Palliative,5.0,,AML Response Criteria,Primary refractory disease,,Not applicable,TREATMENT_17,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_18,Other targeting molecular therapy|Hormonal therapy|Photodynamic therapy,,"{'month_interval': 8, 'day_interval': 240}","{'month_interval': 98, 'day_interval': 2940}",Adjuvant,Palliative,3.0,4.0,Physician Assessed Response Criteria,Immune stable disease (iSD),,Treatment completed as prescribed,TREATMENT_18,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_19,Radiation therapy|Photodynamic therapy,Yes,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 96, 'day_interval': 2880}",Preventative,,,4.0,Cheson CLL 2012 Oncology Response Criteria,Primary refractory disease,2.0,,TREATMENT_19,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_20,Bone marrow transplant|Other targeting molecular therapy,Yes,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 64, 'day_interval': 1920}",Preventative,Curative,5.0,,AML Response Criteria,Progressive disease,2.0,,TREATMENT_20,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_21,,No,"{'month_interval': 39, 'day_interval': 1170}","{'month_interval': 77, 'day_interval': 2310}",Mobilization,Forensic,3.0,3.0,Physician Assessed Response Criteria,Physician assessed stable disease,3.0,Other,TREATMENT_21,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_22,Hormonal therapy|No treatment|Other targeting molecular therapy,,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 77, 'day_interval': 2310}",Preventative,Supportive,5.0,5.0,iRECIST,,,,TREATMENT_22,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_23,Photodynamic therapy|Surgery,Unknown,"{'month_interval': 39, 'day_interval': 1170}","{'month_interval': 68, 'day_interval': 2040}",Radiosensitization,Guidance,7.0,,iRECIST,Major response,5.0,Patient choice (stopped or interrupted treatment),TREATMENT_23,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_24,,Yes,"{'month_interval': 48, 'day_interval': 1440}","{'month_interval': 92, 'day_interval': 2760}",Radiosensitization,Palliative,3.0,,,Complete response,3.0,Not applicable,TREATMENT_24,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_25,Photodynamic therapy|Surgery,,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 80, 'day_interval': 2400}",,Palliative,7.0,3.0,RECIST 1.1,"Hematologic relapse (after CR MRD-, CR, CRi)",,Treatment stopped due to acute toxicity,TREATMENT_25,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_26,,No,"{'month_interval': 17, 'day_interval': 510}",,Preventative,Screening,4.0,3.0,RECIST 1.1,Immune confirmed progressive disease (iCPD),,Treatment incomplete due to technical or organizational problems,TREATMENT_26,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_27,No treatment|Other targeting molecular therapy|Immunotherapy,No,"{'month_interval': 3, 'day_interval': 90}","{'month_interval': 51, 'day_interval': 1530}",Neoadjuvant,Screening,1.0,,iRECIST,Progressive disease,5.0,Other,TREATMENT_27,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_28,Immunotherapy|Other targeting molecular therapy,Unknown,"{'month_interval': 21, 'day_interval': 630}",,Conditioning,,3.0,3.0,,Minor response,4.0,,TREATMENT_28,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_29,Radiation therapy,Unknown,"{'month_interval': 39, 'day_interval': 1170}",,Maintenance,Supportive,6.0,4.0,iRECIST,,1.0,Treatment incomplete because patient died,TREATMENT_29,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_30,Photodynamic therapy,Unknown,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 61, 'day_interval': 1830}",Induction,Diagnostic,1.0,,,Minor response,1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_30,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_31,Other targeting molecular therapy|Surgery,Yes,"{'month_interval': 4, 'day_interval': 120}","{'month_interval': 94, 'day_interval': 2820}",Conditioning,Supportive,4.0,4.0,iRECIST,Progressive disease,1.0,Unknown,TREATMENT_31,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_32,Chemotherapy|Bone marrow transplant,Unknown,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 89, 'day_interval': 2670}",Adjuvant,Screening,,,Cheson CLL 2012 Oncology Response Criteria,Molecular relapse (after CR MRD-),,Treatment stopped due to acute toxicity,TREATMENT_32,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_33,Immunotherapy|Chemotherapy|Hormonal therapy,Unknown,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 62, 'day_interval': 1860}",Mobilization,Curative,5.0,3.0,,Immune confirmed progressive disease (iCPD),3.0,Treatment incomplete because patient died,TREATMENT_33,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_34,,Unknown,"{'month_interval': 44, 'day_interval': 1320}",,Induction,Screening,7.0,3.0,Physician Assessed Response Criteria,Complete remission with incomplete hematologic recovery (CRi),,Patient choice (stopped or interrupted treatment),TREATMENT_34,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_35,Stem cell transplant|Other targeting molecular therapy|Chemotherapy,No,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 68, 'day_interval': 2040}",Induction,Curative,3.0,5.0,Response Assessment in Neuro-Oncology (RANO),Immune uncomfirmed progressive disease (iUPD),,Treatment completed as prescribed,TREATMENT_35,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_36,Photodynamic therapy,Yes,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 93, 'day_interval': 2790}",Preventative,,2.0,4.0,Response Assessment in Neuro-Oncology (RANO),,,Not applicable,TREATMENT_36,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_37,,Unknown,,"{'month_interval': 82, 'day_interval': 2460}",,Curative,5.0,5.0,iRECIST,Immune uncomfirmed progressive disease (iUPD),1.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_37,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_38,,Yes,,"{'month_interval': 89, 'day_interval': 2670}",,Supportive,1.0,4.0,Blazer score,,1.0,,TREATMENT_38,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_39,No treatment,Unknown,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 97, 'day_interval': 2910}",Adjuvant,Palliative,1.0,3.0,iRECIST,Partial response,5.0,Physician decision (stopped or interrupted treatment),TREATMENT_39,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_40,Other targeting molecular therapy|Surgery,,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 77, 'day_interval': 2310}",Conditioning,Palliative,4.0,,Physician Assessed Response Criteria,,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_40,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_41,Photodynamic therapy|No treatment|Immunotherapy,Yes,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 68, 'day_interval': 2040}",Salvage,Guidance,2.0,3.0,iRECIST,,1.0,Treatment stopped due to acute toxicity,TREATMENT_41,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_42,,,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 56, 'day_interval': 1680}",Maintenance,Diagnostic,5.0,5.0,AML Response Criteria,,5.0,Treatment stopped due to acute toxicity,TREATMENT_42,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_43,No treatment|Radiation therapy|Chemotherapy,No,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 96, 'day_interval': 2880}",Neoadjuvant,Forensic,6.0,5.0,Response Assessment in Neuro-Oncology (RANO),Immune partial response (iPR),,Treatment incomplete due to technical or organizational problems,TREATMENT_43,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_44,Photodynamic therapy,No,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 91, 'day_interval': 2730}",Adjuvant,Diagnostic,1.0,5.0,AML Response Criteria,Complete response,2.0,Unknown,TREATMENT_44,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_45,Immunotherapy|Chemotherapy|Stem cell transplant,Unknown,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 53, 'day_interval': 1590}",Salvage,Curative,5.0,4.0,Response Assessment in Neuro-Oncology (RANO),Complete remission,3.0,Treatment incomplete due to technical or organizational problems,TREATMENT_45,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_46,,Unknown,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 54, 'day_interval': 1620}",Mobilization,Guidance,3.0,3.0,Response Assessment in Neuro-Oncology (RANO),Immune confirmed progressive disease (iCPD),3.0,Treatment stopped due to acute toxicity,TREATMENT_46,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_47,Immunotherapy|No treatment,No,"{'month_interval': 3, 'day_interval': 90}","{'month_interval': 75, 'day_interval': 2250}",Conditioning,Diagnostic,2.0,,iRECIST,Morphologic leukemia-free state,,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_47,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_48,Stem cell transplant,Yes,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 67, 'day_interval': 2010}",Induction,Forensic,6.0,3.0,AML Response Criteria,Physician assessed stable disease,,Physician decision (stopped or interrupted treatment),TREATMENT_48,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_49,,No,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 75, 'day_interval': 2250}",Maintenance,Guidance,6.0,4.0,,Complete remission,5.0,,TREATMENT_49,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_50,,Yes,"{'month_interval': 16, 'day_interval': 480}",,Radiosensitization,,5.0,,Blazer score,Stable disease,,Treatment stopped due to acute toxicity,TREATMENT_50,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_51,Stem cell transplant|Immunotherapy,Yes,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 71, 'day_interval': 2130}",Advanced/Metastatic,Palliative,7.0,5.0,,Immune uncomfirmed progressive disease (iUPD),,Physician decision (stopped or interrupted treatment),TREATMENT_51,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_52,Bone marrow transplant|No treatment|Other targeting molecular therapy,Unknown,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 90, 'day_interval': 2700}",Neoadjuvant,Diagnostic,7.0,5.0,RECIST 1.1,Complete remission,1.0,Unknown,TREATMENT_52,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_53,Surgery|Chemotherapy|Hormonal therapy,Unknown,"{'month_interval': 12, 'day_interval': 360}",,Maintenance,Screening,5.0,3.0,Response Assessment in Neuro-Oncology (RANO),Partial response,3.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_53,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_54,No treatment,Unknown,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 78, 'day_interval': 2340}",Neoadjuvant,Palliative,6.0,5.0,,Complete remission,5.0,Physician decision (stopped or interrupted treatment),TREATMENT_54,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_55,,,,"{'month_interval': 94, 'day_interval': 2820}",Locally advanced,Forensic,1.0,5.0,Blazer score,,1.0,Not applicable,TREATMENT_55,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_56,Other targeting molecular therapy|Photodynamic therapy,No,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 92, 'day_interval': 2760}",Neoadjuvant,Guidance,2.0,5.0,iRECIST,No evidence of disease (NED),2.0,Other,TREATMENT_56,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_57,,Yes,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 53, 'day_interval': 1590}",Radiosensitization,Preventive,3.0,3.0,Blazer score,Progressive disease,,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_57,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_58,Radiation therapy|No treatment,Unknown,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 64, 'day_interval': 1920}",Mobilization,Guidance,7.0,,Blazer score,Complete response,,Treatment incomplete due to technical or organizational problems,TREATMENT_58,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_59,,No,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 94, 'day_interval': 2820}",Salvage,Curative,1.0,4.0,Blazer score,Minor response,5.0,Treatment completed as prescribed,TREATMENT_59,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_60,No treatment|Bone marrow transplant|Hormonal therapy,Unknown,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 51, 'day_interval': 1530}",Salvage,Supportive,6.0,4.0,Physician Assessed Response Criteria,Complete remission without measurable residual disease (CR MRD-),5.0,,TREATMENT_60,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_61,Hormonal therapy|Photodynamic therapy|No treatment,No,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 73, 'day_interval': 2190}",Locally advanced,Diagnostic,,4.0,Physician Assessed Response Criteria,,,Treatment stopped due to acute toxicity,TREATMENT_61,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_62,,Yes,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 86, 'day_interval': 2580}",,,1.0,4.0,,Complete remission with incomplete hematologic recovery (CRi),4.0,Unknown,TREATMENT_62,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_63,Immunotherapy,,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 61, 'day_interval': 1830}",Locally advanced,Diagnostic,7.0,3.0,RECIST 1.1,Physician assessed stable disease,,Treatment incomplete due to technical or organizational problems,TREATMENT_63,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_64,No treatment|Immunotherapy,,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 82, 'day_interval': 2460}",Salvage,Forensic,7.0,3.0,Physician Assessed Response Criteria,Minor response,1.0,Unknown,TREATMENT_64,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_65,,No,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 77, 'day_interval': 2310}",Maintenance,Preventive,2.0,3.0,RECIST 1.1,Immune confirmed progressive disease (iCPD),4.0,Other,TREATMENT_65,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_66,Immunotherapy,Yes,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 73, 'day_interval': 2190}",Conditioning,Supportive,4.0,,Cheson CLL 2012 Oncology Response Criteria,Immune uncomfirmed progressive disease (iUPD),4.0,Unknown,TREATMENT_66,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_67,Radiation therapy|Surgery|Immunotherapy,Unknown,"{'month_interval': 48, 'day_interval': 1440}","{'month_interval': 69, 'day_interval': 2070}",Advanced/Metastatic,,,5.0,Blazer score,,2.0,,TREATMENT_67,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_68,,Yes,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 96, 'day_interval': 2880}",Adjuvant,Screening,,,Physician Assessed Response Criteria,Immune confirmed progressive disease (iCPD),2.0,Treatment completed as prescribed,TREATMENT_68,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_69,Stem cell transplant|Photodynamic therapy|Chemotherapy,Unknown,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 69, 'day_interval': 2070}",Radiosensitization,Guidance,5.0,5.0,,"Hematologic relapse (after CR MRD-, CR, CRi)",2.0,Treatment completed as prescribed,TREATMENT_69,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_70,,,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 90, 'day_interval': 2700}",,,,,AML Response Criteria,Complete remission,1.0,,TREATMENT_70,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_71,Photodynamic therapy,Unknown,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 98, 'day_interval': 2940}",,Screening,4.0,4.0,AML Response Criteria,Complete remission with incomplete hematologic recovery (CRi),5.0,,TREATMENT_71,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_72,Stem cell transplant|Bone marrow transplant|No treatment,No,,"{'month_interval': 62, 'day_interval': 1860}",Maintenance,,4.0,4.0,Blazer score,Immune uncomfirmed progressive disease (iUPD),1.0,Treatment stopped due to acute toxicity,TREATMENT_72,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_73,No treatment|Surgery|Radiation therapy,No,,"{'month_interval': 90, 'day_interval': 2700}",Induction,Forensic,6.0,,RECIST 1.1,Complete remission with incomplete hematologic recovery (CRi),5.0,,TREATMENT_73,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_74,,No,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 75, 'day_interval': 2250}",Advanced/Metastatic,Forensic,,4.0,Blazer score,Primary refractory disease,1.0,Unknown,TREATMENT_74,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_75,Surgery|Hormonal therapy|Radiation therapy,Yes,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 64, 'day_interval': 1920}",Neoadjuvant,Screening,1.0,4.0,AML Response Criteria,Stable disease,5.0,Not applicable,TREATMENT_75,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_76,Radiation therapy|Chemotherapy,Unknown,"{'month_interval': 41, 'day_interval': 1230}","{'month_interval': 83, 'day_interval': 2490}",Adjuvant,Screening,4.0,4.0,AML Response Criteria,Complete response,,Other,TREATMENT_76,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_77,Bone marrow transplant|Chemotherapy,,"{'month_interval': 39, 'day_interval': 1170}","{'month_interval': 75, 'day_interval': 2250}",Induction,Screening,6.0,5.0,,,3.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_77,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_78,,Yes,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 98, 'day_interval': 2940}",Radiosensitization,Guidance,,3.0,RECIST 1.1,Physician assessed stable disease,3.0,Unknown,TREATMENT_78,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_79,Bone marrow transplant|Immunotherapy,Unknown,"{'month_interval': 11, 'day_interval': 330}","{'month_interval': 52, 'day_interval': 1560}",,Curative,4.0,,Response Assessment in Neuro-Oncology (RANO),Complete remission without measurable residual disease (CR MRD-),3.0,,TREATMENT_79,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_80,Radiation therapy,No,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 99, 'day_interval': 2970}",Conditioning,Curative,3.0,4.0,RECIST 1.1,Complete response,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_80,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_81,No treatment,Unknown,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 96, 'day_interval': 2880}",Maintenance,Preventive,4.0,3.0,RECIST 1.1,Major response,3.0,Treatment incomplete due to technical or organizational problems,TREATMENT_81,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_82,Bone marrow transplant,Unknown,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 69, 'day_interval': 2070}",Advanced/Metastatic,,,3.0,RECIST 1.1,Complete response,3.0,Treatment stopped due to acute toxicity,TREATMENT_82,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_83,Radiation therapy|Bone marrow transplant|Other targeting molecular therapy,Unknown,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 74, 'day_interval': 2220}",Conditioning,Guidance,4.0,5.0,RECIST 1.1,Immune uncomfirmed progressive disease (iUPD),,Unknown,TREATMENT_83,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_84,Bone marrow transplant|Chemotherapy,Unknown,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 87, 'day_interval': 2610}",Neoadjuvant,Forensic,5.0,3.0,Blazer score,Complete remission,3.0,Not applicable,TREATMENT_84,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_85,Photodynamic therapy|Other targeting molecular therapy,Yes,,"{'month_interval': 63, 'day_interval': 1890}",Induction,Preventive,5.0,3.0,,No evidence of disease (NED),1.0,Treatment incomplete because patient died,TREATMENT_85,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_86,Hormonal therapy|Photodynamic therapy,No,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 96, 'day_interval': 2880}",,,5.0,,RECIST 1.1,Complete remission,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_86,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_87,Stem cell transplant,Yes,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 62, 'day_interval': 1860}",,Forensic,4.0,5.0,,Partial remission,4.0,Treatment completed as prescribed,TREATMENT_87,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_88,Surgery|Bone marrow transplant|Chemotherapy,Unknown,"{'month_interval': 16, 'day_interval': 480}",,,Palliative,,5.0,Cheson CLL 2012 Oncology Response Criteria,Complete remission,4.0,Unknown,TREATMENT_88,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_89,Radiation therapy|Chemotherapy,Unknown,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 75, 'day_interval': 2250}",Conditioning,Diagnostic,6.0,3.0,AML Response Criteria,Complete remission without measurable residual disease (CR MRD-),4.0,,TREATMENT_89,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_90,,,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 59, 'day_interval': 1770}",Conditioning,,3.0,5.0,Response Assessment in Neuro-Oncology (RANO),Minor response,2.0,Patient choice (stopped or interrupted treatment),TREATMENT_90,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_91,Radiation therapy|Chemotherapy|Stem cell transplant,No,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 60, 'day_interval': 1800}",Adjuvant,Guidance,4.0,5.0,Physician Assessed Response Criteria,,2.0,Other,TREATMENT_91,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_92,,,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 90, 'day_interval': 2700}",Advanced/Metastatic,Palliative,,5.0,AML Response Criteria,Physician assessed stable disease,2.0,,TREATMENT_92,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_93,Photodynamic therapy,Unknown,,"{'month_interval': 90, 'day_interval': 2700}",Neoadjuvant,Curative,2.0,5.0,iRECIST,Stable disease,4.0,,TREATMENT_93,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_94,Photodynamic therapy|Hormonal therapy,No,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 76, 'day_interval': 2280}",Maintenance,Screening,7.0,,,,3.0,,TREATMENT_94,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_95,Stem cell transplant|Immunotherapy|No treatment,Unknown,,"{'month_interval': 95, 'day_interval': 2850}",Preventative,,,5.0,Response Assessment in Neuro-Oncology (RANO),"Hematologic relapse (after CR MRD-, CR, CRi)",3.0,Other,TREATMENT_95,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_96,Hormonal therapy|Surgery|Stem cell transplant,No,"{'month_interval': 3, 'day_interval': 90}","{'month_interval': 70, 'day_interval': 2100}",Mobilization,Preventive,3.0,5.0,RECIST 1.1,,1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_96,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_97,Surgery|Radiation therapy|Immunotherapy,Yes,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 71, 'day_interval': 2130}",Advanced/Metastatic,Supportive,6.0,5.0,Response Assessment in Neuro-Oncology (RANO),Minor response,,,TREATMENT_97,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_98,Radiation therapy|No treatment|Immunotherapy,Yes,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 87, 'day_interval': 2610}",Salvage,Guidance,,3.0,,,3.0,Physician decision (stopped or interrupted treatment),TREATMENT_98,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_99,Stem cell transplant,Yes,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 53, 'day_interval': 1590}",Maintenance,Preventive,7.0,,Cheson CLL 2012 Oncology Response Criteria,Progressive disease,1.0,,TREATMENT_99,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_100,Radiation therapy|No treatment|Hormonal therapy,,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 62, 'day_interval': 1860}",Locally advanced,,5.0,,Blazer score,,,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_100,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_101,Radiation therapy|Hormonal therapy,,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 75, 'day_interval': 2250}",,,1.0,5.0,Blazer score,Immune stable disease (iSD),1.0,Other,TREATMENT_101,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_102,,Unknown,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 54, 'day_interval': 1620}",Preventative,Curative,4.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Physician assessed stable disease,5.0,Other,TREATMENT_102,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_103,,Unknown,"{'month_interval': 11, 'day_interval': 330}",,Salvage,Curative,4.0,4.0,,,5.0,Patient choice (stopped or interrupted treatment),TREATMENT_103,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_104,,No,"{'month_interval': 3, 'day_interval': 90}",,Conditioning,,5.0,4.0,RECIST 1.1,Minor response,2.0,Physician decision (stopped or interrupted treatment),TREATMENT_104,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_105,Stem cell transplant|Bone marrow transplant|Surgery,Yes,,"{'month_interval': 69, 'day_interval': 2070}",Advanced/Metastatic,Forensic,2.0,3.0,RECIST 1.1,Complete response,1.0,Treatment incomplete because patient died,TREATMENT_105,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_106,,Unknown,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 81, 'day_interval': 2430}",Maintenance,Forensic,,3.0,Blazer score,Minor response,5.0,,TREATMENT_106,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_107,,Yes,"{'month_interval': 32, 'day_interval': 960}",,Advanced/Metastatic,Screening,5.0,4.0,RECIST 1.1,Immune partial response (iPR),3.0,,TREATMENT_107,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_108,Other targeting molecular therapy,Yes,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 91, 'day_interval': 2730}",Preventative,,,3.0,RECIST 1.1,Physician assessed partial response,2.0,Treatment incomplete due to technical or organizational problems,TREATMENT_108,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_109,Surgery,,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 97, 'day_interval': 2910}",Mobilization,Curative,3.0,4.0,Physician Assessed Response Criteria,Complete remission without measurable residual disease (CR MRD-),,Not applicable,TREATMENT_109,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_110,Chemotherapy|Other targeting molecular therapy,Yes,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 100, 'day_interval': 3000}",Conditioning,Forensic,2.0,5.0,AML Response Criteria,Primary refractory disease,,Treatment incomplete because patient died,TREATMENT_110,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_111,,Unknown,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 52, 'day_interval': 1560}",Maintenance,Screening,6.0,3.0,Physician Assessed Response Criteria,Minor response,1.0,Treatment incomplete because patient died,TREATMENT_111,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_112,,Yes,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 100, 'day_interval': 3000}",Maintenance,Curative,,5.0,,Complete remission,2.0,Physician decision (stopped or interrupted treatment),TREATMENT_112,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_113,Surgery|Stem cell transplant|Radiation therapy,Yes,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 66, 'day_interval': 1980}",Radiosensitization,,3.0,,Cheson CLL 2012 Oncology Response Criteria,No evidence of disease (NED),4.0,,TREATMENT_113,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_114,Hormonal therapy,Unknown,"{'month_interval': 46, 'day_interval': 1380}",,Conditioning,Guidance,,4.0,Physician Assessed Response Criteria,,,Treatment stopped due to acute toxicity,TREATMENT_114,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_115,Bone marrow transplant|Photodynamic therapy|Hormonal therapy,Unknown,,"{'month_interval': 75, 'day_interval': 2250}",Neoadjuvant,Forensic,1.0,3.0,AML Response Criteria,Minor response,5.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_115,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_116,Radiation therapy|Immunotherapy,,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 74, 'day_interval': 2220}",Neoadjuvant,Diagnostic,1.0,3.0,iRECIST,Complete remission without measurable residual disease (CR MRD-),2.0,Treatment incomplete because patient died,TREATMENT_116,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_117,,No,"{'month_interval': 49, 'day_interval': 1470}",,Radiosensitization,Preventive,6.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Immune uncomfirmed progressive disease (iUPD),1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_117,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_118,,No,"{'month_interval': 8, 'day_interval': 240}","{'month_interval': 84, 'day_interval': 2520}",Radiosensitization,Forensic,3.0,5.0,,,5.0,Other,TREATMENT_118,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_119,,No,"{'month_interval': 48, 'day_interval': 1440}","{'month_interval': 92, 'day_interval': 2760}",Adjuvant,Diagnostic,2.0,3.0,,Immune partial response (iPR),2.0,Physician decision (stopped or interrupted treatment),TREATMENT_119,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_120,Other targeting molecular therapy,Unknown,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 81, 'day_interval': 2430}",Adjuvant,Guidance,5.0,5.0,AML Response Criteria,,2.0,Other,TREATMENT_120,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_121,,No,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 55, 'day_interval': 1650}",Induction,Preventive,7.0,,Physician Assessed Response Criteria,Morphologic leukemia-free state,5.0,,TREATMENT_121,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_122,Bone marrow transplant,No,"{'month_interval': 11, 'day_interval': 330}","{'month_interval': 81, 'day_interval': 2430}",Conditioning,Forensic,6.0,5.0,Physician Assessed Response Criteria,Complete response,3.0,,TREATMENT_122,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_123,No treatment,Unknown,"{'month_interval': 41, 'day_interval': 1230}","{'month_interval': 56, 'day_interval': 1680}",Adjuvant,Palliative,7.0,,Response Assessment in Neuro-Oncology (RANO),,1.0,Not applicable,TREATMENT_123,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_124,Stem cell transplant,No,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 75, 'day_interval': 2250}",Conditioning,Screening,,,,,4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_124,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_125,Hormonal therapy|Stem cell transplant|Chemotherapy,No,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 94, 'day_interval': 2820}",Neoadjuvant,Forensic,3.0,4.0,Response Assessment in Neuro-Oncology (RANO),Primary refractory disease,2.0,,TREATMENT_125,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_126,,Yes,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 82, 'day_interval': 2460}",Locally advanced,Forensic,1.0,4.0,Cheson CLL 2012 Oncology Response Criteria,,5.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_126,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_127,Surgery,No,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 97, 'day_interval': 2910}",Advanced/Metastatic,Diagnostic,7.0,5.0,Response Assessment in Neuro-Oncology (RANO),,,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_127,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_128,Immunotherapy,Yes,"{'month_interval': 10, 'day_interval': 300}","{'month_interval': 64, 'day_interval': 1920}",Adjuvant,Supportive,7.0,4.0,,Immune partial response (iPR),,Unknown,TREATMENT_128,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_129,Bone marrow transplant,Unknown,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 93, 'day_interval': 2790}",,Screening,6.0,4.0,AML Response Criteria,Immune uncomfirmed progressive disease (iUPD),1.0,Unknown,TREATMENT_129,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_130,Radiation therapy,Unknown,,,Locally advanced,Screening,7.0,4.0,iRECIST,Immune complete response (iCR),,Treatment incomplete due to technical or organizational problems,TREATMENT_130,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_131,,Yes,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 50, 'day_interval': 1500}",Induction,Screening,2.0,3.0,iRECIST,Immune stable disease (iSD),3.0,Treatment completed as prescribed,TREATMENT_131,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_132,Immunotherapy,Yes,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 99, 'day_interval': 2970}",Preventative,Preventive,2.0,5.0,Response Assessment in Neuro-Oncology (RANO),Immune stable disease (iSD),5.0,Physician decision (stopped or interrupted treatment),TREATMENT_132,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_133,No treatment,Yes,,"{'month_interval': 92, 'day_interval': 2760}",Advanced/Metastatic,Diagnostic,2.0,4.0,Blazer score,Immune stable disease (iSD),2.0,,TREATMENT_133,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_134,Photodynamic therapy|Chemotherapy,Unknown,"{'month_interval': 39, 'day_interval': 1170}","{'month_interval': 85, 'day_interval': 2550}",Neoadjuvant,Preventive,1.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Complete remission without measurable residual disease (CR MRD-),4.0,Physician decision (stopped or interrupted treatment),TREATMENT_134,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_135,Hormonal therapy,Unknown,"{'month_interval': 3, 'day_interval': 90}","{'month_interval': 63, 'day_interval': 1890}",Conditioning,,2.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Immune partial response (iPR),1.0,Patient choice (stopped or interrupted treatment),TREATMENT_135,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_136,Hormonal therapy|Bone marrow transplant|Chemotherapy,Yes,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 86, 'day_interval': 2580}",Radiosensitization,Curative,5.0,5.0,Blazer score,,3.0,,TREATMENT_136,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_137,,Yes,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 84, 'day_interval': 2520}",Induction,Supportive,5.0,4.0,,Complete remission with incomplete hematologic recovery (CRi),4.0,Not applicable,TREATMENT_137,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_138,Stem cell transplant|Hormonal therapy,No,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 91, 'day_interval': 2730}",Radiosensitization,Screening,,,,Partial response,,Not applicable,TREATMENT_138,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_139,Radiation therapy|No treatment,Yes,,"{'month_interval': 90, 'day_interval': 2700}",Maintenance,,7.0,,Cheson CLL 2012 Oncology Response Criteria,Complete remission without measurable residual disease (CR MRD-),,Treatment incomplete due to technical or organizational problems,TREATMENT_139,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_140,,Yes,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 79, 'day_interval': 2370}",Conditioning,Palliative,3.0,3.0,Cheson CLL 2012 Oncology Response Criteria,,2.0,Treatment completed as prescribed,TREATMENT_140,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_141,Chemotherapy,Yes,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 83, 'day_interval': 2490}",Locally advanced,Guidance,6.0,4.0,RECIST 1.1,Progressive disease,2.0,Treatment stopped due to acute toxicity,TREATMENT_141,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_142,Immunotherapy,Yes,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 99, 'day_interval': 2970}",Conditioning,,6.0,,AML Response Criteria,Physician assessed stable disease,4.0,Physician decision (stopped or interrupted treatment),TREATMENT_142,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_143,,Unknown,,"{'month_interval': 52, 'day_interval': 1560}",Salvage,Guidance,5.0,4.0,AML Response Criteria,Major response,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_143,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_144,Immunotherapy|Bone marrow transplant|Photodynamic therapy,Yes,"{'month_interval': 23, 'day_interval': 690}","{'month_interval': 58, 'day_interval': 1740}",Locally advanced,Curative,7.0,5.0,Response Assessment in Neuro-Oncology (RANO),Immune uncomfirmed progressive disease (iUPD),2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_144,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_145,Bone marrow transplant|Hormonal therapy,Yes,"{'month_interval': 11, 'day_interval': 330}","{'month_interval': 90, 'day_interval': 2700}",Maintenance,Curative,2.0,5.0,AML Response Criteria,"Hematologic relapse (after CR MRD-, CR, CRi)",,Patient choice (stopped or interrupted treatment),TREATMENT_145,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_146,,Yes,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 61, 'day_interval': 1830}",Preventative,Screening,,3.0,Physician Assessed Response Criteria,Partial response,3.0,Patient choice (stopped or interrupted treatment),TREATMENT_146,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_147,,Yes,"{'month_interval': 39, 'day_interval': 1170}",,Neoadjuvant,Palliative,4.0,3.0,RECIST 1.1,Complete response,3.0,Treatment completed as prescribed,TREATMENT_147,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_148,Other targeting molecular therapy,No,"{'month_interval': 48, 'day_interval': 1440}","{'month_interval': 85, 'day_interval': 2550}",Locally advanced,Supportive,2.0,5.0,Response Assessment in Neuro-Oncology (RANO),Complete remission without measurable residual disease (CR MRD-),,Unknown,TREATMENT_148,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_149,Bone marrow transplant|Radiation therapy,Yes,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 78, 'day_interval': 2340}",Salvage,Preventive,7.0,4.0,Cheson CLL 2012 Oncology Response Criteria,,,Treatment incomplete because patient died,TREATMENT_149,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_150,Radiation therapy,No,,,Radiosensitization,Guidance,1.0,5.0,AML Response Criteria,Molecular relapse (after CR MRD-),,,TREATMENT_150,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_151,,Yes,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 52, 'day_interval': 1560}",Preventative,Supportive,7.0,4.0,Blazer score,,3.0,Not applicable,TREATMENT_151,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_152,,Yes,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 68, 'day_interval': 2040}",Advanced/Metastatic,Screening,,3.0,,Complete remission without measurable residual disease (CR MRD-),1.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_152,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_153,Immunotherapy|Photodynamic therapy|Hormonal therapy,Unknown,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 52, 'day_interval': 1560}",Induction,Screening,,,RECIST 1.1,Immune complete response (iCR),2.0,Other,TREATMENT_153,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_154,,Unknown,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 62, 'day_interval': 1860}",,Guidance,3.0,3.0,Physician Assessed Response Criteria,Minor response,5.0,Not applicable,TREATMENT_154,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_155,Photodynamic therapy|Stem cell transplant|Bone marrow transplant,Unknown,"{'month_interval': 22, 'day_interval': 660}",,,Screening,1.0,3.0,Physician Assessed Response Criteria,,3.0,Treatment incomplete because patient died,TREATMENT_155,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_156,Stem cell transplant|Photodynamic therapy,,"{'month_interval': 8, 'day_interval': 240}",,Preventative,Guidance,,5.0,,Minor response,4.0,,TREATMENT_156,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_157,,No,"{'month_interval': 23, 'day_interval': 690}","{'month_interval': 69, 'day_interval': 2070}",Adjuvant,Palliative,6.0,3.0,RECIST 1.1,Immune uncomfirmed progressive disease (iUPD),2.0,Patient choice (stopped or interrupted treatment),TREATMENT_157,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_158,Radiation therapy|Photodynamic therapy|Surgery,Yes,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 76, 'day_interval': 2280}",,Curative,7.0,,iRECIST,Primary refractory disease,3.0,Treatment completed as prescribed,TREATMENT_158,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_159,Photodynamic therapy|Surgery,Unknown,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 50, 'day_interval': 1500}",Advanced/Metastatic,Curative,6.0,3.0,RECIST 1.1,Complete remission,5.0,Treatment stopped due to acute toxicity,TREATMENT_159,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_160,Chemotherapy|Radiation therapy|No treatment,No,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 90, 'day_interval': 2700}",Maintenance,Palliative,,4.0,Blazer score,Immune stable disease (iSD),,Physician decision (stopped or interrupted treatment),TREATMENT_160,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_1,Photodynamic therapy,Yes,,"{'month_interval': 97, 'day_interval': 2910}",Conditioning,Guidance,3.0,3.0,iRECIST,Stable disease,1.0,Not applicable,TREATMENT_161,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_2,,No,,"{'month_interval': 87, 'day_interval': 2610}",Neoadjuvant,,5.0,3.0,Physician Assessed Response Criteria,,4.0,,TREATMENT_162,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_3,No treatment,Yes,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 65, 'day_interval': 1950}",Neoadjuvant,Diagnostic,3.0,4.0,AML Response Criteria,,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_163,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_4,No treatment|Immunotherapy|Stem cell transplant,Yes,"{'month_interval': 9, 'day_interval': 270}","{'month_interval': 55, 'day_interval': 1650}",Induction,Palliative,4.0,3.0,iRECIST,,5.0,Treatment completed as prescribed,TREATMENT_164,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_5,,Unknown,"{'month_interval': 48, 'day_interval': 1440}","{'month_interval': 51, 'day_interval': 1530}",Preventative,Forensic,6.0,,AML Response Criteria,Molecular relapse (after CR MRD-),2.0,Treatment stopped due to acute toxicity,TREATMENT_165,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_6,Hormonal therapy|Radiation therapy,No,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 82, 'day_interval': 2460}",Adjuvant,Supportive,1.0,5.0,Blazer score,Immune confirmed progressive disease (iCPD),2.0,,TREATMENT_166,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_7,Radiation therapy|Bone marrow transplant,Yes,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 59, 'day_interval': 1770}",Advanced/Metastatic,,,5.0,iRECIST,Major response,5.0,Other,TREATMENT_167,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_8,Immunotherapy|Chemotherapy,No,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 90, 'day_interval': 2700}",,Diagnostic,,3.0,iRECIST,"Hematologic relapse (after CR MRD-, CR, CRi)",5.0,Physician decision (stopped or interrupted treatment),TREATMENT_168,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_9,Other targeting molecular therapy|Bone marrow transplant,Yes,"{'month_interval': 26, 'day_interval': 780}",,Induction,Preventive,4.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Complete remission,4.0,,TREATMENT_169,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_10,,Unknown,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 86, 'day_interval': 2580}",Maintenance,Guidance,7.0,3.0,AML Response Criteria,"Hematologic relapse (after CR MRD-, CR, CRi)",,Not applicable,TREATMENT_170,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_11,,No,"{'month_interval': 4, 'day_interval': 120}",,Advanced/Metastatic,Diagnostic,6.0,5.0,AML Response Criteria,,1.0,Unknown,TREATMENT_171,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_12,,Yes,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 90, 'day_interval': 2700}",Radiosensitization,Supportive,6.0,4.0,,Molecular relapse (after CR MRD-),3.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_172,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_13,No treatment|Radiation therapy,No,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 91, 'day_interval': 2730}",Salvage,Guidance,4.0,,AML Response Criteria,Minor response,,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_173,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_14,,Yes,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 55, 'day_interval': 1650}",Advanced/Metastatic,Supportive,6.0,4.0,,Immune confirmed progressive disease (iCPD),4.0,Patient choice (stopped or interrupted treatment),TREATMENT_174,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_15,Hormonal therapy|Chemotherapy,Unknown,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 86, 'day_interval': 2580}",Maintenance,Palliative,1.0,3.0,Response Assessment in Neuro-Oncology (RANO),,,Treatment completed as prescribed,TREATMENT_175,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_16,Chemotherapy|Hormonal therapy|Other targeting molecular therapy,Yes,,"{'month_interval': 99, 'day_interval': 2970}",,Forensic,5.0,5.0,Cheson CLL 2012 Oncology Response Criteria,,,Treatment stopped due to acute toxicity,TREATMENT_176,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_17,Hormonal therapy|Photodynamic therapy,Unknown,"{'month_interval': 34, 'day_interval': 1020}",,Advanced/Metastatic,Curative,6.0,5.0,RECIST 1.1,No evidence of disease (NED),3.0,Treatment incomplete because patient died,TREATMENT_177,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_18,,Yes,"{'month_interval': 48, 'day_interval': 1440}","{'month_interval': 93, 'day_interval': 2790}",Adjuvant,Forensic,1.0,4.0,Response Assessment in Neuro-Oncology (RANO),Immune stable disease (iSD),2.0,Treatment incomplete because patient died,TREATMENT_178,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_19,Other targeting molecular therapy|Chemotherapy|Bone marrow transplant,Yes,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 96, 'day_interval': 2880}",Radiosensitization,Guidance,6.0,3.0,Physician Assessed Response Criteria,Physician assessed complete response,1.0,Treatment completed as prescribed,TREATMENT_179,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_20,Other targeting molecular therapy|Hormonal therapy,Unknown,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 57, 'day_interval': 1710}",,Palliative,,3.0,,"Hematologic relapse (after CR MRD-, CR, CRi)",1.0,,TREATMENT_180,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_21,Radiation therapy|Chemotherapy,Unknown,,"{'month_interval': 56, 'day_interval': 1680}",Neoadjuvant,,4.0,4.0,Physician Assessed Response Criteria,Immune complete response (iCR),1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_181,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_22,Stem cell transplant,No,"{'month_interval': 8, 'day_interval': 240}",,Locally advanced,Forensic,5.0,3.0,,Immune complete response (iCR),3.0,Other,TREATMENT_182,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_23,,Yes,"{'month_interval': 23, 'day_interval': 690}","{'month_interval': 88, 'day_interval': 2640}",,Diagnostic,7.0,4.0,,Complete response,2.0,,TREATMENT_183,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_24,No treatment|Bone marrow transplant,Yes,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 88, 'day_interval': 2640}",Preventative,Curative,7.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Complete remission without measurable residual disease (CR MRD-),1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_184,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_25,,No,,"{'month_interval': 94, 'day_interval': 2820}",Preventative,Curative,5.0,,Cheson CLL 2012 Oncology Response Criteria,Minor response,2.0,Physician decision (stopped or interrupted treatment),TREATMENT_185,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_26,,No,,"{'month_interval': 79, 'day_interval': 2370}",,Forensic,4.0,3.0,RECIST 1.1,"Hematologic relapse (after CR MRD-, CR, CRi)",,Treatment incomplete due to technical or organizational problems,TREATMENT_186,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_27,,No,"{'month_interval': 49, 'day_interval': 1470}",,Conditioning,Guidance,,5.0,Blazer score,Primary refractory disease,3.0,Treatment stopped due to acute toxicity,TREATMENT_187,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_28,Other targeting molecular therapy|Bone marrow transplant|Surgery,Yes,,"{'month_interval': 56, 'day_interval': 1680}",Salvage,Screening,3.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Physician assessed partial response,1.0,,TREATMENT_188,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_29,Other targeting molecular therapy,No,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 84, 'day_interval': 2520}",Salvage,Guidance,7.0,,Response Assessment in Neuro-Oncology (RANO),Physician assessed partial response,,Treatment incomplete because patient died,TREATMENT_189,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_30,Hormonal therapy,,"{'month_interval': 33, 'day_interval': 990}",,,Screening,7.0,4.0,Physician Assessed Response Criteria,,1.0,Treatment completed as prescribed,TREATMENT_190,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_31,Other targeting molecular therapy|Photodynamic therapy,Yes,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 64, 'day_interval': 1920}",Preventative,Preventive,4.0,5.0,,Physician assessed partial response,4.0,Other,TREATMENT_191,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_32,No treatment,No,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 62, 'day_interval': 1860}",,Diagnostic,7.0,5.0,Response Assessment in Neuro-Oncology (RANO),Molecular relapse (after CR MRD-),1.0,,TREATMENT_192,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_33,,Yes,"{'month_interval': 14, 'day_interval': 420}","{'month_interval': 83, 'day_interval': 2490}",Conditioning,Palliative,5.0,3.0,RECIST 1.1,,,Treatment completed as prescribed,TREATMENT_193,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_34,Surgery|Hormonal therapy|Radiation therapy,Unknown,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 91, 'day_interval': 2730}",Induction,,7.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Complete remission,,Unknown,TREATMENT_194,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_35,Chemotherapy|Other targeting molecular therapy,Yes,,"{'month_interval': 81, 'day_interval': 2430}",Locally advanced,Guidance,5.0,,Blazer score,,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_195,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_36,No treatment|Hormonal therapy,Unknown,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 84, 'day_interval': 2520}",Locally advanced,Forensic,4.0,,,Minor response,,Other,TREATMENT_196,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_37,,No,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 56, 'day_interval': 1680}",Conditioning,Guidance,7.0,3.0,Response Assessment in Neuro-Oncology (RANO),,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_197,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_38,Immunotherapy|Chemotherapy|Hormonal therapy,No,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 98, 'day_interval': 2940}",Advanced/Metastatic,Forensic,,5.0,Blazer score,,2.0,,TREATMENT_198,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_39,Surgery|Bone marrow transplant,,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 100, 'day_interval': 3000}",Induction,,3.0,4.0,iRECIST,Immune partial response (iPR),4.0,Patient choice (stopped or interrupted treatment),TREATMENT_199,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_40,Hormonal therapy,No,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 51, 'day_interval': 1530}",Maintenance,Forensic,7.0,3.0,Physician Assessed Response Criteria,Minor response,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_200,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_41,Immunotherapy,,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 85, 'day_interval': 2550}",Induction,Curative,4.0,4.0,iRECIST,"Hematologic relapse (after CR MRD-, CR, CRi)",1.0,Treatment completed as prescribed,TREATMENT_201,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_42,,Yes,,"{'month_interval': 62, 'day_interval': 1860}",,Forensic,,5.0,AML Response Criteria,Physician assessed partial response,3.0,Treatment stopped due to acute toxicity,TREATMENT_202,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_43,Radiation therapy|Other targeting molecular therapy|Immunotherapy,No,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 75, 'day_interval': 2250}",Advanced/Metastatic,Preventive,1.0,,Blazer score,Major response,,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_203,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_44,Photodynamic therapy|Immunotherapy|Bone marrow transplant,Unknown,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 81, 'day_interval': 2430}",Induction,Forensic,1.0,4.0,iRECIST,No evidence of disease (NED),,Treatment completed as prescribed,TREATMENT_204,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_45,Surgery,No,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 93, 'day_interval': 2790}",Adjuvant,Supportive,4.0,5.0,Cheson CLL 2012 Oncology Response Criteria,,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_205,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_46,,Unknown,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 58, 'day_interval': 1740}",,Preventive,4.0,5.0,Response Assessment in Neuro-Oncology (RANO),Complete remission without measurable residual disease (CR MRD-),4.0,Other,TREATMENT_206,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_47,Immunotherapy|Stem cell transplant|Bone marrow transplant,Unknown,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 71, 'day_interval': 2130}",Salvage,Supportive,4.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Immune complete response (iCR),,Not applicable,TREATMENT_207,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_48,Immunotherapy|No treatment,,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 84, 'day_interval': 2520}",Induction,Guidance,7.0,3.0,Response Assessment in Neuro-Oncology (RANO),Minor response,5.0,Treatment stopped due to acute toxicity,TREATMENT_208,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_49,,Yes,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 63, 'day_interval': 1890}",Salvage,Screening,5.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Major response,3.0,Treatment completed as prescribed,TREATMENT_209,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_50,Surgery,Unknown,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 79, 'day_interval': 2370}",Advanced/Metastatic,Supportive,2.0,,Response Assessment in Neuro-Oncology (RANO),,1.0,Other,TREATMENT_210,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_51,,Unknown,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 64, 'day_interval': 1920}",Locally advanced,Curative,4.0,5.0,Physician Assessed Response Criteria,Progressive disease,,Patient choice (stopped or interrupted treatment),TREATMENT_211,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_52,Photodynamic therapy|No treatment,No,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 87, 'day_interval': 2610}",Mobilization,Palliative,7.0,3.0,iRECIST,Morphologic leukemia-free state,3.0,Physician decision (stopped or interrupted treatment),TREATMENT_212,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_53,Surgery|Bone marrow transplant,Yes,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 56, 'day_interval': 1680}",Adjuvant,Palliative,1.0,4.0,AML Response Criteria,Morphologic leukemia-free state,2.0,Not applicable,TREATMENT_213,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_54,,,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 57, 'day_interval': 1710}",Advanced/Metastatic,Supportive,2.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Partial response,4.0,,TREATMENT_214,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_55,Stem cell transplant,Yes,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 67, 'day_interval': 2010}",Preventative,Diagnostic,6.0,3.0,,Minor response,5.0,Treatment stopped due to acute toxicity,TREATMENT_215,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_56,Immunotherapy|Photodynamic therapy,Unknown,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 84, 'day_interval': 2520}",Mobilization,Palliative,3.0,4.0,Blazer score,Major response,1.0,,TREATMENT_216,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_57,Photodynamic therapy|No treatment,Yes,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 51, 'day_interval': 1530}",Conditioning,,7.0,3.0,RECIST 1.1,Physician assessed stable disease,,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_217,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_58,No treatment|Hormonal therapy,Yes,,,Radiosensitization,Forensic,2.0,3.0,RECIST 1.1,Complete response,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_218,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_59,Chemotherapy|Bone marrow transplant|No treatment,Yes,,"{'month_interval': 54, 'day_interval': 1620}",Induction,,5.0,3.0,AML Response Criteria,,,Unknown,TREATMENT_219,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_60,Radiation therapy|Bone marrow transplant,No,"{'month_interval': 5, 'day_interval': 150}",,Radiosensitization,,6.0,4.0,AML Response Criteria,,3.0,Other,TREATMENT_220,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_61,Immunotherapy|Hormonal therapy|Chemotherapy,No,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 68, 'day_interval': 2040}",Locally advanced,Palliative,2.0,5.0,Response Assessment in Neuro-Oncology (RANO),No evidence of disease (NED),5.0,Treatment incomplete due to technical or organizational problems,TREATMENT_221,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_62,Hormonal therapy|Photodynamic therapy|Surgery,Unknown,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 95, 'day_interval': 2850}",Conditioning,Forensic,7.0,3.0,,Physician assessed complete response,,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_222,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_63,Stem cell transplant|No treatment|Hormonal therapy,,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 86, 'day_interval': 2580}",Maintenance,Preventive,6.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Minor response,4.0,,TREATMENT_223,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_64,Radiation therapy,Yes,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 86, 'day_interval': 2580}",Neoadjuvant,,,5.0,RECIST 1.1,Complete response,1.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_224,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_65,Immunotherapy,Unknown,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 100, 'day_interval': 3000}",Radiosensitization,Curative,2.0,,Cheson CLL 2012 Oncology Response Criteria,No evidence of disease (NED),2.0,,TREATMENT_225,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_66,Photodynamic therapy|Other targeting molecular therapy,No,"{'month_interval': 14, 'day_interval': 420}",,Radiosensitization,Forensic,,4.0,Physician Assessed Response Criteria,Immune confirmed progressive disease (iCPD),2.0,Treatment incomplete due to technical or organizational problems,TREATMENT_226,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_67,,,,"{'month_interval': 56, 'day_interval': 1680}",Locally advanced,,5.0,3.0,Blazer score,Progressive disease,2.0,Treatment completed as prescribed,TREATMENT_227,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_68,Chemotherapy,Yes,"{'month_interval': 44, 'day_interval': 1320}","{'month_interval': 70, 'day_interval': 2100}",Induction,Screening,3.0,5.0,RECIST 1.1,Minor response,2.0,Not applicable,TREATMENT_228,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_69,Surgery,No,"{'month_interval': 41, 'day_interval': 1230}","{'month_interval': 74, 'day_interval': 2220}",Locally advanced,Supportive,1.0,3.0,AML Response Criteria,Physician assessed complete response,2.0,Treatment completed as prescribed,TREATMENT_229,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_70,Bone marrow transplant|Immunotherapy|Surgery,No,,,Radiosensitization,Preventive,2.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Physician assessed partial response,2.0,Patient choice (stopped or interrupted treatment),TREATMENT_230,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_71,,,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 85, 'day_interval': 2550}",Advanced/Metastatic,Preventive,6.0,,Physician Assessed Response Criteria,,1.0,,TREATMENT_231,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_72,,Yes,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 90, 'day_interval': 2700}",Advanced/Metastatic,,6.0,5.0,,Immune stable disease (iSD),2.0,,TREATMENT_232,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_73,Hormonal therapy|Photodynamic therapy,Unknown,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 87, 'day_interval': 2610}",Radiosensitization,Palliative,3.0,5.0,Response Assessment in Neuro-Oncology (RANO),,4.0,Physician decision (stopped or interrupted treatment),TREATMENT_233,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_74,Radiation therapy|Chemotherapy,Yes,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 59, 'day_interval': 1770}",Preventative,Curative,5.0,4.0,Cheson CLL 2012 Oncology Response Criteria,No evidence of disease (NED),2.0,Treatment incomplete because patient died,TREATMENT_234,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_75,Chemotherapy,Unknown,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 64, 'day_interval': 1920}",Adjuvant,Preventive,4.0,,Cheson CLL 2012 Oncology Response Criteria,Minor response,2.0,,TREATMENT_235,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_76,,Yes,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 63, 'day_interval': 1890}",Induction,Curative,2.0,,Response Assessment in Neuro-Oncology (RANO),,,Patient choice (stopped or interrupted treatment),TREATMENT_236,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_77,,No,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 53, 'day_interval': 1590}",,Forensic,2.0,3.0,RECIST 1.1,Stable disease,4.0,Treatment incomplete because patient died,TREATMENT_237,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_78,,Unknown,,"{'month_interval': 93, 'day_interval': 2790}",Induction,Preventive,3.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Partial response,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_238,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_79,Radiation therapy,Unknown,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 89, 'day_interval': 2670}",Induction,Guidance,3.0,,AML Response Criteria,Complete remission with incomplete hematologic recovery (CRi),2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_239,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_80,Surgery,Yes,"{'month_interval': 39, 'day_interval': 1170}","{'month_interval': 100, 'day_interval': 3000}",Maintenance,Supportive,7.0,3.0,,Partial remission,5.0,Patient choice (stopped or interrupted treatment),TREATMENT_240,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_81,Surgery|Chemotherapy|Bone marrow transplant,No,"{'month_interval': 1, 'day_interval': 30}",,Conditioning,Guidance,,3.0,iRECIST,Partial response,1.0,Other,TREATMENT_241,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_82,Bone marrow transplant|Hormonal therapy|Chemotherapy,Yes,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 60, 'day_interval': 1800}",Advanced/Metastatic,Screening,3.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Minor response,5.0,Unknown,TREATMENT_242,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_83,Radiation therapy|Stem cell transplant,Yes,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 85, 'day_interval': 2550}",Neoadjuvant,Curative,,4.0,RECIST 1.1,,3.0,Other,TREATMENT_243,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_84,Radiation therapy|Surgery,No,"{'month_interval': 8, 'day_interval': 240}","{'month_interval': 80, 'day_interval': 2400}",,Palliative,1.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Partial response,3.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_244,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_85,,Yes,,,Neoadjuvant,Curative,,3.0,,Molecular relapse (after CR MRD-),4.0,,TREATMENT_245,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_86,,Unknown,"{'month_interval': 48, 'day_interval': 1440}","{'month_interval': 91, 'day_interval': 2730}",Preventative,Supportive,2.0,5.0,,Immune stable disease (iSD),1.0,Treatment completed as prescribed,TREATMENT_246,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_87,Stem cell transplant,No,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 91, 'day_interval': 2730}",Adjuvant,Guidance,4.0,5.0,Response Assessment in Neuro-Oncology (RANO),,1.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_247,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_88,,No,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 76, 'day_interval': 2280}",,Palliative,5.0,3.0,Physician Assessed Response Criteria,Immune confirmed progressive disease (iCPD),3.0,Treatment completed as prescribed,TREATMENT_248,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_89,Stem cell transplant,Yes,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 61, 'day_interval': 1830}",,Diagnostic,3.0,3.0,,Complete remission without measurable residual disease (CR MRD-),2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_249,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_90,Bone marrow transplant|Photodynamic therapy,,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 92, 'day_interval': 2760}",Mobilization,Forensic,6.0,4.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed partial response,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_250,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_91,Hormonal therapy|Immunotherapy|Other targeting molecular therapy,Unknown,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 97, 'day_interval': 2910}",,Screening,5.0,5.0,Physician Assessed Response Criteria,Complete remission with incomplete hematologic recovery (CRi),3.0,Other,TREATMENT_251,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_92,,Yes,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 68, 'day_interval': 2040}",Neoadjuvant,,2.0,5.0,RECIST 1.1,"Hematologic relapse (after CR MRD-, CR, CRi)",3.0,Physician decision (stopped or interrupted treatment),TREATMENT_252,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_93,Hormonal therapy,Unknown,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 84, 'day_interval': 2520}",Induction,Diagnostic,4.0,5.0,Blazer score,Immune complete response (iCR),1.0,Patient choice (stopped or interrupted treatment),TREATMENT_253,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_94,No treatment|Bone marrow transplant|Radiation therapy,Unknown,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 53, 'day_interval': 1590}",Salvage,Forensic,4.0,,AML Response Criteria,Primary refractory disease,3.0,,TREATMENT_254,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_95,Hormonal therapy|Chemotherapy,,,"{'month_interval': 79, 'day_interval': 2370}",Advanced/Metastatic,Screening,6.0,4.0,Physician Assessed Response Criteria,,5.0,,TREATMENT_255,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_96,Stem cell transplant,Unknown,"{'month_interval': 9, 'day_interval': 270}",,Maintenance,,5.0,4.0,Blazer score,Complete remission without measurable residual disease (CR MRD-),,,TREATMENT_256,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_97,,No,"{'month_interval': 10, 'day_interval': 300}","{'month_interval': 100, 'day_interval': 3000}",Neoadjuvant,Diagnostic,6.0,,Physician Assessed Response Criteria,Complete remission with incomplete hematologic recovery (CRi),5.0,Treatment completed as prescribed,TREATMENT_257,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_98,Chemotherapy|Immunotherapy|Other targeting molecular therapy,Yes,"{'month_interval': 11, 'day_interval': 330}",,Salvage,Supportive,5.0,3.0,,,,,TREATMENT_258,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_99,Immunotherapy|No treatment,Yes,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 50, 'day_interval': 1500}",Advanced/Metastatic,Forensic,3.0,,Physician Assessed Response Criteria,Complete response,3.0,,TREATMENT_259,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_100,Radiation therapy|Photodynamic therapy|Immunotherapy,Unknown,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 53, 'day_interval': 1590}",Radiosensitization,Preventive,5.0,4.0,,Molecular relapse (after CR MRD-),1.0,Physician decision (stopped or interrupted treatment),TREATMENT_260,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_101,No treatment|Hormonal therapy,Unknown,"{'month_interval': 3, 'day_interval': 90}","{'month_interval': 89, 'day_interval': 2670}",Radiosensitization,,7.0,4.0,Response Assessment in Neuro-Oncology (RANO),,3.0,Other,TREATMENT_261,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_102,,No,"{'month_interval': 18, 'day_interval': 540}","{'month_interval': 51, 'day_interval': 1530}",Adjuvant,,4.0,3.0,AML Response Criteria,Partial remission,2.0,Unknown,TREATMENT_262,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_103,Immunotherapy,Yes,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 81, 'day_interval': 2430}",,Preventive,3.0,,Cheson CLL 2012 Oncology Response Criteria,Progressive disease,5.0,,TREATMENT_263,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_104,Photodynamic therapy,No,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 87, 'day_interval': 2610}",,Screening,,3.0,,Morphologic leukemia-free state,5.0,Patient choice (stopped or interrupted treatment),TREATMENT_264,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_105,Stem cell transplant|Radiation therapy|No treatment,Unknown,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 92, 'day_interval': 2760}",Mobilization,Guidance,1.0,,Physician Assessed Response Criteria,,5.0,Treatment incomplete because patient died,TREATMENT_265,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_106,Photodynamic therapy|Radiation therapy,No,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 74, 'day_interval': 2220}",Neoadjuvant,Diagnostic,1.0,4.0,AML Response Criteria,Complete remission,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_266,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_107,No treatment,Unknown,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 94, 'day_interval': 2820}",Induction,Supportive,,5.0,Physician Assessed Response Criteria,Complete response,,Treatment incomplete due to technical or organizational problems,TREATMENT_267,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_108,,Yes,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 51, 'day_interval': 1530}",Salvage,Guidance,7.0,3.0,AML Response Criteria,,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_268,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_109,Bone marrow transplant|Chemotherapy|Immunotherapy,No,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 60, 'day_interval': 1800}",Maintenance,Preventive,,3.0,Blazer score,Progressive disease,5.0,Treatment completed as prescribed,TREATMENT_269,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_110,Immunotherapy|Radiation therapy|Chemotherapy,Unknown,,"{'month_interval': 78, 'day_interval': 2340}",Advanced/Metastatic,,7.0,4.0,iRECIST,Complete response,3.0,Treatment incomplete because patient died,TREATMENT_270,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_111,Surgery,,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 59, 'day_interval': 1770}",Neoadjuvant,Guidance,4.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Complete remission without measurable residual disease (CR MRD-),5.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_271,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_112,Chemotherapy|Other targeting molecular therapy|Surgery,Yes,"{'month_interval': 10, 'day_interval': 300}","{'month_interval': 62, 'day_interval': 1860}",Salvage,Forensic,3.0,5.0,Physician Assessed Response Criteria,Physician assessed complete response,5.0,,TREATMENT_272,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_113,,No,"{'month_interval': 44, 'day_interval': 1320}","{'month_interval': 89, 'day_interval': 2670}",Conditioning,Guidance,2.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Partial remission,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_273,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_114,Chemotherapy|No treatment,Yes,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 50, 'day_interval': 1500}",Neoadjuvant,,,,AML Response Criteria,Major response,,,TREATMENT_274,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_115,Chemotherapy|Other targeting molecular therapy|No treatment,Yes,"{'month_interval': 38, 'day_interval': 1140}",,Conditioning,,2.0,5.0,RECIST 1.1,,3.0,Treatment stopped due to acute toxicity,TREATMENT_275,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_116,,No,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 69, 'day_interval': 2070}",Adjuvant,,2.0,4.0,,Progressive disease,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_276,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_117,Radiation therapy|Immunotherapy|Bone marrow transplant,Yes,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 80, 'day_interval': 2400}",Salvage,Preventive,2.0,5.0,iRECIST,Major response,,Other,TREATMENT_277,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_118,Bone marrow transplant|Chemotherapy,No,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 51, 'day_interval': 1530}",,Diagnostic,5.0,3.0,RECIST 1.1,Partial response,4.0,Other,TREATMENT_278,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_119,,Yes,,"{'month_interval': 59, 'day_interval': 1770}",Advanced/Metastatic,Supportive,2.0,3.0,AML Response Criteria,Minor response,3.0,,TREATMENT_279,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_120,,Yes,,"{'month_interval': 75, 'day_interval': 2250}",Induction,Screening,1.0,4.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed stable disease,3.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_280,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_121,No treatment,No,,,Conditioning,Preventive,6.0,5.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed stable disease,1.0,Not applicable,TREATMENT_281,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_122,,No,,"{'month_interval': 60, 'day_interval': 1800}",Radiosensitization,Screening,5.0,3.0,iRECIST,,1.0,Unknown,TREATMENT_282,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_123,Hormonal therapy|Chemotherapy,Unknown,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 85, 'day_interval': 2550}",Locally advanced,Forensic,7.0,3.0,AML Response Criteria,Primary refractory disease,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_283,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_124,Chemotherapy|Bone marrow transplant,Unknown,,"{'month_interval': 67, 'day_interval': 2010}",Induction,Curative,,3.0,,Complete response,4.0,,TREATMENT_284,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_125,Photodynamic therapy|Bone marrow transplant|Stem cell transplant,Yes,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 94, 'day_interval': 2820}",Locally advanced,Forensic,6.0,3.0,iRECIST,Primary refractory disease,2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_285,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_126,Hormonal therapy|Radiation therapy,Unknown,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 51, 'day_interval': 1530}",Advanced/Metastatic,Palliative,1.0,3.0,AML Response Criteria,Morphologic leukemia-free state,2.0,Other,TREATMENT_286,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_127,,Unknown,"{'month_interval': 4, 'day_interval': 120}",,Maintenance,Diagnostic,3.0,,Physician Assessed Response Criteria,No evidence of disease (NED),2.0,Treatment incomplete because patient died,TREATMENT_287,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_128,,No,,"{'month_interval': 77, 'day_interval': 2310}",Advanced/Metastatic,Curative,4.0,,Cheson CLL 2012 Oncology Response Criteria,Immune partial response (iPR),1.0,Treatment completed as prescribed,TREATMENT_288,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_129,Bone marrow transplant|No treatment|Photodynamic therapy,No,"{'month_interval': 11, 'day_interval': 330}","{'month_interval': 72, 'day_interval': 2160}",,Diagnostic,,,Blazer score,Minor response,2.0,Treatment stopped due to acute toxicity,TREATMENT_289,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_130,,Unknown,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 78, 'day_interval': 2340}",Advanced/Metastatic,Forensic,7.0,3.0,RECIST 1.1,Partial remission,1.0,Treatment completed as prescribed,TREATMENT_290,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_131,No treatment|Other targeting molecular therapy,No,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 65, 'day_interval': 1950}",,Screening,7.0,4.0,Blazer score,Complete response,1.0,Treatment incomplete because patient died,TREATMENT_291,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_132,Radiation therapy,Yes,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 84, 'day_interval': 2520}",Induction,Screening,4.0,4.0,,Complete remission with incomplete hematologic recovery (CRi),5.0,Physician decision (stopped or interrupted treatment),TREATMENT_292,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_133,,Yes,"{'month_interval': 50, 'day_interval': 1500}",,,Guidance,6.0,,,Stable disease,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_293,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_134,,Yes,,"{'month_interval': 73, 'day_interval': 2190}",Induction,Curative,7.0,4.0,,Complete response,3.0,Not applicable,TREATMENT_294,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_135,,Yes,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 50, 'day_interval': 1500}",,,,3.0,AML Response Criteria,Progressive disease,,,TREATMENT_295,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_136,Radiation therapy|Immunotherapy,No,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 52, 'day_interval': 1560}",Preventative,,7.0,4.0,,,1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_296,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_137,Stem cell transplant|Bone marrow transplant|Radiation therapy,Yes,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 55, 'day_interval': 1650}",,Supportive,3.0,5.0,Response Assessment in Neuro-Oncology (RANO),Immune complete response (iCR),1.0,Patient choice (stopped or interrupted treatment),TREATMENT_297,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_138,Immunotherapy|No treatment,Unknown,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 76, 'day_interval': 2280}",Induction,Screening,6.0,3.0,AML Response Criteria,Major response,2.0,Treatment completed as prescribed,TREATMENT_298,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_139,Radiation therapy|Surgery|Other targeting molecular therapy,No,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 71, 'day_interval': 2130}",Neoadjuvant,Supportive,7.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Physician assessed stable disease,5.0,Treatment incomplete because patient died,TREATMENT_299,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_140,Stem cell transplant,Yes,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 71, 'day_interval': 2130}",Preventative,Palliative,6.0,4.0,,Major response,3.0,Not applicable,TREATMENT_300,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_141,,Yes,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 60, 'day_interval': 1800}",Advanced/Metastatic,Diagnostic,1.0,,Response Assessment in Neuro-Oncology (RANO),Morphologic leukemia-free state,2.0,Not applicable,TREATMENT_301,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_142,No treatment|Chemotherapy,Yes,,,Radiosensitization,Forensic,4.0,5.0,Physician Assessed Response Criteria,Immune uncomfirmed progressive disease (iUPD),2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_302,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_143,Chemotherapy|Other targeting molecular therapy|Surgery,Yes,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 61, 'day_interval': 1830}",Maintenance,Palliative,4.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Immune partial response (iPR),3.0,Unknown,TREATMENT_303,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_144,No treatment,Yes,,"{'month_interval': 67, 'day_interval': 2010}",Maintenance,,5.0,5.0,Response Assessment in Neuro-Oncology (RANO),Partial remission,,Not applicable,TREATMENT_304,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_145,Chemotherapy|No treatment|Immunotherapy,Unknown,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 94, 'day_interval': 2820}",,Diagnostic,4.0,4.0,Physician Assessed Response Criteria,,,Other,TREATMENT_305,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_146,Chemotherapy|Hormonal therapy,Yes,"{'month_interval': 41, 'day_interval': 1230}","{'month_interval': 76, 'day_interval': 2280}",Locally advanced,Screening,3.0,5.0,iRECIST,Immune confirmed progressive disease (iCPD),3.0,Unknown,TREATMENT_306,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_147,Bone marrow transplant|Hormonal therapy|Surgery,Unknown,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 64, 'day_interval': 1920}",,Guidance,7.0,5.0,,Physician assessed stable disease,4.0,Treatment incomplete because patient died,TREATMENT_307,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_148,Stem cell transplant|Other targeting molecular therapy|Bone marrow transplant,No,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 98, 'day_interval': 2940}",Radiosensitization,Screening,,,Physician Assessed Response Criteria,Partial response,1.0,Treatment incomplete because patient died,TREATMENT_308,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_149,Stem cell transplant|Surgery|Immunotherapy,Yes,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 50, 'day_interval': 1500}",Mobilization,Guidance,4.0,5.0,iRECIST,Stable disease,2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_309,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_150,Photodynamic therapy|Immunotherapy|Surgery,No,"{'month_interval': 47, 'day_interval': 1410}",,,Diagnostic,6.0,3.0,RECIST 1.1,Partial response,5.0,Treatment stopped due to acute toxicity,TREATMENT_310,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_151,,Yes,"{'month_interval': 23, 'day_interval': 690}","{'month_interval': 98, 'day_interval': 2940}",Conditioning,Supportive,7.0,4.0,RECIST 1.1,Stable disease,3.0,Treatment incomplete due to technical or organizational problems,TREATMENT_311,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_152,Surgery,,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 54, 'day_interval': 1620}",Maintenance,Screening,3.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Molecular relapse (after CR MRD-),4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_312,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_153,Chemotherapy,Unknown,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 73, 'day_interval': 2190}",Salvage,Supportive,1.0,5.0,,Morphologic leukemia-free state,4.0,Not applicable,TREATMENT_313,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_154,Other targeting molecular therapy|Immunotherapy|Radiation therapy,No,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 55, 'day_interval': 1650}",Advanced/Metastatic,Preventive,7.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Minor response,5.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_314,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_155,Bone marrow transplant|Hormonal therapy,Unknown,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 51, 'day_interval': 1530}",Adjuvant,Diagnostic,,5.0,AML Response Criteria,Immune complete response (iCR),1.0,Patient choice (stopped or interrupted treatment),TREATMENT_315,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_156,Photodynamic therapy|Radiation therapy|Stem cell transplant,Unknown,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 80, 'day_interval': 2400}",,Guidance,1.0,5.0,Physician Assessed Response Criteria,Complete remission without measurable residual disease (CR MRD-),5.0,Treatment incomplete due to technical or organizational problems,TREATMENT_316,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_157,,Yes,"{'month_interval': 4, 'day_interval': 120}","{'month_interval': 61, 'day_interval': 1830}",Maintenance,Forensic,5.0,5.0,Blazer score,Major response,5.0,,TREATMENT_317,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_158,Photodynamic therapy|Bone marrow transplant,Unknown,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 95, 'day_interval': 2850}",Maintenance,Curative,7.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Immune uncomfirmed progressive disease (iUPD),3.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_318,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_159,,Yes,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 65, 'day_interval': 1950}",Adjuvant,,5.0,3.0,Blazer score,Immune confirmed progressive disease (iCPD),1.0,Physician decision (stopped or interrupted treatment),TREATMENT_319,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_160,Hormonal therapy|Radiation therapy,Unknown,"{'month_interval': 34, 'day_interval': 1020}",,,Preventive,1.0,4.0,Blazer score,,3.0,Treatment stopped due to acute toxicity,TREATMENT_320,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_1,Other targeting molecular therapy,,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 85, 'day_interval': 2550}",Preventative,Forensic,,4.0,AML Response Criteria,,1.0,Other,TREATMENT_321,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_2,Stem cell transplant|Hormonal therapy|Surgery,No,,"{'month_interval': 71, 'day_interval': 2130}",Radiosensitization,Curative,3.0,,AML Response Criteria,,,Not applicable,TREATMENT_322,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_3,Surgery|Other targeting molecular therapy,Unknown,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 85, 'day_interval': 2550}",Maintenance,Screening,7.0,,Response Assessment in Neuro-Oncology (RANO),Progressive disease,,Not applicable,TREATMENT_323,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_4,Radiation therapy|Surgery|Photodynamic therapy,Unknown,"{'month_interval': 4, 'day_interval': 120}","{'month_interval': 76, 'day_interval': 2280}",Induction,,2.0,,,Immune stable disease (iSD),4.0,,TREATMENT_324,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_5,Hormonal therapy|Radiation therapy,No,"{'month_interval': 11, 'day_interval': 330}",,Mobilization,Guidance,,5.0,Physician Assessed Response Criteria,,4.0,,TREATMENT_325,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_6,Immunotherapy|Surgery,Yes,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 54, 'day_interval': 1620}",,Forensic,3.0,3.0,RECIST 1.1,Partial remission,4.0,Not applicable,TREATMENT_326,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_7,,Yes,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 68, 'day_interval': 2040}",Induction,Screening,5.0,3.0,Physician Assessed Response Criteria,,1.0,Treatment stopped due to acute toxicity,TREATMENT_327,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_8,,Yes,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 93, 'day_interval': 2790}",Locally advanced,Diagnostic,1.0,,Cheson CLL 2012 Oncology Response Criteria,Partial remission,2.0,Physician decision (stopped or interrupted treatment),TREATMENT_328,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_9,Surgery|No treatment,Yes,"{'month_interval': 11, 'day_interval': 330}",,,Diagnostic,1.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Stable disease,,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_329,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_10,Other targeting molecular therapy|Surgery|Stem cell transplant,Unknown,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 67, 'day_interval': 2010}",Locally advanced,Diagnostic,4.0,4.0,RECIST 1.1,,1.0,Treatment incomplete because patient died,TREATMENT_330,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_11,Hormonal therapy,No,"{'month_interval': 15, 'day_interval': 450}",,Preventative,,2.0,5.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed complete response,1.0,Unknown,TREATMENT_331,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_12,,Yes,"{'month_interval': 18, 'day_interval': 540}","{'month_interval': 72, 'day_interval': 2160}",Locally advanced,Diagnostic,6.0,3.0,Physician Assessed Response Criteria,Immune stable disease (iSD),1.0,Unknown,TREATMENT_332,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_13,,No,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 70, 'day_interval': 2100}",,Forensic,3.0,5.0,Blazer score,,,Treatment completed as prescribed,TREATMENT_333,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_14,No treatment|Bone marrow transplant,Unknown,,,Radiosensitization,Diagnostic,3.0,4.0,AML Response Criteria,,1.0,Treatment completed as prescribed,TREATMENT_334,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_15,Surgery|No treatment|Stem cell transplant,No,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 72, 'day_interval': 2160}",,Forensic,,3.0,iRECIST,Immune complete response (iCR),3.0,Treatment incomplete because patient died,TREATMENT_335,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_16,Surgery,Yes,"{'month_interval': 41, 'day_interval': 1230}",,Preventative,Palliative,6.0,,AML Response Criteria,Complete response,5.0,Treatment incomplete because patient died,TREATMENT_336,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_17,Photodynamic therapy|Immunotherapy|Bone marrow transplant,No,"{'month_interval': 9, 'day_interval': 270}","{'month_interval': 56, 'day_interval': 1680}",Mobilization,Supportive,4.0,5.0,,Minor response,2.0,Not applicable,TREATMENT_337,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_18,No treatment|Other targeting molecular therapy|Radiation therapy,Unknown,,"{'month_interval': 93, 'day_interval': 2790}",Neoadjuvant,Curative,3.0,,Blazer score,Complete remission with incomplete hematologic recovery (CRi),4.0,,TREATMENT_338,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_19,Immunotherapy|Hormonal therapy,Unknown,"{'month_interval': 40, 'day_interval': 1200}",,Salvage,Forensic,3.0,5.0,Response Assessment in Neuro-Oncology (RANO),,3.0,Treatment stopped due to acute toxicity,TREATMENT_339,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_20,Hormonal therapy|Other targeting molecular therapy|Radiation therapy,Yes,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 73, 'day_interval': 2190}",,Diagnostic,3.0,3.0,AML Response Criteria,Immune complete response (iCR),4.0,Physician decision (stopped or interrupted treatment),TREATMENT_340,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_21,Photodynamic therapy,Unknown,,"{'month_interval': 75, 'day_interval': 2250}",Advanced/Metastatic,Forensic,3.0,4.0,,Immune complete response (iCR),,Treatment stopped due to acute toxicity,TREATMENT_341,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_22,Other targeting molecular therapy|Stem cell transplant,Yes,,"{'month_interval': 95, 'day_interval': 2850}",Adjuvant,Palliative,5.0,3.0,Cheson CLL 2012 Oncology Response Criteria,,2.0,Not applicable,TREATMENT_342,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_23,Immunotherapy|Chemotherapy,No,"{'month_interval': 43, 'day_interval': 1290}",,Mobilization,Curative,4.0,4.0,iRECIST,Physician assessed partial response,1.0,,TREATMENT_343,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_24,,Unknown,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 89, 'day_interval': 2670}",Conditioning,Palliative,4.0,4.0,RECIST 1.1,Complete response,5.0,Treatment completed as prescribed,TREATMENT_344,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_25,No treatment|Immunotherapy|Hormonal therapy,Unknown,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 61, 'day_interval': 1830}",Conditioning,Preventive,1.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Progressive disease,5.0,Not applicable,TREATMENT_345,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_26,,,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 89, 'day_interval': 2670}",,,2.0,,Response Assessment in Neuro-Oncology (RANO),Minor response,4.0,Physician decision (stopped or interrupted treatment),TREATMENT_346,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_27,Radiation therapy|Photodynamic therapy,Unknown,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 60, 'day_interval': 1800}",Radiosensitization,Preventive,3.0,5.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed stable disease,5.0,Treatment incomplete because patient died,TREATMENT_347,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_28,No treatment|Surgery|Other targeting molecular therapy,Unknown,"{'month_interval': 26, 'day_interval': 780}",,Advanced/Metastatic,Curative,2.0,,,Immune complete response (iCR),3.0,Patient choice (stopped or interrupted treatment),TREATMENT_348,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_29,,Unknown,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 69, 'day_interval': 2070}",Induction,Preventive,,4.0,Response Assessment in Neuro-Oncology (RANO),Immune stable disease (iSD),,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_349,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_30,,Unknown,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 90, 'day_interval': 2700}",Salvage,Diagnostic,5.0,5.0,AML Response Criteria,,,,TREATMENT_350,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_31,Chemotherapy|No treatment,Yes,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 69, 'day_interval': 2070}",,,1.0,4.0,RECIST 1.1,Morphologic leukemia-free state,5.0,Other,TREATMENT_351,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_32,Other targeting molecular therapy|No treatment|Radiation therapy,Yes,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 76, 'day_interval': 2280}",Mobilization,Palliative,6.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Stable disease,,Patient choice (stopped or interrupted treatment),TREATMENT_352,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_33,Other targeting molecular therapy|Radiation therapy,,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 61, 'day_interval': 1830}",Adjuvant,Curative,6.0,4.0,Physician Assessed Response Criteria,Physician assessed stable disease,,Treatment incomplete due to technical or organizational problems,TREATMENT_353,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_34,Stem cell transplant|Hormonal therapy,No,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 74, 'day_interval': 2220}",Advanced/Metastatic,Forensic,,5.0,Cheson CLL 2012 Oncology Response Criteria,Immune partial response (iPR),1.0,,TREATMENT_354,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_35,Bone marrow transplant,No,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 72, 'day_interval': 2160}",Adjuvant,,3.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Physician assessed partial response,3.0,Not applicable,TREATMENT_355,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_36,Stem cell transplant|Surgery,Unknown,,"{'month_interval': 50, 'day_interval': 1500}",Adjuvant,,7.0,4.0,Response Assessment in Neuro-Oncology (RANO),Major response,4.0,Other,TREATMENT_356,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_37,No treatment,Unknown,"{'month_interval': 35, 'day_interval': 1050}",,Induction,Screening,6.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Immune stable disease (iSD),2.0,,TREATMENT_357,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_38,Photodynamic therapy|Stem cell transplant|Bone marrow transplant,Yes,"{'month_interval': 4, 'day_interval': 120}","{'month_interval': 64, 'day_interval': 1920}",Advanced/Metastatic,Supportive,3.0,,Response Assessment in Neuro-Oncology (RANO),Immune partial response (iPR),5.0,Patient choice (stopped or interrupted treatment),TREATMENT_358,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_39,Radiation therapy|No treatment,No,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 92, 'day_interval': 2760}",Induction,Guidance,5.0,5.0,RECIST 1.1,"Hematologic relapse (after CR MRD-, CR, CRi)",3.0,Physician decision (stopped or interrupted treatment),TREATMENT_359,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_40,Other targeting molecular therapy,Unknown,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 52, 'day_interval': 1560}",Neoadjuvant,Forensic,2.0,4.0,,,1.0,Treatment stopped due to acute toxicity,TREATMENT_360,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_41,Stem cell transplant|Photodynamic therapy,No,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 73, 'day_interval': 2190}",Radiosensitization,Curative,,4.0,Cheson CLL 2012 Oncology Response Criteria,Minor response,4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_361,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_42,Immunotherapy,No,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 51, 'day_interval': 1530}",Neoadjuvant,Supportive,3.0,4.0,AML Response Criteria,Immune uncomfirmed progressive disease (iUPD),3.0,Treatment incomplete because patient died,TREATMENT_362,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_43,Surgery|Bone marrow transplant,Unknown,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 59, 'day_interval': 1770}",Preventative,Guidance,,3.0,RECIST 1.1,"Hematologic relapse (after CR MRD-, CR, CRi)",,Treatment incomplete because patient died,TREATMENT_363,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_44,Immunotherapy|Photodynamic therapy|Radiation therapy,No,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 70, 'day_interval': 2100}",Advanced/Metastatic,Curative,3.0,,RECIST 1.1,Physician assessed partial response,,Patient choice (stopped or interrupted treatment),TREATMENT_364,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_45,,Unknown,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 60, 'day_interval': 1800}",Preventative,Screening,6.0,4.0,,Major response,,Treatment completed as prescribed,TREATMENT_365,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_46,Chemotherapy|Bone marrow transplant|Hormonal therapy,Yes,"{'month_interval': 18, 'day_interval': 540}","{'month_interval': 59, 'day_interval': 1770}",Conditioning,Screening,2.0,4.0,iRECIST,Minor response,,,TREATMENT_366,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_47,Bone marrow transplant,Yes,"{'month_interval': 14, 'day_interval': 420}","{'month_interval': 80, 'day_interval': 2400}",Radiosensitization,,4.0,3.0,iRECIST,Minor response,4.0,Physician decision (stopped or interrupted treatment),TREATMENT_367,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_48,Bone marrow transplant|Photodynamic therapy,Yes,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 77, 'day_interval': 2310}",Radiosensitization,,1.0,4.0,Physician Assessed Response Criteria,Immune uncomfirmed progressive disease (iUPD),1.0,Treatment completed as prescribed,TREATMENT_368,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_49,,No,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 62, 'day_interval': 1860}",Advanced/Metastatic,Palliative,3.0,,iRECIST,,4.0,Not applicable,TREATMENT_369,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_50,Other targeting molecular therapy|Photodynamic therapy,No,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 77, 'day_interval': 2310}",Induction,Palliative,4.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Complete remission,,Unknown,TREATMENT_370,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_51,,Yes,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 68, 'day_interval': 2040}",Mobilization,Screening,7.0,3.0,,Minor response,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_371,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_52,,,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 76, 'day_interval': 2280}",Induction,,3.0,,Blazer score,Stable disease,1.0,,TREATMENT_372,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_53,No treatment|Bone marrow transplant,Unknown,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 60, 'day_interval': 1800}",Advanced/Metastatic,Guidance,5.0,5.0,Cheson CLL 2012 Oncology Response Criteria,,2.0,Treatment incomplete due to technical or organizational problems,TREATMENT_373,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_54,Hormonal therapy|Chemotherapy,Yes,"{'month_interval': 48, 'day_interval': 1440}","{'month_interval': 73, 'day_interval': 2190}",Conditioning,Diagnostic,2.0,5.0,Blazer score,No evidence of disease (NED),,Unknown,TREATMENT_374,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_55,Radiation therapy|Photodynamic therapy|No treatment,Yes,"{'month_interval': 28, 'day_interval': 840}",,Preventative,Preventive,4.0,3.0,,Immune uncomfirmed progressive disease (iUPD),,Other,TREATMENT_375,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_56,Surgery,Yes,,"{'month_interval': 56, 'day_interval': 1680}",Preventative,,4.0,4.0,Response Assessment in Neuro-Oncology (RANO),Minor response,4.0,Other,TREATMENT_376,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_57,Other targeting molecular therapy|Stem cell transplant|Photodynamic therapy,Yes,"{'month_interval': 10, 'day_interval': 300}","{'month_interval': 51, 'day_interval': 1530}",Induction,Diagnostic,5.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Major response,1.0,Other,TREATMENT_377,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_58,Radiation therapy,,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 50, 'day_interval': 1500}",,,2.0,3.0,AML Response Criteria,Minor response,4.0,Treatment stopped due to acute toxicity,TREATMENT_378,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_59,Stem cell transplant|Hormonal therapy|Bone marrow transplant,Yes,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 70, 'day_interval': 2100}",Induction,Palliative,2.0,,iRECIST,Primary refractory disease,3.0,,TREATMENT_379,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_60,Radiation therapy,Unknown,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 62, 'day_interval': 1860}",Salvage,Screening,6.0,,,Partial remission,2.0,Not applicable,TREATMENT_380,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_61,,No,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 79, 'day_interval': 2370}",Salvage,Screening,3.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Complete response,3.0,,TREATMENT_381,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_62,No treatment|Chemotherapy,Unknown,"{'month_interval': 35, 'day_interval': 1050}",,,Curative,,,Cheson CLL 2012 Oncology Response Criteria,Molecular relapse (after CR MRD-),4.0,Treatment completed as prescribed,TREATMENT_382,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_63,No treatment,Unknown,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 94, 'day_interval': 2820}",Conditioning,Preventive,1.0,4.0,RECIST 1.1,Immune uncomfirmed progressive disease (iUPD),1.0,Not applicable,TREATMENT_383,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_64,Immunotherapy|Hormonal therapy|Other targeting molecular therapy,Unknown,"{'month_interval': 31, 'day_interval': 930}",,Salvage,,6.0,3.0,,Minor response,,Treatment incomplete because patient died,TREATMENT_384,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_65,,Unknown,"{'month_interval': 7, 'day_interval': 210}",,,Supportive,,3.0,Cheson CLL 2012 Oncology Response Criteria,Complete response,2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_385,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_66,Other targeting molecular therapy|Radiation therapy|Immunotherapy,Unknown,"{'month_interval': 48, 'day_interval': 1440}","{'month_interval': 53, 'day_interval': 1590}",Salvage,Preventive,3.0,5.0,Blazer score,,4.0,Treatment completed as prescribed,TREATMENT_386,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_67,Photodynamic therapy|Chemotherapy|Other targeting molecular therapy,No,,,Neoadjuvant,Palliative,3.0,5.0,Physician Assessed Response Criteria,Physician assessed partial response,,Physician decision (stopped or interrupted treatment),TREATMENT_387,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_68,No treatment,Unknown,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 60, 'day_interval': 1800}",Neoadjuvant,Palliative,7.0,3.0,Physician Assessed Response Criteria,Morphologic leukemia-free state,,Unknown,TREATMENT_388,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_69,,No,"{'month_interval': 11, 'day_interval': 330}",,,Palliative,3.0,5.0,RECIST 1.1,,5.0,Other,TREATMENT_389,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_70,,No,,"{'month_interval': 73, 'day_interval': 2190}",Radiosensitization,Screening,4.0,4.0,Blazer score,Partial remission,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_390,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_71,Radiation therapy|Hormonal therapy,No,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 64, 'day_interval': 1920}",Mobilization,Guidance,3.0,,RECIST 1.1,Physician assessed complete response,2.0,,TREATMENT_391,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_72,Hormonal therapy|Immunotherapy,Yes,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 72, 'day_interval': 2160}",Neoadjuvant,Diagnostic,1.0,5.0,RECIST 1.1,Immune uncomfirmed progressive disease (iUPD),1.0,,TREATMENT_392,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_73,,No,"{'month_interval': 10, 'day_interval': 300}","{'month_interval': 79, 'day_interval': 2370}",Preventative,Diagnostic,5.0,3.0,,Primary refractory disease,1.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_393,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_74,Stem cell transplant|Bone marrow transplant|Other targeting molecular therapy,No,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 50, 'day_interval': 1500}",,Curative,1.0,4.0,AML Response Criteria,Minor response,3.0,Treatment incomplete because patient died,TREATMENT_394,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_75,No treatment|Surgery,Unknown,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 77, 'day_interval': 2310}",Induction,Forensic,,4.0,Blazer score,Complete remission without measurable residual disease (CR MRD-),,Treatment incomplete due to technical or organizational problems,TREATMENT_395,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_76,Photodynamic therapy|Radiation therapy,No,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 77, 'day_interval': 2310}",Salvage,,2.0,4.0,RECIST 1.1,Progressive disease,1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_396,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_77,Immunotherapy|Hormonal therapy|Other targeting molecular therapy,No,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 55, 'day_interval': 1650}",Salvage,Palliative,,4.0,AML Response Criteria,Primary refractory disease,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_397,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_78,Chemotherapy|Other targeting molecular therapy,No,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 57, 'day_interval': 1710}",Neoadjuvant,Guidance,1.0,4.0,Response Assessment in Neuro-Oncology (RANO),,,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_398,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_79,No treatment,No,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 57, 'day_interval': 1710}",Locally advanced,Curative,3.0,5.0,Response Assessment in Neuro-Oncology (RANO),Molecular relapse (after CR MRD-),,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_399,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_80,No treatment,Unknown,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 52, 'day_interval': 1560}",Preventative,Forensic,3.0,5.0,Physician Assessed Response Criteria,Partial remission,4.0,Not applicable,TREATMENT_400,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_81,No treatment|Photodynamic therapy|Chemotherapy,No,"{'month_interval': 28, 'day_interval': 840}",,Locally advanced,Supportive,,,,Progressive disease,,Treatment incomplete because patient died,TREATMENT_401,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_82,Stem cell transplant,Unknown,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 94, 'day_interval': 2820}",Mobilization,Screening,4.0,,Response Assessment in Neuro-Oncology (RANO),Stable disease,3.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_402,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_83,No treatment|Photodynamic therapy,Yes,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 74, 'day_interval': 2220}",,Diagnostic,1.0,4.0,Blazer score,,1.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_403,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_84,No treatment,Yes,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 68, 'day_interval': 2040}",,Guidance,6.0,5.0,iRECIST,,4.0,Other,TREATMENT_404,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_85,No treatment|Other targeting molecular therapy|Bone marrow transplant,No,"{'month_interval': 1, 'day_interval': 30}",,Neoadjuvant,,5.0,4.0,AML Response Criteria,Primary refractory disease,,Patient choice (stopped or interrupted treatment),TREATMENT_405,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_86,Bone marrow transplant|Radiation therapy,Yes,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 74, 'day_interval': 2220}",Locally advanced,,2.0,3.0,Physician Assessed Response Criteria,Progressive disease,2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_406,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_87,Immunotherapy|Other targeting molecular therapy|Bone marrow transplant,No,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 97, 'day_interval': 2910}",,,5.0,5.0,Physician Assessed Response Criteria,Stable disease,1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_407,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_88,Bone marrow transplant|Chemotherapy|Immunotherapy,Yes,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 75, 'day_interval': 2250}",Conditioning,Supportive,7.0,3.0,Response Assessment in Neuro-Oncology (RANO),Complete remission,2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_408,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_89,Surgery|No treatment,Unknown,"{'month_interval': 3, 'day_interval': 90}",,Neoadjuvant,Diagnostic,3.0,4.0,Cheson CLL 2012 Oncology Response Criteria,"Hematologic relapse (after CR MRD-, CR, CRi)",,Patient choice (stopped or interrupted treatment),TREATMENT_409,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_90,Surgery|Bone marrow transplant|Radiation therapy,Yes,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 54, 'day_interval': 1620}",Conditioning,Curative,3.0,5.0,Response Assessment in Neuro-Oncology (RANO),Primary refractory disease,1.0,Treatment incomplete because patient died,TREATMENT_410,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_91,Radiation therapy,No,,"{'month_interval': 70, 'day_interval': 2100}",,Guidance,4.0,4.0,Cheson CLL 2012 Oncology Response Criteria,,4.0,Treatment completed as prescribed,TREATMENT_411,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_92,Radiation therapy|Other targeting molecular therapy,Yes,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 79, 'day_interval': 2370}",Salvage,,2.0,3.0,AML Response Criteria,,5.0,Not applicable,TREATMENT_412,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_93,Immunotherapy|No treatment|Surgery,No,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 90, 'day_interval': 2700}",Advanced/Metastatic,Guidance,6.0,4.0,Physician Assessed Response Criteria,Morphologic leukemia-free state,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_413,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_94,Other targeting molecular therapy|Immunotherapy,Yes,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 87, 'day_interval': 2610}",Maintenance,Forensic,1.0,,,Complete response,,Physician decision (stopped or interrupted treatment),TREATMENT_414,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_95,Bone marrow transplant,Yes,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 69, 'day_interval': 2070}",Induction,,6.0,,Physician Assessed Response Criteria,No evidence of disease (NED),4.0,Treatment completed as prescribed,TREATMENT_415,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_96,No treatment|Photodynamic therapy,Yes,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 65, 'day_interval': 1950}",Conditioning,Guidance,5.0,,Physician Assessed Response Criteria,Complete response,,Not applicable,TREATMENT_416,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_97,Radiation therapy,No,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 100, 'day_interval': 3000}",Maintenance,Forensic,4.0,4.0,Physician Assessed Response Criteria,Molecular relapse (after CR MRD-),1.0,Physician decision (stopped or interrupted treatment),TREATMENT_417,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_98,Chemotherapy|Stem cell transplant,No,"{'month_interval': 29, 'day_interval': 870}",,Advanced/Metastatic,Supportive,4.0,5.0,AML Response Criteria,Physician assessed stable disease,,,TREATMENT_418,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_99,,Yes,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 76, 'day_interval': 2280}",Preventative,Guidance,7.0,4.0,AML Response Criteria,Stable disease,1.0,Unknown,TREATMENT_419,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_100,Surgery,Unknown,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 72, 'day_interval': 2160}",Induction,Preventive,,4.0,Cheson CLL 2012 Oncology Response Criteria,,,Treatment incomplete due to technical or organizational problems,TREATMENT_420,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_101,Stem cell transplant,Unknown,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 81, 'day_interval': 2430}",Adjuvant,Diagnostic,4.0,5.0,RECIST 1.1,Physician assessed partial response,4.0,Other,TREATMENT_421,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_102,Photodynamic therapy,Yes,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 53, 'day_interval': 1590}",,Diagnostic,3.0,5.0,Response Assessment in Neuro-Oncology (RANO),Molecular relapse (after CR MRD-),,Other,TREATMENT_422,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_103,Photodynamic therapy|Chemotherapy,No,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 59, 'day_interval': 1770}",Induction,Forensic,,4.0,Physician Assessed Response Criteria,Complete remission without measurable residual disease (CR MRD-),4.0,Physician decision (stopped or interrupted treatment),TREATMENT_423,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_104,Hormonal therapy|Photodynamic therapy,Yes,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 59, 'day_interval': 1770}",Conditioning,Curative,2.0,,Response Assessment in Neuro-Oncology (RANO),Complete remission,3.0,Treatment completed as prescribed,TREATMENT_424,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_105,Other targeting molecular therapy|Chemotherapy|Radiation therapy,No,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 53, 'day_interval': 1590}",Mobilization,Screening,4.0,,Response Assessment in Neuro-Oncology (RANO),Complete remission without measurable residual disease (CR MRD-),,Treatment stopped due to acute toxicity,TREATMENT_425,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_106,Photodynamic therapy|Chemotherapy|Immunotherapy,Unknown,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 68, 'day_interval': 2040}",Mobilization,Preventive,7.0,3.0,RECIST 1.1,"Hematologic relapse (after CR MRD-, CR, CRi)",1.0,Not applicable,TREATMENT_426,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_107,,No,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 70, 'day_interval': 2100}",Locally advanced,Forensic,7.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Major response,2.0,Treatment incomplete because patient died,TREATMENT_427,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_108,Chemotherapy|Photodynamic therapy|Stem cell transplant,,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 90, 'day_interval': 2700}",Locally advanced,Preventive,1.0,5.0,AML Response Criteria,Minor response,5.0,Other,TREATMENT_428,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_109,Bone marrow transplant|Stem cell transplant,No,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 78, 'day_interval': 2340}",Advanced/Metastatic,Curative,3.0,3.0,Blazer score,Partial response,5.0,Treatment completed as prescribed,TREATMENT_429,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_110,,No,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 59, 'day_interval': 1770}",Conditioning,Guidance,5.0,,iRECIST,Partial response,,Unknown,TREATMENT_430,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_111,Stem cell transplant|No treatment,Yes,"{'month_interval': 30, 'day_interval': 900}",,Mobilization,Screening,6.0,3.0,Response Assessment in Neuro-Oncology (RANO),Immune partial response (iPR),2.0,Other,TREATMENT_431,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_112,Photodynamic therapy,No,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 99, 'day_interval': 2970}",,Preventive,1.0,5.0,Blazer score,Molecular relapse (after CR MRD-),1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_432,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_113,Hormonal therapy,Yes,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 81, 'day_interval': 2430}",Advanced/Metastatic,Diagnostic,4.0,4.0,AML Response Criteria,Complete response,,Treatment incomplete because patient died,TREATMENT_433,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_114,,No,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 82, 'day_interval': 2460}",Advanced/Metastatic,Guidance,,5.0,Cheson CLL 2012 Oncology Response Criteria,,4.0,Physician decision (stopped or interrupted treatment),TREATMENT_434,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_115,No treatment|Immunotherapy,,"{'month_interval': 43, 'day_interval': 1290}",,Adjuvant,Diagnostic,7.0,,Cheson CLL 2012 Oncology Response Criteria,Major response,4.0,Other,TREATMENT_435,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_116,Bone marrow transplant|Chemotherapy|No treatment,No,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 92, 'day_interval': 2760}",Mobilization,Screening,4.0,5.0,RECIST 1.1,Complete remission without measurable residual disease (CR MRD-),5.0,Unknown,TREATMENT_436,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_117,Bone marrow transplant|Immunotherapy|Photodynamic therapy,Yes,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 62, 'day_interval': 1860}",Adjuvant,Screening,5.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Immune uncomfirmed progressive disease (iUPD),3.0,Unknown,TREATMENT_437,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_118,Surgery|Photodynamic therapy,Yes,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 84, 'day_interval': 2520}",Induction,Diagnostic,5.0,5.0,Physician Assessed Response Criteria,Complete remission with incomplete hematologic recovery (CRi),1.0,Not applicable,TREATMENT_438,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_119,Hormonal therapy|Chemotherapy|Surgery,,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 84, 'day_interval': 2520}",Conditioning,Guidance,7.0,,Cheson CLL 2012 Oncology Response Criteria,Partial remission,1.0,,TREATMENT_439,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_120,Photodynamic therapy,No,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 93, 'day_interval': 2790}",Induction,Palliative,1.0,5.0,Cheson CLL 2012 Oncology Response Criteria,No evidence of disease (NED),2.0,,TREATMENT_440,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_121,Chemotherapy,,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 94, 'day_interval': 2820}",Maintenance,Supportive,6.0,4.0,Response Assessment in Neuro-Oncology (RANO),Primary refractory disease,3.0,Treatment completed as prescribed,TREATMENT_441,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_122,No treatment,Yes,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 95, 'day_interval': 2850}",Neoadjuvant,Forensic,4.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Major response,,Treatment incomplete because patient died,TREATMENT_442,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_123,,No,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 61, 'day_interval': 1830}",Preventative,Palliative,7.0,5.0,Response Assessment in Neuro-Oncology (RANO),Progressive disease,1.0,,TREATMENT_443,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_124,Stem cell transplant|Chemotherapy,No,,"{'month_interval': 58, 'day_interval': 1740}",Induction,Screening,5.0,,iRECIST,,5.0,Treatment incomplete because patient died,TREATMENT_444,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_125,Chemotherapy|Photodynamic therapy,Unknown,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 70, 'day_interval': 2100}",Maintenance,Preventive,5.0,3.0,iRECIST,Complete remission with incomplete hematologic recovery (CRi),1.0,,TREATMENT_445,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_126,,Yes,,"{'month_interval': 58, 'day_interval': 1740}",,Supportive,7.0,4.0,,Partial remission,1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_446,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_127,No treatment|Chemotherapy,No,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 89, 'day_interval': 2670}",Mobilization,Guidance,2.0,,,Complete remission without measurable residual disease (CR MRD-),,Treatment incomplete because patient died,TREATMENT_447,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_128,Surgery,Unknown,"{'month_interval': 21, 'day_interval': 630}",,Adjuvant,,6.0,4.0,,Immune complete response (iCR),1.0,Treatment stopped due to acute toxicity,TREATMENT_448,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_129,,Unknown,"{'month_interval': 9, 'day_interval': 270}","{'month_interval': 86, 'day_interval': 2580}",,Diagnostic,1.0,,Response Assessment in Neuro-Oncology (RANO),Molecular relapse (after CR MRD-),3.0,Other,TREATMENT_449,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_130,Stem cell transplant|Radiation therapy,No,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 52, 'day_interval': 1560}",Adjuvant,,5.0,5.0,Response Assessment in Neuro-Oncology (RANO),Primary refractory disease,2.0,Physician decision (stopped or interrupted treatment),TREATMENT_450,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_131,Hormonal therapy|Stem cell transplant,Unknown,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 56, 'day_interval': 1680}",Adjuvant,Curative,1.0,,RECIST 1.1,Physician assessed partial response,,,TREATMENT_451,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_132,,No,"{'month_interval': 39, 'day_interval': 1170}","{'month_interval': 85, 'day_interval': 2550}",Maintenance,Forensic,6.0,4.0,iRECIST,Major response,,Physician decision (stopped or interrupted treatment),TREATMENT_452,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_133,Surgery|Stem cell transplant|Hormonal therapy,No,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 84, 'day_interval': 2520}",Salvage,Diagnostic,4.0,3.0,Response Assessment in Neuro-Oncology (RANO),Immune partial response (iPR),,,TREATMENT_453,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_134,Chemotherapy|Bone marrow transplant|Immunotherapy,No,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 74, 'day_interval': 2220}",Locally advanced,Supportive,1.0,5.0,Blazer score,Molecular relapse (after CR MRD-),4.0,,TREATMENT_454,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_135,Radiation therapy|Surgery|Stem cell transplant,Unknown,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 65, 'day_interval': 1950}",Maintenance,,1.0,4.0,Response Assessment in Neuro-Oncology (RANO),Partial response,4.0,,TREATMENT_455,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_136,Radiation therapy|No treatment|Immunotherapy,Unknown,"{'month_interval': 44, 'day_interval': 1320}","{'month_interval': 77, 'day_interval': 2310}",,Curative,,,iRECIST,"Hematologic relapse (after CR MRD-, CR, CRi)",3.0,Treatment incomplete because patient died,TREATMENT_456,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_137,,Yes,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 67, 'day_interval': 2010}",Radiosensitization,,1.0,4.0,Blazer score,Complete remission without measurable residual disease (CR MRD-),,Unknown,TREATMENT_457,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_138,Stem cell transplant|Radiation therapy,No,"{'month_interval': 28, 'day_interval': 840}",,Preventative,Preventive,,4.0,iRECIST,,,Patient choice (stopped or interrupted treatment),TREATMENT_458,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_139,Radiation therapy|Hormonal therapy,,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 61, 'day_interval': 1830}",Preventative,Diagnostic,2.0,4.0,Response Assessment in Neuro-Oncology (RANO),Complete response,3.0,,TREATMENT_459,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_140,Photodynamic therapy|No treatment|Stem cell transplant,Yes,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 89, 'day_interval': 2670}",Radiosensitization,Palliative,,4.0,Cheson CLL 2012 Oncology Response Criteria,,1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_460,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_141,Stem cell transplant,No,"{'month_interval': 3, 'day_interval': 90}","{'month_interval': 99, 'day_interval': 2970}",Neoadjuvant,Diagnostic,6.0,5.0,RECIST 1.1,Partial response,3.0,Not applicable,TREATMENT_461,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_142,,Yes,"{'month_interval': 39, 'day_interval': 1170}","{'month_interval': 98, 'day_interval': 2940}",Induction,Screening,5.0,3.0,,Primary refractory disease,3.0,,TREATMENT_462,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_143,Chemotherapy|Surgery|Hormonal therapy,,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 51, 'day_interval': 1530}",Adjuvant,Palliative,5.0,3.0,AML Response Criteria,Complete remission without measurable residual disease (CR MRD-),,Not applicable,TREATMENT_463,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_144,Stem cell transplant|Surgery,No,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 88, 'day_interval': 2640}",Maintenance,Diagnostic,7.0,5.0,,Immune uncomfirmed progressive disease (iUPD),5.0,,TREATMENT_464,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_145,No treatment|Hormonal therapy,Yes,"{'month_interval': 10, 'day_interval': 300}",,Salvage,,6.0,3.0,RECIST 1.1,,2.0,Unknown,TREATMENT_465,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_146,,Yes,"{'month_interval': 9, 'day_interval': 270}",,Mobilization,,3.0,3.0,AML Response Criteria,Minor response,2.0,Treatment completed as prescribed,TREATMENT_466,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_147,Chemotherapy|Hormonal therapy,No,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 76, 'day_interval': 2280}",Preventative,Supportive,1.0,4.0,,Complete remission,4.0,Treatment completed as prescribed,TREATMENT_467,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_148,Photodynamic therapy,Unknown,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 57, 'day_interval': 1710}",Maintenance,Screening,,3.0,Physician Assessed Response Criteria,Complete response,1.0,Unknown,TREATMENT_468,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_149,,Yes,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 88, 'day_interval': 2640}",Neoadjuvant,Supportive,3.0,,AML Response Criteria,Physician assessed complete response,1.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_469,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_150,Surgery|Stem cell transplant|Immunotherapy,Yes,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 88, 'day_interval': 2640}",Salvage,Supportive,3.0,3.0,RECIST 1.1,Immune uncomfirmed progressive disease (iUPD),3.0,,TREATMENT_470,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_151,Radiation therapy,Yes,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 54, 'day_interval': 1620}",Adjuvant,Supportive,7.0,5.0,Response Assessment in Neuro-Oncology (RANO),Immune confirmed progressive disease (iCPD),2.0,Physician decision (stopped or interrupted treatment),TREATMENT_471,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_152,Stem cell transplant|Radiation therapy,No,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 59, 'day_interval': 1770}",,Guidance,1.0,5.0,RECIST 1.1,Primary refractory disease,,,TREATMENT_472,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_153,,Unknown,"{'month_interval': 1, 'day_interval': 30}",,Adjuvant,Screening,3.0,3.0,RECIST 1.1,Minor response,5.0,Treatment stopped due to acute toxicity,TREATMENT_473,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_154,Other targeting molecular therapy,Yes,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 69, 'day_interval': 2070}",Adjuvant,Supportive,,,Cheson CLL 2012 Oncology Response Criteria,Partial response,2.0,Treatment completed as prescribed,TREATMENT_474,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_155,Bone marrow transplant,Unknown,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 54, 'day_interval': 1620}",,Guidance,1.0,,Cheson CLL 2012 Oncology Response Criteria,Complete remission with incomplete hematologic recovery (CRi),,Not applicable,TREATMENT_475,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_156,Bone marrow transplant,Unknown,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 99, 'day_interval': 2970}",Salvage,Supportive,2.0,3.0,RECIST 1.1,,1.0,Treatment incomplete because patient died,TREATMENT_476,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_157,Immunotherapy,Unknown,"{'month_interval': 1, 'day_interval': 30}",,Preventative,Palliative,,5.0,,Immune confirmed progressive disease (iCPD),4.0,Not applicable,TREATMENT_477,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_158,Photodynamic therapy|No treatment,No,"{'month_interval': 48, 'day_interval': 1440}","{'month_interval': 97, 'day_interval': 2910}",Mobilization,Supportive,5.0,4.0,RECIST 1.1,Morphologic leukemia-free state,,,TREATMENT_478,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_159,Chemotherapy,No,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 63, 'day_interval': 1890}",Conditioning,Screening,4.0,3.0,RECIST 1.1,No evidence of disease (NED),3.0,Unknown,TREATMENT_479,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_160,,Yes,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 71, 'day_interval': 2130}",Advanced/Metastatic,Forensic,2.0,4.0,Response Assessment in Neuro-Oncology (RANO),Minor response,5.0,Treatment stopped due to acute toxicity,TREATMENT_480,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_1,,Yes,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 52, 'day_interval': 1560}",Induction,Palliative,,,,Complete response,,,TREATMENT_481,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_2,Bone marrow transplant,No,"{'month_interval': 11, 'day_interval': 330}","{'month_interval': 70, 'day_interval': 2100}",Maintenance,Forensic,3.0,5.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed stable disease,3.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_482,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_3,,No,,,Locally advanced,Forensic,2.0,3.0,Cheson CLL 2012 Oncology Response Criteria,,3.0,,TREATMENT_483,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_4,,Unknown,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 90, 'day_interval': 2700}",,Guidance,6.0,5.0,iRECIST,Minor response,4.0,Treatment completed as prescribed,TREATMENT_484,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_5,Bone marrow transplant|Radiation therapy|Photodynamic therapy,No,"{'month_interval': 27, 'day_interval': 810}",,Neoadjuvant,Screening,1.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Physician assessed partial response,3.0,Other,TREATMENT_485,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_6,Radiation therapy|Photodynamic therapy,Unknown,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 86, 'day_interval': 2580}",Salvage,Screening,,4.0,AML Response Criteria,Immune stable disease (iSD),,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_486,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_7,,No,"{'month_interval': 46, 'day_interval': 1380}",,Mobilization,,2.0,4.0,,Immune complete response (iCR),3.0,Physician decision (stopped or interrupted treatment),TREATMENT_487,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_8,Photodynamic therapy,Yes,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 88, 'day_interval': 2640}",Neoadjuvant,Supportive,2.0,4.0,,"Hematologic relapse (after CR MRD-, CR, CRi)",4.0,Patient choice (stopped or interrupted treatment),TREATMENT_488,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_9,,Unknown,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 85, 'day_interval': 2550}",Mobilization,Supportive,4.0,5.0,Blazer score,Minor response,,Unknown,TREATMENT_489,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_10,,Yes,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 66, 'day_interval': 1980}",Preventative,Guidance,,,Physician Assessed Response Criteria,,,Physician decision (stopped or interrupted treatment),TREATMENT_490,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_11,,,,,Mobilization,Palliative,2.0,4.0,Response Assessment in Neuro-Oncology (RANO),Minor response,4.0,Unknown,TREATMENT_491,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_12,,Unknown,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 63, 'day_interval': 1890}",Conditioning,Curative,6.0,3.0,,Molecular relapse (after CR MRD-),2.0,Not applicable,TREATMENT_492,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_13,No treatment|Radiation therapy,,,"{'month_interval': 86, 'day_interval': 2580}",Radiosensitization,Diagnostic,5.0,5.0,,Partial remission,1.0,,TREATMENT_493,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_14,Other targeting molecular therapy|Radiation therapy|Bone marrow transplant,Yes,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 77, 'day_interval': 2310}",Locally advanced,Guidance,3.0,5.0,AML Response Criteria,Immune confirmed progressive disease (iCPD),2.0,,TREATMENT_494,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_15,Photodynamic therapy|Other targeting molecular therapy|Hormonal therapy,No,,"{'month_interval': 91, 'day_interval': 2730}",Adjuvant,Screening,3.0,3.0,RECIST 1.1,Stable disease,4.0,Unknown,TREATMENT_495,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_16,,Unknown,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 91, 'day_interval': 2730}",Radiosensitization,Supportive,5.0,5.0,Physician Assessed Response Criteria,Physician assessed stable disease,2.0,Treatment stopped due to acute toxicity,TREATMENT_496,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_17,Stem cell transplant|No treatment,Unknown,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 76, 'day_interval': 2280}",Locally advanced,Preventive,,3.0,iRECIST,Progressive disease,5.0,,TREATMENT_497,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_18,,Unknown,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 56, 'day_interval': 1680}",Radiosensitization,Screening,3.0,,,No evidence of disease (NED),,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_498,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_19,No treatment,No,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 51, 'day_interval': 1530}",Mobilization,Forensic,6.0,5.0,AML Response Criteria,Physician assessed partial response,1.0,Treatment completed as prescribed,TREATMENT_499,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_20,Photodynamic therapy|Bone marrow transplant|Radiation therapy,Yes,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 51, 'day_interval': 1530}",Conditioning,Screening,7.0,,,Immune uncomfirmed progressive disease (iUPD),3.0,Unknown,TREATMENT_500,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_21,,Unknown,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 55, 'day_interval': 1650}",Radiosensitization,Guidance,1.0,5.0,AML Response Criteria,Immune complete response (iCR),5.0,Treatment stopped due to acute toxicity,TREATMENT_501,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_22,Hormonal therapy|Bone marrow transplant,,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 61, 'day_interval': 1830}",Neoadjuvant,Forensic,1.0,3.0,,Complete remission without measurable residual disease (CR MRD-),1.0,Treatment incomplete because patient died,TREATMENT_502,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_23,Bone marrow transplant|Radiation therapy|Stem cell transplant,Yes,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 85, 'day_interval': 2550}",Conditioning,Guidance,7.0,3.0,iRECIST,Complete remission without measurable residual disease (CR MRD-),5.0,Patient choice (stopped or interrupted treatment),TREATMENT_503,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_24,Photodynamic therapy,No,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 55, 'day_interval': 1650}",Radiosensitization,Supportive,6.0,3.0,AML Response Criteria,No evidence of disease (NED),,Other,TREATMENT_504,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_25,,No,,"{'month_interval': 75, 'day_interval': 2250}",Preventative,Palliative,2.0,4.0,Response Assessment in Neuro-Oncology (RANO),,4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_505,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_26,,No,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 61, 'day_interval': 1830}",,,2.0,5.0,RECIST 1.1,Physician assessed partial response,3.0,Treatment incomplete due to technical or organizational problems,TREATMENT_506,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_27,,Unknown,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 64, 'day_interval': 1920}",Neoadjuvant,Guidance,5.0,4.0,iRECIST,Partial remission,,Not applicable,TREATMENT_507,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_28,Bone marrow transplant,No,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 100, 'day_interval': 3000}",Locally advanced,Palliative,1.0,4.0,Physician Assessed Response Criteria,Immune uncomfirmed progressive disease (iUPD),,Treatment stopped due to acute toxicity,TREATMENT_508,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_29,Radiation therapy,Unknown,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 63, 'day_interval': 1890}",Locally advanced,Forensic,3.0,3.0,,Immune partial response (iPR),4.0,,TREATMENT_509,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_30,,No,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 84, 'day_interval': 2520}",Adjuvant,,2.0,,Blazer score,Complete response,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_510,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_31,,Unknown,"{'month_interval': 11, 'day_interval': 330}","{'month_interval': 100, 'day_interval': 3000}",Advanced/Metastatic,Curative,1.0,,Physician Assessed Response Criteria,Complete response,4.0,Other,TREATMENT_511,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_32,Hormonal therapy|Radiation therapy,Unknown,"{'month_interval': 44, 'day_interval': 1320}",,Induction,Forensic,7.0,,Cheson CLL 2012 Oncology Response Criteria,Physician assessed partial response,3.0,Physician decision (stopped or interrupted treatment),TREATMENT_512,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_33,Hormonal therapy,Yes,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 87, 'day_interval': 2610}",Maintenance,Curative,,5.0,Cheson CLL 2012 Oncology Response Criteria,Minor response,1.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_513,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_34,,Yes,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 89, 'day_interval': 2670}",Radiosensitization,Preventive,7.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Complete response,,Other,TREATMENT_514,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_35,,No,,,Induction,Diagnostic,5.0,4.0,Physician Assessed Response Criteria,Complete remission without measurable residual disease (CR MRD-),3.0,,TREATMENT_515,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_36,Immunotherapy,Unknown,,"{'month_interval': 92, 'day_interval': 2760}",Radiosensitization,Diagnostic,3.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Progressive disease,4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_516,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_37,Immunotherapy,Unknown,"{'month_interval': 14, 'day_interval': 420}","{'month_interval': 57, 'day_interval': 1710}",Neoadjuvant,Preventive,2.0,4.0,,,1.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_517,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_38,Other targeting molecular therapy,No,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 72, 'day_interval': 2160}",Adjuvant,Guidance,2.0,4.0,Cheson CLL 2012 Oncology Response Criteria,,1.0,Other,TREATMENT_518,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_39,Stem cell transplant,No,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 90, 'day_interval': 2700}",Salvage,Screening,2.0,3.0,Blazer score,Complete response,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_519,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_40,Hormonal therapy|Immunotherapy,Unknown,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 60, 'day_interval': 1800}",Preventative,Preventive,5.0,5.0,RECIST 1.1,No evidence of disease (NED),,Not applicable,TREATMENT_520,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_41,Photodynamic therapy|No treatment|Stem cell transplant,Yes,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 94, 'day_interval': 2820}",Mobilization,Forensic,7.0,4.0,,,1.0,Not applicable,TREATMENT_521,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_42,Other targeting molecular therapy,Yes,"{'month_interval': 34, 'day_interval': 1020}",,Conditioning,,,4.0,Physician Assessed Response Criteria,Physician assessed stable disease,4.0,,TREATMENT_522,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_43,No treatment|Stem cell transplant|Surgery,Yes,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 76, 'day_interval': 2280}",Neoadjuvant,Guidance,7.0,4.0,,,5.0,Patient choice (stopped or interrupted treatment),TREATMENT_523,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_44,Radiation therapy,,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 77, 'day_interval': 2310}",Locally advanced,Curative,,3.0,Blazer score,Immune stable disease (iSD),5.0,Treatment completed as prescribed,TREATMENT_524,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_45,Hormonal therapy,Yes,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 93, 'day_interval': 2790}",Maintenance,,5.0,4.0,Physician Assessed Response Criteria,Molecular relapse (after CR MRD-),3.0,Patient choice (stopped or interrupted treatment),TREATMENT_525,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_46,,Yes,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 86, 'day_interval': 2580}",Radiosensitization,,7.0,4.0,Blazer score,Minor response,1.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_526,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_47,,Unknown,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 71, 'day_interval': 2130}",Conditioning,,4.0,5.0,,"Hematologic relapse (after CR MRD-, CR, CRi)",5.0,Treatment completed as prescribed,TREATMENT_527,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_48,,Yes,,"{'month_interval': 72, 'day_interval': 2160}",Adjuvant,Forensic,4.0,4.0,Cheson CLL 2012 Oncology Response Criteria,,,,TREATMENT_528,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_49,Radiation therapy|Bone marrow transplant|Surgery,,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 89, 'day_interval': 2670}",Radiosensitization,Guidance,1.0,4.0,,,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_529,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_50,Bone marrow transplant|Hormonal therapy|Stem cell transplant,No,"{'month_interval': 18, 'day_interval': 540}","{'month_interval': 58, 'day_interval': 1740}",Mobilization,,4.0,3.0,Blazer score,,2.0,Treatment incomplete due to technical or organizational problems,TREATMENT_530,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_51,Radiation therapy,Unknown,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 81, 'day_interval': 2430}",Induction,Supportive,4.0,3.0,Cheson CLL 2012 Oncology Response Criteria,"Hematologic relapse (after CR MRD-, CR, CRi)",3.0,Not applicable,TREATMENT_531,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_52,Photodynamic therapy|Chemotherapy|Immunotherapy,No,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 74, 'day_interval': 2220}",Maintenance,,1.0,,Response Assessment in Neuro-Oncology (RANO),,5.0,Other,TREATMENT_532,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_53,,Unknown,"{'month_interval': 8, 'day_interval': 240}",,Neoadjuvant,Supportive,4.0,4.0,Response Assessment in Neuro-Oncology (RANO),Molecular relapse (after CR MRD-),2.0,,TREATMENT_533,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_54,Chemotherapy,Unknown,,"{'month_interval': 63, 'day_interval': 1890}",Advanced/Metastatic,,1.0,4.0,AML Response Criteria,Partial remission,,Unknown,TREATMENT_534,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_55,Photodynamic therapy|Stem cell transplant|Chemotherapy,Yes,"{'month_interval': 18, 'day_interval': 540}","{'month_interval': 63, 'day_interval': 1890}",Adjuvant,Palliative,2.0,5.0,Cheson CLL 2012 Oncology Response Criteria,,5.0,Physician decision (stopped or interrupted treatment),TREATMENT_535,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_56,Radiation therapy|Stem cell transplant,Yes,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 96, 'day_interval': 2880}",Advanced/Metastatic,Guidance,,4.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed complete response,,Not applicable,TREATMENT_536,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_57,No treatment,Unknown,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 78, 'day_interval': 2340}",Advanced/Metastatic,Screening,3.0,3.0,,Primary refractory disease,5.0,Not applicable,TREATMENT_537,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_58,Chemotherapy,No,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 93, 'day_interval': 2790}",Salvage,Curative,2.0,4.0,Response Assessment in Neuro-Oncology (RANO),Complete remission with incomplete hematologic recovery (CRi),5.0,Treatment stopped due to acute toxicity,TREATMENT_538,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_59,,No,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 87, 'day_interval': 2610}",,Preventive,7.0,4.0,Physician Assessed Response Criteria,Primary refractory disease,1.0,Not applicable,TREATMENT_539,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_60,Immunotherapy|No treatment,No,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 60, 'day_interval': 1800}",,Screening,1.0,4.0,iRECIST,,4.0,Physician decision (stopped or interrupted treatment),TREATMENT_540,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_61,Other targeting molecular therapy,Yes,,"{'month_interval': 96, 'day_interval': 2880}",Mobilization,Preventive,,4.0,AML Response Criteria,Complete remission without measurable residual disease (CR MRD-),4.0,,TREATMENT_541,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_62,,Yes,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 93, 'day_interval': 2790}",Conditioning,Palliative,4.0,3.0,Blazer score,Immune partial response (iPR),3.0,Patient choice (stopped or interrupted treatment),TREATMENT_542,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_63,Radiation therapy|Immunotherapy|Surgery,Unknown,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 59, 'day_interval': 1770}",,Forensic,5.0,5.0,Physician Assessed Response Criteria,Complete remission with incomplete hematologic recovery (CRi),2.0,Treatment completed as prescribed,TREATMENT_543,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_64,No treatment,Unknown,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 79, 'day_interval': 2370}",,,,3.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed stable disease,,,TREATMENT_544,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_65,,No,"{'month_interval': 10, 'day_interval': 300}",,Locally advanced,Palliative,4.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Minor response,3.0,Physician decision (stopped or interrupted treatment),TREATMENT_545,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_66,Immunotherapy,Unknown,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 76, 'day_interval': 2280}",Salvage,Diagnostic,2.0,,Cheson CLL 2012 Oncology Response Criteria,Stable disease,5.0,Treatment incomplete because patient died,TREATMENT_546,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_67,Radiation therapy|Stem cell transplant|Bone marrow transplant,No,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 90, 'day_interval': 2700}",Radiosensitization,Screening,7.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Immune confirmed progressive disease (iCPD),1.0,Physician decision (stopped or interrupted treatment),TREATMENT_547,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_68,Other targeting molecular therapy|Photodynamic therapy,Yes,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 59, 'day_interval': 1770}",Maintenance,Palliative,,,iRECIST,Immune complete response (iCR),2.0,Physician decision (stopped or interrupted treatment),TREATMENT_548,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_69,,Yes,"{'month_interval': 8, 'day_interval': 240}","{'month_interval': 91, 'day_interval': 2730}",Neoadjuvant,Palliative,4.0,4.0,,Complete remission without measurable residual disease (CR MRD-),3.0,Other,TREATMENT_549,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_70,Hormonal therapy|Radiation therapy,No,"{'month_interval': 23, 'day_interval': 690}","{'month_interval': 83, 'day_interval': 2490}",Locally advanced,Curative,1.0,3.0,Physician Assessed Response Criteria,Major response,,Treatment completed as prescribed,TREATMENT_550,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_71,,No,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 58, 'day_interval': 1740}",Maintenance,Guidance,3.0,3.0,,Minor response,2.0,Treatment incomplete due to technical or organizational problems,TREATMENT_551,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_72,Chemotherapy|Surgery,Unknown,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 92, 'day_interval': 2760}",Radiosensitization,Guidance,4.0,4.0,RECIST 1.1,,2.0,Not applicable,TREATMENT_552,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_73,Other targeting molecular therapy|Chemotherapy,Unknown,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 83, 'day_interval': 2490}",Locally advanced,,3.0,5.0,RECIST 1.1,,5.0,,TREATMENT_553,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_74,Surgery|Immunotherapy,Yes,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 88, 'day_interval': 2640}",Locally advanced,Curative,5.0,4.0,Physician Assessed Response Criteria,"Hematologic relapse (after CR MRD-, CR, CRi)",5.0,Treatment incomplete due to technical or organizational problems,TREATMENT_554,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_75,Surgery|Radiation therapy,Yes,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 94, 'day_interval': 2820}",,Guidance,3.0,5.0,AML Response Criteria,Molecular relapse (after CR MRD-),,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_555,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_76,Bone marrow transplant|Immunotherapy|Surgery,Yes,"{'month_interval': 44, 'day_interval': 1320}","{'month_interval': 72, 'day_interval': 2160}",Neoadjuvant,Guidance,4.0,5.0,AML Response Criteria,Minor response,3.0,Patient choice (stopped or interrupted treatment),TREATMENT_556,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_77,Surgery|Chemotherapy|No treatment,No,"{'month_interval': 11, 'day_interval': 330}",,Conditioning,Screening,5.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Morphologic leukemia-free state,,Treatment incomplete because patient died,TREATMENT_557,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_78,Radiation therapy,Yes,"{'month_interval': 18, 'day_interval': 540}","{'month_interval': 70, 'day_interval': 2100}",Adjuvant,Supportive,4.0,5.0,Response Assessment in Neuro-Oncology (RANO),,5.0,Other,TREATMENT_558,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_79,Stem cell transplant|Bone marrow transplant|Immunotherapy,Yes,"{'month_interval': 23, 'day_interval': 690}","{'month_interval': 80, 'day_interval': 2400}",Mobilization,Curative,2.0,,Cheson CLL 2012 Oncology Response Criteria,Minor response,4.0,Treatment completed as prescribed,TREATMENT_559,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_80,Stem cell transplant|Other targeting molecular therapy,Unknown,,"{'month_interval': 86, 'day_interval': 2580}",,Supportive,7.0,,,Molecular relapse (after CR MRD-),,Not applicable,TREATMENT_560,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_81,Chemotherapy|Radiation therapy|Immunotherapy,Unknown,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 81, 'day_interval': 2430}",Maintenance,Forensic,2.0,5.0,iRECIST,,,Treatment incomplete due to technical or organizational problems,TREATMENT_561,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_82,Bone marrow transplant|Chemotherapy,Yes,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 84, 'day_interval': 2520}",Neoadjuvant,Forensic,4.0,4.0,,Complete remission without measurable residual disease (CR MRD-),,Treatment completed as prescribed,TREATMENT_562,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_83,Stem cell transplant,Unknown,"{'month_interval': 44, 'day_interval': 1320}","{'month_interval': 70, 'day_interval': 2100}",Radiosensitization,Palliative,2.0,3.0,Response Assessment in Neuro-Oncology (RANO),,1.0,,TREATMENT_563,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_84,Stem cell transplant|Other targeting molecular therapy|Radiation therapy,Unknown,"{'month_interval': 44, 'day_interval': 1320}","{'month_interval': 68, 'day_interval': 2040}",Radiosensitization,Guidance,5.0,5.0,RECIST 1.1,Complete remission without measurable residual disease (CR MRD-),2.0,Treatment incomplete due to technical or organizational problems,TREATMENT_564,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_85,Other targeting molecular therapy|Bone marrow transplant,Unknown,"{'month_interval': 43, 'day_interval': 1290}",,Mobilization,Supportive,2.0,4.0,Response Assessment in Neuro-Oncology (RANO),Complete response,3.0,,TREATMENT_565,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_86,Stem cell transplant|Surgery,Yes,,"{'month_interval': 54, 'day_interval': 1620}",Advanced/Metastatic,Curative,7.0,5.0,iRECIST,,1.0,,TREATMENT_566,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_87,Immunotherapy|Radiation therapy|Other targeting molecular therapy,No,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 72, 'day_interval': 2160}",Preventative,Palliative,,5.0,Response Assessment in Neuro-Oncology (RANO),Molecular relapse (after CR MRD-),3.0,,TREATMENT_567,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_88,Photodynamic therapy,No,"{'month_interval': 9, 'day_interval': 270}","{'month_interval': 92, 'day_interval': 2760}",Radiosensitization,,,,iRECIST,,2.0,,TREATMENT_568,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_89,Immunotherapy|Other targeting molecular therapy,Yes,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 84, 'day_interval': 2520}",,Forensic,4.0,4.0,iRECIST,,5.0,Physician decision (stopped or interrupted treatment),TREATMENT_569,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_90,Bone marrow transplant|Hormonal therapy|Stem cell transplant,Unknown,,"{'month_interval': 74, 'day_interval': 2220}",,Diagnostic,3.0,5.0,iRECIST,Complete response,,Patient choice (stopped or interrupted treatment),TREATMENT_570,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_91,Hormonal therapy|No treatment|Bone marrow transplant,Yes,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 82, 'day_interval': 2460}",Neoadjuvant,,4.0,,Physician Assessed Response Criteria,,,Not applicable,TREATMENT_571,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_92,,No,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 96, 'day_interval': 2880}",Neoadjuvant,Guidance,1.0,4.0,RECIST 1.1,,3.0,Physician decision (stopped or interrupted treatment),TREATMENT_572,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_93,Other targeting molecular therapy,No,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 71, 'day_interval': 2130}",Induction,Screening,,5.0,AML Response Criteria,,1.0,Unknown,TREATMENT_573,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_94,,Unknown,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 61, 'day_interval': 1830}",,Forensic,7.0,5.0,Blazer score,Immune confirmed progressive disease (iCPD),3.0,,TREATMENT_574,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_95,Surgery,No,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 82, 'day_interval': 2460}",Mobilization,Guidance,4.0,3.0,RECIST 1.1,Complete response,,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_575,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_96,,,"{'month_interval': 39, 'day_interval': 1170}","{'month_interval': 54, 'day_interval': 1620}",Advanced/Metastatic,Diagnostic,,3.0,RECIST 1.1,Primary refractory disease,2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_576,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_97,Radiation therapy|No treatment|Surgery,,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 79, 'day_interval': 2370}",Advanced/Metastatic,Diagnostic,7.0,4.0,RECIST 1.1,Immune complete response (iCR),,Patient choice (stopped or interrupted treatment),TREATMENT_577,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_98,Bone marrow transplant|No treatment|Other targeting molecular therapy,No,"{'month_interval': 35, 'day_interval': 1050}",,Neoadjuvant,Supportive,7.0,3.0,AML Response Criteria,Immune partial response (iPR),1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_578,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_99,Hormonal therapy|Immunotherapy,,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 72, 'day_interval': 2160}",Salvage,Screening,6.0,3.0,,Primary refractory disease,,,TREATMENT_579,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_100,Radiation therapy|Surgery|Photodynamic therapy,Yes,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 56, 'day_interval': 1680}",Preventative,Supportive,2.0,,RECIST 1.1,Physician assessed stable disease,5.0,Physician decision (stopped or interrupted treatment),TREATMENT_580,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_101,,Unknown,"{'month_interval': 21, 'day_interval': 630}",,Radiosensitization,,,4.0,,,5.0,Not applicable,TREATMENT_581,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_102,Photodynamic therapy|Immunotherapy,Yes,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 57, 'day_interval': 1710}",Salvage,Forensic,4.0,4.0,Physician Assessed Response Criteria,Complete remission without measurable residual disease (CR MRD-),4.0,Treatment stopped due to acute toxicity,TREATMENT_582,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_103,No treatment|Radiation therapy|Other targeting molecular therapy,Yes,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 90, 'day_interval': 2700}",Conditioning,Forensic,,5.0,RECIST 1.1,Physician assessed complete response,3.0,,TREATMENT_583,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_104,Bone marrow transplant|Chemotherapy|Stem cell transplant,No,,"{'month_interval': 58, 'day_interval': 1740}",Adjuvant,Palliative,,,Cheson CLL 2012 Oncology Response Criteria,,2.0,Treatment completed as prescribed,TREATMENT_584,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_105,Immunotherapy|Radiation therapy,Unknown,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 50, 'day_interval': 1500}",Adjuvant,Guidance,1.0,4.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed partial response,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_585,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_106,Stem cell transplant|Bone marrow transplant|Surgery,Yes,"{'month_interval': 23, 'day_interval': 690}","{'month_interval': 56, 'day_interval': 1680}",Mobilization,Curative,6.0,5.0,iRECIST,Immune confirmed progressive disease (iCPD),1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_586,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_107,,Yes,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 89, 'day_interval': 2670}",Radiosensitization,Curative,,5.0,Physician Assessed Response Criteria,Molecular relapse (after CR MRD-),5.0,Patient choice (stopped or interrupted treatment),TREATMENT_587,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_108,Surgery|Other targeting molecular therapy,Yes,"{'month_interval': 17, 'day_interval': 510}",,Neoadjuvant,Diagnostic,7.0,,iRECIST,,2.0,Treatment incomplete because patient died,TREATMENT_588,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_109,Radiation therapy|Photodynamic therapy,,,"{'month_interval': 77, 'day_interval': 2310}",Preventative,Diagnostic,6.0,3.0,,Complete remission without measurable residual disease (CR MRD-),2.0,Patient choice (stopped or interrupted treatment),TREATMENT_589,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_110,Photodynamic therapy|No treatment,Yes,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 100, 'day_interval': 3000}",Conditioning,Guidance,3.0,,Blazer score,Physician assessed stable disease,3.0,Not applicable,TREATMENT_590,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_111,,,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 80, 'day_interval': 2400}",Mobilization,Guidance,3.0,3.0,Response Assessment in Neuro-Oncology (RANO),"Hematologic relapse (after CR MRD-, CR, CRi)",2.0,Patient choice (stopped or interrupted treatment),TREATMENT_591,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_112,Radiation therapy|Chemotherapy,No,"{'month_interval': 39, 'day_interval': 1170}","{'month_interval': 79, 'day_interval': 2370}",Salvage,,6.0,3.0,,,4.0,Other,TREATMENT_592,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_113,Chemotherapy,No,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 69, 'day_interval': 2070}",Radiosensitization,Preventive,6.0,4.0,Cheson CLL 2012 Oncology Response Criteria,"Hematologic relapse (after CR MRD-, CR, CRi)",1.0,Treatment incomplete because patient died,TREATMENT_593,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_114,Radiation therapy|Photodynamic therapy,Unknown,,"{'month_interval': 81, 'day_interval': 2430}",Preventative,Guidance,6.0,4.0,AML Response Criteria,Major response,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_594,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_115,Immunotherapy|Bone marrow transplant|Radiation therapy,,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 94, 'day_interval': 2820}",Locally advanced,Preventive,,3.0,AML Response Criteria,Primary refractory disease,,Other,TREATMENT_595,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_116,,Yes,"{'month_interval': 3, 'day_interval': 90}","{'month_interval': 56, 'day_interval': 1680}",,Forensic,6.0,4.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed partial response,2.0,Unknown,TREATMENT_596,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_117,Surgery,Yes,"{'month_interval': 14, 'day_interval': 420}","{'month_interval': 62, 'day_interval': 1860}",,,,4.0,Cheson CLL 2012 Oncology Response Criteria,,2.0,Physician decision (stopped or interrupted treatment),TREATMENT_597,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_118,,Unknown,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 55, 'day_interval': 1650}",Radiosensitization,Palliative,5.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Primary refractory disease,3.0,Physician decision (stopped or interrupted treatment),TREATMENT_598,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_119,Bone marrow transplant|Photodynamic therapy,No,"{'month_interval': 10, 'day_interval': 300}","{'month_interval': 96, 'day_interval': 2880}",,Preventive,1.0,,AML Response Criteria,,5.0,Treatment incomplete due to technical or organizational problems,TREATMENT_599,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_120,,Yes,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 56, 'day_interval': 1680}",Maintenance,Screening,,3.0,,,4.0,Other,TREATMENT_600,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_121,,Unknown,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 86, 'day_interval': 2580}",Adjuvant,Curative,,5.0,Blazer score,Immune complete response (iCR),3.0,Treatment incomplete due to technical or organizational problems,TREATMENT_601,DONOR_1,SYNTHETIC-1
PRIMARY_DIAGNOSIS_122,Hormonal therapy,,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 96, 'day_interval': 2880}",Locally advanced,Guidance,7.0,5.0,Cheson CLL 2012 Oncology Response Criteria,,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_602,DONOR_2,SYNTHETIC-1
PRIMARY_DIAGNOSIS_123,Hormonal therapy,Unknown,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 69, 'day_interval': 2070}",Adjuvant,Diagnostic,2.0,4.0,Blazer score,,4.0,Physician decision (stopped or interrupted treatment),TREATMENT_603,DONOR_3,SYNTHETIC-1
PRIMARY_DIAGNOSIS_124,Other targeting molecular therapy|No treatment,Yes,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 99, 'day_interval': 2970}",Locally advanced,,6.0,4.0,Physician Assessed Response Criteria,Complete response,2.0,Physician decision (stopped or interrupted treatment),TREATMENT_604,DONOR_4,SYNTHETIC-1
PRIMARY_DIAGNOSIS_125,,No,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 92, 'day_interval': 2760}",Radiosensitization,Preventive,,4.0,iRECIST,Morphologic leukemia-free state,3.0,,TREATMENT_605,DONOR_5,SYNTHETIC-1
PRIMARY_DIAGNOSIS_126,,Unknown,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 73, 'day_interval': 2190}",Mobilization,Diagnostic,4.0,4.0,iRECIST,Physician assessed complete response,,Treatment incomplete due to technical or organizational problems,TREATMENT_606,DONOR_6,SYNTHETIC-1
PRIMARY_DIAGNOSIS_127,Surgery|Bone marrow transplant,Unknown,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 79, 'day_interval': 2370}",Maintenance,Guidance,1.0,,Cheson CLL 2012 Oncology Response Criteria,Physician assessed partial response,3.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_607,DONOR_7,SYNTHETIC-1
PRIMARY_DIAGNOSIS_128,Chemotherapy|Radiation therapy,Unknown,,"{'month_interval': 51, 'day_interval': 1530}",,Supportive,3.0,3.0,iRECIST,Physician assessed complete response,2.0,Patient choice (stopped or interrupted treatment),TREATMENT_608,DONOR_8,SYNTHETIC-1
PRIMARY_DIAGNOSIS_129,,Unknown,"{'month_interval': 3, 'day_interval': 90}","{'month_interval': 55, 'day_interval': 1650}",Salvage,Forensic,5.0,5.0,,Partial response,2.0,,TREATMENT_609,DONOR_9,SYNTHETIC-1
PRIMARY_DIAGNOSIS_130,Surgery,,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 73, 'day_interval': 2190}",Adjuvant,Diagnostic,3.0,,Physician Assessed Response Criteria,Physician assessed partial response,,,TREATMENT_610,DONOR_10,SYNTHETIC-1
PRIMARY_DIAGNOSIS_131,,No,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 86, 'day_interval': 2580}",Salvage,Guidance,,3.0,Blazer score,Complete response,2.0,Treatment completed as prescribed,TREATMENT_611,DONOR_11,SYNTHETIC-1
PRIMARY_DIAGNOSIS_132,Other targeting molecular therapy|Photodynamic therapy,No,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 72, 'day_interval': 2160}",Neoadjuvant,Supportive,2.0,3.0,Physician Assessed Response Criteria,,3.0,Treatment incomplete due to technical or organizational problems,TREATMENT_612,DONOR_12,SYNTHETIC-1
PRIMARY_DIAGNOSIS_133,Immunotherapy,No,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 53, 'day_interval': 1590}",Locally advanced,Diagnostic,,3.0,iRECIST,,,Treatment incomplete due to technical or organizational problems,TREATMENT_613,DONOR_13,SYNTHETIC-1
PRIMARY_DIAGNOSIS_134,Stem cell transplant|Immunotherapy,Unknown,,"{'month_interval': 50, 'day_interval': 1500}",Neoadjuvant,Supportive,4.0,3.0,,,1.0,Treatment stopped due to acute toxicity,TREATMENT_614,DONOR_14,SYNTHETIC-1
PRIMARY_DIAGNOSIS_135,Surgery,No,,"{'month_interval': 67, 'day_interval': 2010}",Preventative,Forensic,3.0,4.0,Blazer score,No evidence of disease (NED),1.0,Unknown,TREATMENT_615,DONOR_15,SYNTHETIC-1
PRIMARY_DIAGNOSIS_136,Chemotherapy|Radiation therapy|Stem cell transplant,No,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 83, 'day_interval': 2490}",Conditioning,,4.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Physician assessed stable disease,2.0,Patient choice (stopped or interrupted treatment),TREATMENT_616,DONOR_16,SYNTHETIC-1
PRIMARY_DIAGNOSIS_137,Photodynamic therapy|Radiation therapy|Surgery,No,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 80, 'day_interval': 2400}",,Preventive,1.0,,Blazer score,,2.0,Treatment stopped due to acute toxicity,TREATMENT_617,DONOR_17,SYNTHETIC-1
PRIMARY_DIAGNOSIS_138,Immunotherapy|Photodynamic therapy,Unknown,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 75, 'day_interval': 2250}",Mobilization,Guidance,7.0,,AML Response Criteria,No evidence of disease (NED),4.0,Other,TREATMENT_618,DONOR_18,SYNTHETIC-1
PRIMARY_DIAGNOSIS_139,Chemotherapy|Photodynamic therapy|Hormonal therapy,Yes,"{'month_interval': 33, 'day_interval': 990}",,Advanced/Metastatic,Palliative,3.0,5.0,,Progressive disease,4.0,,TREATMENT_619,DONOR_19,SYNTHETIC-1
PRIMARY_DIAGNOSIS_140,Hormonal therapy|Stem cell transplant|Chemotherapy,Yes,"{'month_interval': 9, 'day_interval': 270}","{'month_interval': 57, 'day_interval': 1710}",Preventative,Curative,2.0,4.0,Physician Assessed Response Criteria,Complete response,1.0,Treatment completed as prescribed,TREATMENT_620,DONOR_20,SYNTHETIC-1
PRIMARY_DIAGNOSIS_141,No treatment,Yes,"{'month_interval': 44, 'day_interval': 1320}","{'month_interval': 77, 'day_interval': 2310}",Maintenance,Forensic,6.0,3.0,AML Response Criteria,Immune complete response (iCR),3.0,Treatment incomplete because patient died,TREATMENT_621,DONOR_21,SYNTHETIC-1
PRIMARY_DIAGNOSIS_142,,,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 80, 'day_interval': 2400}",Radiosensitization,Forensic,4.0,5.0,,,2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_622,DONOR_22,SYNTHETIC-1
PRIMARY_DIAGNOSIS_143,Hormonal therapy,No,,"{'month_interval': 92, 'day_interval': 2760}",Locally advanced,,4.0,4.0,iRECIST,Major response,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_623,DONOR_23,SYNTHETIC-1
PRIMARY_DIAGNOSIS_144,Hormonal therapy,No,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 83, 'day_interval': 2490}",Preventative,Supportive,5.0,3.0,Response Assessment in Neuro-Oncology (RANO),Immune confirmed progressive disease (iCPD),2.0,Unknown,TREATMENT_624,DONOR_24,SYNTHETIC-1
PRIMARY_DIAGNOSIS_145,Bone marrow transplant,,"{'month_interval': 21, 'day_interval': 630}",,Adjuvant,Diagnostic,7.0,5.0,,Physician assessed stable disease,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_625,DONOR_25,SYNTHETIC-1
PRIMARY_DIAGNOSIS_146,,Unknown,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 56, 'day_interval': 1680}",Preventative,Supportive,1.0,5.0,RECIST 1.1,Immune uncomfirmed progressive disease (iUPD),4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_626,DONOR_26,SYNTHETIC-1
PRIMARY_DIAGNOSIS_147,Bone marrow transplant,Unknown,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 89, 'day_interval': 2670}",,Diagnostic,7.0,3.0,Response Assessment in Neuro-Oncology (RANO),Immune stable disease (iSD),5.0,Not applicable,TREATMENT_627,DONOR_27,SYNTHETIC-1
PRIMARY_DIAGNOSIS_148,Chemotherapy|Other targeting molecular therapy|Hormonal therapy,Yes,,"{'month_interval': 78, 'day_interval': 2340}",,,2.0,5.0,Physician Assessed Response Criteria,No evidence of disease (NED),1.0,Treatment incomplete because patient died,TREATMENT_628,DONOR_28,SYNTHETIC-1
PRIMARY_DIAGNOSIS_149,Immunotherapy|Chemotherapy,Yes,"{'month_interval': 14, 'day_interval': 420}","{'month_interval': 50, 'day_interval': 1500}",,Diagnostic,4.0,3.0,Response Assessment in Neuro-Oncology (RANO),,,,TREATMENT_629,DONOR_29,SYNTHETIC-1
PRIMARY_DIAGNOSIS_150,,Yes,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 71, 'day_interval': 2130}",Preventative,Screening,3.0,5.0,,,,,TREATMENT_630,DONOR_30,SYNTHETIC-1
PRIMARY_DIAGNOSIS_151,Other targeting molecular therapy|Chemotherapy|Hormonal therapy,Yes,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 65, 'day_interval': 1950}",Salvage,Supportive,6.0,5.0,Response Assessment in Neuro-Oncology (RANO),Immune stable disease (iSD),3.0,Patient choice (stopped or interrupted treatment),TREATMENT_631,DONOR_31,SYNTHETIC-1
PRIMARY_DIAGNOSIS_152,No treatment|Immunotherapy,,"{'month_interval': 23, 'day_interval': 690}","{'month_interval': 51, 'day_interval': 1530}",Preventative,Forensic,3.0,5.0,Physician Assessed Response Criteria,Morphologic leukemia-free state,,Patient choice (stopped or interrupted treatment),TREATMENT_632,DONOR_32,SYNTHETIC-1
PRIMARY_DIAGNOSIS_153,Radiation therapy|Stem cell transplant|Hormonal therapy,,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 80, 'day_interval': 2400}",Adjuvant,Curative,3.0,5.0,RECIST 1.1,Stable disease,3.0,,TREATMENT_633,DONOR_33,SYNTHETIC-1
PRIMARY_DIAGNOSIS_154,Other targeting molecular therapy,Unknown,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 72, 'day_interval': 2160}",Radiosensitization,Screening,4.0,5.0,Cheson CLL 2012 Oncology Response Criteria,,,Treatment incomplete due to technical or organizational problems,TREATMENT_634,DONOR_34,SYNTHETIC-1
PRIMARY_DIAGNOSIS_155,,Yes,"{'month_interval': 15, 'day_interval': 450}",,Advanced/Metastatic,Guidance,1.0,3.0,,Primary refractory disease,,Patient choice (stopped or interrupted treatment),TREATMENT_635,DONOR_35,SYNTHETIC-1
PRIMARY_DIAGNOSIS_156,,No,"{'month_interval': 22, 'day_interval': 660}",,Induction,Curative,2.0,5.0,Cheson CLL 2012 Oncology Response Criteria,,4.0,Physician decision (stopped or interrupted treatment),TREATMENT_636,DONOR_36,SYNTHETIC-1
PRIMARY_DIAGNOSIS_157,,Unknown,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 76, 'day_interval': 2280}",,Forensic,,3.0,Physician Assessed Response Criteria,Morphologic leukemia-free state,1.0,Treatment stopped due to acute toxicity,TREATMENT_637,DONOR_37,SYNTHETIC-1
PRIMARY_DIAGNOSIS_158,Surgery|Hormonal therapy,Yes,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 53, 'day_interval': 1590}",Radiosensitization,Supportive,5.0,4.0,iRECIST,Morphologic leukemia-free state,5.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_638,DONOR_38,SYNTHETIC-1
PRIMARY_DIAGNOSIS_159,Immunotherapy|Surgery,No,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 63, 'day_interval': 1890}",Salvage,Screening,7.0,3.0,AML Response Criteria,Immune complete response (iCR),1.0,Other,TREATMENT_639,DONOR_39,SYNTHETIC-1
PRIMARY_DIAGNOSIS_160,Photodynamic therapy|Bone marrow transplant|Radiation therapy,,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 66, 'day_interval': 1980}",Adjuvant,Palliative,1.0,3.0,AML Response Criteria,,,Treatment completed as prescribed,TREATMENT_640,DONOR_40,SYNTHETIC-1
PRIMARY_DIAGNOSIS_161,,Yes,"{'month_interval': 4, 'day_interval': 120}",,Maintenance,Forensic,1.0,4.0,,Physician assessed partial response,,Treatment stopped due to acute toxicity,TREATMENT_641,DONOR_41,SYNTHETIC-2
PRIMARY_DIAGNOSIS_162,Stem cell transplant|Chemotherapy|Photodynamic therapy,No,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 52, 'day_interval': 1560}",Preventative,Curative,6.0,3.0,Cheson CLL 2012 Oncology Response Criteria,No evidence of disease (NED),2.0,Treatment stopped due to acute toxicity,TREATMENT_642,DONOR_42,SYNTHETIC-2
PRIMARY_DIAGNOSIS_163,No treatment|Photodynamic therapy|Stem cell transplant,No,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 94, 'day_interval': 2820}",,Curative,1.0,3.0,iRECIST,Complete remission with incomplete hematologic recovery (CRi),4.0,Treatment incomplete because patient died,TREATMENT_643,DONOR_43,SYNTHETIC-2
PRIMARY_DIAGNOSIS_164,Bone marrow transplant|Surgery|Stem cell transplant,No,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 60, 'day_interval': 1800}",Locally advanced,Screening,5.0,5.0,Blazer score,Stable disease,2.0,,TREATMENT_644,DONOR_44,SYNTHETIC-2
PRIMARY_DIAGNOSIS_165,,,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 97, 'day_interval': 2910}",Maintenance,Diagnostic,4.0,4.0,RECIST 1.1,Immune stable disease (iSD),,Not applicable,TREATMENT_645,DONOR_45,SYNTHETIC-2
PRIMARY_DIAGNOSIS_166,Immunotherapy|Chemotherapy|No treatment,Yes,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 73, 'day_interval': 2190}",Neoadjuvant,Screening,7.0,3.0,Blazer score,Complete response,2.0,,TREATMENT_646,DONOR_46,SYNTHETIC-2
PRIMARY_DIAGNOSIS_167,,Yes,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 84, 'day_interval': 2520}",Conditioning,Screening,7.0,3.0,Blazer score,,,Patient choice (stopped or interrupted treatment),TREATMENT_647,DONOR_47,SYNTHETIC-2
PRIMARY_DIAGNOSIS_168,Photodynamic therapy|Other targeting molecular therapy|No treatment,Yes,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 64, 'day_interval': 1920}",Neoadjuvant,Supportive,2.0,4.0,Response Assessment in Neuro-Oncology (RANO),Molecular relapse (after CR MRD-),,Patient choice (stopped or interrupted treatment),TREATMENT_648,DONOR_48,SYNTHETIC-2
PRIMARY_DIAGNOSIS_169,Radiation therapy|No treatment|Chemotherapy,Yes,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 50, 'day_interval': 1500}",,,6.0,3.0,AML Response Criteria,Stable disease,2.0,,TREATMENT_649,DONOR_49,SYNTHETIC-2
PRIMARY_DIAGNOSIS_170,Photodynamic therapy|Chemotherapy,Yes,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 62, 'day_interval': 1860}",Mobilization,Curative,,,Physician Assessed Response Criteria,"Hematologic relapse (after CR MRD-, CR, CRi)",5.0,Treatment stopped due to acute toxicity,TREATMENT_650,DONOR_50,SYNTHETIC-2
PRIMARY_DIAGNOSIS_171,Chemotherapy|Surgery,No,"{'month_interval': 10, 'day_interval': 300}",,Radiosensitization,,1.0,,AML Response Criteria,Minor response,1.0,,TREATMENT_651,DONOR_51,SYNTHETIC-2
PRIMARY_DIAGNOSIS_172,Immunotherapy,Unknown,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 50, 'day_interval': 1500}",Salvage,Forensic,5.0,,Cheson CLL 2012 Oncology Response Criteria,Progressive disease,3.0,Other,TREATMENT_652,DONOR_52,SYNTHETIC-2
PRIMARY_DIAGNOSIS_173,Stem cell transplant,Yes,,"{'month_interval': 64, 'day_interval': 1920}",Neoadjuvant,Guidance,7.0,5.0,Blazer score,Immune complete response (iCR),,Treatment stopped due to acute toxicity,TREATMENT_653,DONOR_53,SYNTHETIC-2
PRIMARY_DIAGNOSIS_174,Stem cell transplant|Radiation therapy,Yes,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 88, 'day_interval': 2640}",Salvage,Guidance,,3.0,AML Response Criteria,Primary refractory disease,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_654,DONOR_54,SYNTHETIC-2
PRIMARY_DIAGNOSIS_175,Immunotherapy|Chemotherapy,No,,"{'month_interval': 68, 'day_interval': 2040}",Induction,Diagnostic,2.0,,,Physician assessed partial response,5.0,,TREATMENT_655,DONOR_55,SYNTHETIC-2
PRIMARY_DIAGNOSIS_176,Other targeting molecular therapy,,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 81, 'day_interval': 2430}",Adjuvant,Preventive,2.0,5.0,RECIST 1.1,Partial remission,,Treatment incomplete because patient died,TREATMENT_656,DONOR_56,SYNTHETIC-2
PRIMARY_DIAGNOSIS_177,Other targeting molecular therapy,Unknown,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 60, 'day_interval': 1800}",,Palliative,2.0,4.0,Blazer score,Immune complete response (iCR),2.0,Physician decision (stopped or interrupted treatment),TREATMENT_657,DONOR_57,SYNTHETIC-2
PRIMARY_DIAGNOSIS_178,,No,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 67, 'day_interval': 2010}",Adjuvant,Palliative,1.0,4.0,Blazer score,Physician assessed partial response,4.0,,TREATMENT_658,DONOR_58,SYNTHETIC-2
PRIMARY_DIAGNOSIS_179,,No,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 55, 'day_interval': 1650}",Conditioning,Guidance,5.0,4.0,Blazer score,,1.0,,TREATMENT_659,DONOR_59,SYNTHETIC-2
PRIMARY_DIAGNOSIS_180,No treatment|Hormonal therapy,No,"{'month_interval': 29, 'day_interval': 870}",,Radiosensitization,Guidance,7.0,5.0,AML Response Criteria,Partial response,1.0,Unknown,TREATMENT_660,DONOR_60,SYNTHETIC-2
PRIMARY_DIAGNOSIS_181,Immunotherapy,Unknown,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 66, 'day_interval': 1980}",Adjuvant,Preventive,5.0,5.0,,Partial response,2.0,Treatment incomplete because patient died,TREATMENT_661,DONOR_61,SYNTHETIC-2
PRIMARY_DIAGNOSIS_182,Chemotherapy,Yes,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 63, 'day_interval': 1890}",Induction,Guidance,2.0,4.0,Response Assessment in Neuro-Oncology (RANO),"Hematologic relapse (after CR MRD-, CR, CRi)",1.0,Other,TREATMENT_662,DONOR_62,SYNTHETIC-2
PRIMARY_DIAGNOSIS_183,,Unknown,"{'month_interval': 10, 'day_interval': 300}","{'month_interval': 62, 'day_interval': 1860}",Neoadjuvant,Guidance,5.0,5.0,iRECIST,Major response,3.0,Treatment stopped due to acute toxicity,TREATMENT_663,DONOR_63,SYNTHETIC-2
PRIMARY_DIAGNOSIS_184,No treatment|Other targeting molecular therapy,No,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 95, 'day_interval': 2850}",,,4.0,4.0,Blazer score,Immune uncomfirmed progressive disease (iUPD),2.0,Treatment completed as prescribed,TREATMENT_664,DONOR_64,SYNTHETIC-2
PRIMARY_DIAGNOSIS_185,,Unknown,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 62, 'day_interval': 1860}",Salvage,Guidance,5.0,5.0,iRECIST,Complete remission without measurable residual disease (CR MRD-),2.0,Other,TREATMENT_665,DONOR_65,SYNTHETIC-2
PRIMARY_DIAGNOSIS_186,,Yes,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 67, 'day_interval': 2010}",Salvage,Curative,7.0,4.0,,,,Unknown,TREATMENT_666,DONOR_66,SYNTHETIC-2
PRIMARY_DIAGNOSIS_187,No treatment,Unknown,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 98, 'day_interval': 2940}",Maintenance,Curative,7.0,4.0,,,2.0,Physician decision (stopped or interrupted treatment),TREATMENT_667,DONOR_67,SYNTHETIC-2
PRIMARY_DIAGNOSIS_188,Stem cell transplant|Hormonal therapy,Unknown,"{'month_interval': 8, 'day_interval': 240}","{'month_interval': 60, 'day_interval': 1800}",Locally advanced,Palliative,3.0,4.0,Response Assessment in Neuro-Oncology (RANO),Immune confirmed progressive disease (iCPD),4.0,Other,TREATMENT_668,DONOR_68,SYNTHETIC-2
PRIMARY_DIAGNOSIS_189,Hormonal therapy|Immunotherapy,Yes,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 81, 'day_interval': 2430}",Advanced/Metastatic,Guidance,,3.0,iRECIST,No evidence of disease (NED),5.0,Physician decision (stopped or interrupted treatment),TREATMENT_669,DONOR_69,SYNTHETIC-2
PRIMARY_DIAGNOSIS_190,No treatment|Other targeting molecular therapy,,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 85, 'day_interval': 2550}",Advanced/Metastatic,Curative,2.0,,iRECIST,Partial response,,Treatment incomplete due to technical or organizational problems,TREATMENT_670,DONOR_70,SYNTHETIC-2
PRIMARY_DIAGNOSIS_191,Surgery|Photodynamic therapy,Yes,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 82, 'day_interval': 2460}",Adjuvant,Preventive,7.0,4.0,Blazer score,Complete response,3.0,Treatment incomplete because patient died,TREATMENT_671,DONOR_41,SYNTHETIC-2
PRIMARY_DIAGNOSIS_192,Immunotherapy|Other targeting molecular therapy,Yes,,"{'month_interval': 63, 'day_interval': 1890}",Advanced/Metastatic,,,5.0,Physician Assessed Response Criteria,No evidence of disease (NED),,Treatment completed as prescribed,TREATMENT_672,DONOR_42,SYNTHETIC-2
PRIMARY_DIAGNOSIS_193,,No,"{'month_interval': 4, 'day_interval': 120}","{'month_interval': 91, 'day_interval': 2730}",Induction,Curative,,5.0,Cheson CLL 2012 Oncology Response Criteria,Complete remission with incomplete hematologic recovery (CRi),4.0,Physician decision (stopped or interrupted treatment),TREATMENT_673,DONOR_43,SYNTHETIC-2
PRIMARY_DIAGNOSIS_194,Photodynamic therapy|Radiation therapy,Yes,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 67, 'day_interval': 2010}",Salvage,Forensic,5.0,4.0,,,,Treatment completed as prescribed,TREATMENT_674,DONOR_44,SYNTHETIC-2
PRIMARY_DIAGNOSIS_195,,Yes,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 68, 'day_interval': 2040}",,Guidance,,,Physician Assessed Response Criteria,Complete remission,3.0,Treatment completed as prescribed,TREATMENT_675,DONOR_45,SYNTHETIC-2
PRIMARY_DIAGNOSIS_196,Surgery|Radiation therapy,No,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 52, 'day_interval': 1560}",,Palliative,6.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Physician assessed stable disease,3.0,Treatment completed as prescribed,TREATMENT_676,DONOR_46,SYNTHETIC-2
PRIMARY_DIAGNOSIS_197,Photodynamic therapy|Radiation therapy,No,"{'month_interval': 12, 'day_interval': 360}",,Mobilization,,3.0,3.0,AML Response Criteria,,4.0,Other,TREATMENT_677,DONOR_47,SYNTHETIC-2
PRIMARY_DIAGNOSIS_198,Stem cell transplant|Photodynamic therapy,Yes,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 86, 'day_interval': 2580}",Maintenance,Forensic,5.0,4.0,AML Response Criteria,Immune confirmed progressive disease (iCPD),3.0,Treatment completed as prescribed,TREATMENT_678,DONOR_48,SYNTHETIC-2
PRIMARY_DIAGNOSIS_199,Radiation therapy|Chemotherapy,,"{'month_interval': 44, 'day_interval': 1320}","{'month_interval': 56, 'day_interval': 1680}",Salvage,,,5.0,Physician Assessed Response Criteria,Minor response,,Treatment incomplete because patient died,TREATMENT_679,DONOR_49,SYNTHETIC-2
PRIMARY_DIAGNOSIS_200,Bone marrow transplant|No treatment,,"{'month_interval': 41, 'day_interval': 1230}","{'month_interval': 75, 'day_interval': 2250}",Radiosensitization,Forensic,,5.0,Physician Assessed Response Criteria,Physician assessed complete response,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_680,DONOR_50,SYNTHETIC-2
PRIMARY_DIAGNOSIS_201,Stem cell transplant|No treatment|Bone marrow transplant,,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 97, 'day_interval': 2910}",Mobilization,Palliative,5.0,3.0,Blazer score,Complete response,3.0,Treatment completed as prescribed,TREATMENT_681,DONOR_51,SYNTHETIC-2
PRIMARY_DIAGNOSIS_202,Stem cell transplant|Chemotherapy,No,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 81, 'day_interval': 2430}",Locally advanced,Palliative,5.0,5.0,iRECIST,Molecular relapse (after CR MRD-),4.0,,TREATMENT_682,DONOR_52,SYNTHETIC-2
PRIMARY_DIAGNOSIS_203,,Yes,"{'month_interval': 27, 'day_interval': 810}",,Adjuvant,Supportive,1.0,3.0,Physician Assessed Response Criteria,Immune uncomfirmed progressive disease (iUPD),1.0,Physician decision (stopped or interrupted treatment),TREATMENT_683,DONOR_53,SYNTHETIC-2
PRIMARY_DIAGNOSIS_204,Immunotherapy|Radiation therapy|Photodynamic therapy,Yes,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 53, 'day_interval': 1590}",Locally advanced,Diagnostic,,3.0,iRECIST,Partial response,4.0,Treatment incomplete because patient died,TREATMENT_684,DONOR_54,SYNTHETIC-2
PRIMARY_DIAGNOSIS_205,Bone marrow transplant|Other targeting molecular therapy|Photodynamic therapy,Yes,"{'month_interval': 31, 'day_interval': 930}",,Maintenance,Palliative,6.0,4.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed complete response,,Patient choice (stopped or interrupted treatment),TREATMENT_685,DONOR_55,SYNTHETIC-2
PRIMARY_DIAGNOSIS_206,,Unknown,"{'month_interval': 44, 'day_interval': 1320}","{'month_interval': 62, 'day_interval': 1860}",Preventative,Forensic,2.0,5.0,iRECIST,Complete remission without measurable residual disease (CR MRD-),4.0,Physician decision (stopped or interrupted treatment),TREATMENT_686,DONOR_56,SYNTHETIC-2
PRIMARY_DIAGNOSIS_207,Photodynamic therapy|Bone marrow transplant,No,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 66, 'day_interval': 1980}",,Palliative,7.0,5.0,RECIST 1.1,Minor response,2.0,Unknown,TREATMENT_687,DONOR_57,SYNTHETIC-2
PRIMARY_DIAGNOSIS_208,No treatment,No,,"{'month_interval': 64, 'day_interval': 1920}",Advanced/Metastatic,Supportive,3.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Minor response,,,TREATMENT_688,DONOR_58,SYNTHETIC-2
PRIMARY_DIAGNOSIS_209,,Yes,,"{'month_interval': 93, 'day_interval': 2790}",Salvage,Diagnostic,6.0,5.0,RECIST 1.1,Immune partial response (iPR),3.0,Patient choice (stopped or interrupted treatment),TREATMENT_689,DONOR_59,SYNTHETIC-2
PRIMARY_DIAGNOSIS_210,No treatment|Stem cell transplant,Yes,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 65, 'day_interval': 1950}",Preventative,Diagnostic,1.0,3.0,Blazer score,,,Unknown,TREATMENT_690,DONOR_60,SYNTHETIC-2
PRIMARY_DIAGNOSIS_211,,Yes,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 74, 'day_interval': 2220}",Preventative,Supportive,6.0,4.0,Response Assessment in Neuro-Oncology (RANO),Stable disease,,Physician decision (stopped or interrupted treatment),TREATMENT_691,DONOR_61,SYNTHETIC-2
PRIMARY_DIAGNOSIS_212,Photodynamic therapy,Yes,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 59, 'day_interval': 1770}",,Palliative,7.0,5.0,AML Response Criteria,,,Treatment stopped due to acute toxicity,TREATMENT_692,DONOR_62,SYNTHETIC-2
PRIMARY_DIAGNOSIS_213,Radiation therapy|Chemotherapy,No,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 74, 'day_interval': 2220}",Advanced/Metastatic,Supportive,4.0,3.0,RECIST 1.1,Molecular relapse (after CR MRD-),,Physician decision (stopped or interrupted treatment),TREATMENT_693,DONOR_63,SYNTHETIC-2
PRIMARY_DIAGNOSIS_214,Hormonal therapy|Other targeting molecular therapy|Stem cell transplant,Yes,,"{'month_interval': 100, 'day_interval': 3000}",Mobilization,Supportive,3.0,4.0,Cheson CLL 2012 Oncology Response Criteria,No evidence of disease (NED),5.0,Treatment stopped due to acute toxicity,TREATMENT_694,DONOR_64,SYNTHETIC-2
PRIMARY_DIAGNOSIS_215,,Yes,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 96, 'day_interval': 2880}",Maintenance,Preventive,6.0,5.0,,Complete response,2.0,Treatment incomplete because patient died,TREATMENT_695,DONOR_65,SYNTHETIC-2
PRIMARY_DIAGNOSIS_216,Immunotherapy,No,"{'month_interval': 11, 'day_interval': 330}","{'month_interval': 51, 'day_interval': 1530}",Induction,Guidance,6.0,5.0,RECIST 1.1,,1.0,Other,TREATMENT_696,DONOR_66,SYNTHETIC-2
PRIMARY_DIAGNOSIS_217,Immunotherapy,Yes,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 72, 'day_interval': 2160}",Neoadjuvant,Palliative,3.0,5.0,AML Response Criteria,Minor response,1.0,,TREATMENT_697,DONOR_67,SYNTHETIC-2
PRIMARY_DIAGNOSIS_218,No treatment|Photodynamic therapy|Radiation therapy,Unknown,,"{'month_interval': 51, 'day_interval': 1530}",Radiosensitization,Palliative,,4.0,Physician Assessed Response Criteria,Primary refractory disease,4.0,Treatment completed as prescribed,TREATMENT_698,DONOR_68,SYNTHETIC-2
PRIMARY_DIAGNOSIS_219,Surgery|Hormonal therapy,No,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 76, 'day_interval': 2280}",Conditioning,Guidance,4.0,5.0,AML Response Criteria,Complete remission,1.0,Treatment completed as prescribed,TREATMENT_699,DONOR_69,SYNTHETIC-2
PRIMARY_DIAGNOSIS_220,Stem cell transplant|Immunotherapy|Other targeting molecular therapy,Unknown,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 64, 'day_interval': 1920}",Radiosensitization,Diagnostic,1.0,4.0,iRECIST,Physician assessed partial response,3.0,Treatment incomplete because patient died,TREATMENT_700,DONOR_70,SYNTHETIC-2
PRIMARY_DIAGNOSIS_221,Chemotherapy,No,"{'month_interval': 36, 'day_interval': 1080}",,,Supportive,,4.0,RECIST 1.1,,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_701,DONOR_41,SYNTHETIC-2
PRIMARY_DIAGNOSIS_222,Immunotherapy,No,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 84, 'day_interval': 2520}",Salvage,Diagnostic,5.0,3.0,,Partial remission,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_702,DONOR_42,SYNTHETIC-2
PRIMARY_DIAGNOSIS_223,Stem cell transplant|Surgery,Yes,,"{'month_interval': 66, 'day_interval': 1980}",Neoadjuvant,Preventive,5.0,3.0,iRECIST,No evidence of disease (NED),4.0,Unknown,TREATMENT_703,DONOR_43,SYNTHETIC-2
PRIMARY_DIAGNOSIS_224,Hormonal therapy,Unknown,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 52, 'day_interval': 1560}",Locally advanced,,4.0,4.0,iRECIST,Progressive disease,3.0,Treatment stopped due to acute toxicity,TREATMENT_704,DONOR_44,SYNTHETIC-2
PRIMARY_DIAGNOSIS_225,,,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 89, 'day_interval': 2670}",Maintenance,Diagnostic,6.0,3.0,iRECIST,"Hematologic relapse (after CR MRD-, CR, CRi)",,Patient choice (stopped or interrupted treatment),TREATMENT_705,DONOR_45,SYNTHETIC-2
PRIMARY_DIAGNOSIS_226,,Yes,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 51, 'day_interval': 1530}",Conditioning,Supportive,,,Response Assessment in Neuro-Oncology (RANO),,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_706,DONOR_46,SYNTHETIC-2
PRIMARY_DIAGNOSIS_227,No treatment,No,"{'month_interval': 39, 'day_interval': 1170}",,Neoadjuvant,Preventive,1.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Complete response,1.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_707,DONOR_47,SYNTHETIC-2
PRIMARY_DIAGNOSIS_228,Immunotherapy|Stem cell transplant|Surgery,,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 96, 'day_interval': 2880}",Advanced/Metastatic,Screening,,4.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed complete response,1.0,,TREATMENT_708,DONOR_48,SYNTHETIC-2
PRIMARY_DIAGNOSIS_229,Other targeting molecular therapy|Photodynamic therapy,,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 55, 'day_interval': 1650}",Neoadjuvant,Diagnostic,3.0,4.0,iRECIST,Immune stable disease (iSD),5.0,Treatment incomplete due to technical or organizational problems,TREATMENT_709,DONOR_49,SYNTHETIC-2
PRIMARY_DIAGNOSIS_230,,Unknown,,,Preventative,Guidance,2.0,4.0,Cheson CLL 2012 Oncology Response Criteria,,3.0,Treatment completed as prescribed,TREATMENT_710,DONOR_50,SYNTHETIC-2
PRIMARY_DIAGNOSIS_231,Stem cell transplant,Unknown,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 58, 'day_interval': 1740}",Salvage,Forensic,4.0,,Blazer score,Complete response,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_711,DONOR_51,SYNTHETIC-2
PRIMARY_DIAGNOSIS_232,Immunotherapy,No,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 83, 'day_interval': 2490}",Adjuvant,Preventive,5.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Stable disease,2.0,Unknown,TREATMENT_712,DONOR_52,SYNTHETIC-2
PRIMARY_DIAGNOSIS_233,Surgery|Bone marrow transplant,Yes,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 86, 'day_interval': 2580}",Locally advanced,Forensic,2.0,4.0,iRECIST,Complete remission without measurable residual disease (CR MRD-),4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_713,DONOR_53,SYNTHETIC-2
PRIMARY_DIAGNOSIS_234,Stem cell transplant,No,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 51, 'day_interval': 1530}",Radiosensitization,Screening,3.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Primary refractory disease,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_714,DONOR_54,SYNTHETIC-2
PRIMARY_DIAGNOSIS_235,Hormonal therapy|Other targeting molecular therapy,Yes,"{'month_interval': 23, 'day_interval': 690}",,Preventative,Diagnostic,1.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Complete remission with incomplete hematologic recovery (CRi),4.0,,TREATMENT_715,DONOR_55,SYNTHETIC-2
PRIMARY_DIAGNOSIS_236,No treatment,Unknown,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 71, 'day_interval': 2130}",Induction,Palliative,5.0,4.0,AML Response Criteria,Physician assessed complete response,4.0,,TREATMENT_716,DONOR_56,SYNTHETIC-2
PRIMARY_DIAGNOSIS_237,,Yes,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 56, 'day_interval': 1680}",Conditioning,,5.0,3.0,Physician Assessed Response Criteria,"Hematologic relapse (after CR MRD-, CR, CRi)",,,TREATMENT_717,DONOR_57,SYNTHETIC-2
PRIMARY_DIAGNOSIS_238,,Unknown,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 75, 'day_interval': 2250}",Adjuvant,Diagnostic,4.0,5.0,Physician Assessed Response Criteria,Immune uncomfirmed progressive disease (iUPD),2.0,Treatment completed as prescribed,TREATMENT_718,DONOR_58,SYNTHETIC-2
PRIMARY_DIAGNOSIS_239,Immunotherapy|Surgery|Stem cell transplant,Unknown,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 87, 'day_interval': 2610}",Mobilization,Forensic,4.0,,Blazer score,Primary refractory disease,3.0,,TREATMENT_719,DONOR_59,SYNTHETIC-2
PRIMARY_DIAGNOSIS_240,Hormonal therapy,Unknown,"{'month_interval': 9, 'day_interval': 270}","{'month_interval': 89, 'day_interval': 2670}",Maintenance,,2.0,,iRECIST,No evidence of disease (NED),1.0,Unknown,TREATMENT_720,DONOR_60,SYNTHETIC-2
PRIMARY_DIAGNOSIS_241,Other targeting molecular therapy|Chemotherapy|No treatment,Yes,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 74, 'day_interval': 2220}",Locally advanced,Diagnostic,3.0,4.0,Physician Assessed Response Criteria,,5.0,Unknown,TREATMENT_721,DONOR_61,SYNTHETIC-2
PRIMARY_DIAGNOSIS_242,Stem cell transplant,No,,"{'month_interval': 71, 'day_interval': 2130}",Mobilization,Guidance,6.0,3.0,AML Response Criteria,Minor response,2.0,,TREATMENT_722,DONOR_62,SYNTHETIC-2
PRIMARY_DIAGNOSIS_243,,Unknown,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 95, 'day_interval': 2850}",Locally advanced,Supportive,5.0,3.0,RECIST 1.1,Primary refractory disease,5.0,Treatment completed as prescribed,TREATMENT_723,DONOR_63,SYNTHETIC-2
PRIMARY_DIAGNOSIS_244,Stem cell transplant|Other targeting molecular therapy|Photodynamic therapy,Yes,"{'month_interval': 9, 'day_interval': 270}","{'month_interval': 68, 'day_interval': 2040}",Advanced/Metastatic,Forensic,5.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Stable disease,3.0,Physician decision (stopped or interrupted treatment),TREATMENT_724,DONOR_64,SYNTHETIC-2
PRIMARY_DIAGNOSIS_245,No treatment|Surgery|Radiation therapy,Yes,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 92, 'day_interval': 2760}",,,6.0,5.0,AML Response Criteria,Partial response,,Treatment completed as prescribed,TREATMENT_725,DONOR_65,SYNTHETIC-2
PRIMARY_DIAGNOSIS_246,,Unknown,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 82, 'day_interval': 2460}",Neoadjuvant,Preventive,1.0,,,Immune uncomfirmed progressive disease (iUPD),,Treatment stopped due to acute toxicity,TREATMENT_726,DONOR_66,SYNTHETIC-2
PRIMARY_DIAGNOSIS_247,,Unknown,"{'month_interval': 39, 'day_interval': 1170}","{'month_interval': 56, 'day_interval': 1680}",Preventative,Palliative,5.0,5.0,iRECIST,,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_727,DONOR_67,SYNTHETIC-2
PRIMARY_DIAGNOSIS_248,,Yes,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 52, 'day_interval': 1560}",,Palliative,2.0,5.0,Response Assessment in Neuro-Oncology (RANO),Immune stable disease (iSD),,Not applicable,TREATMENT_728,DONOR_68,SYNTHETIC-2
PRIMARY_DIAGNOSIS_249,Bone marrow transplant,,,"{'month_interval': 76, 'day_interval': 2280}",Locally advanced,Curative,2.0,,Cheson CLL 2012 Oncology Response Criteria,Molecular relapse (after CR MRD-),,Patient choice (stopped or interrupted treatment),TREATMENT_729,DONOR_69,SYNTHETIC-2
PRIMARY_DIAGNOSIS_250,Immunotherapy|Hormonal therapy,Unknown,"{'month_interval': 11, 'day_interval': 330}","{'month_interval': 93, 'day_interval': 2790}",Neoadjuvant,,,4.0,,Molecular relapse (after CR MRD-),2.0,Other,TREATMENT_730,DONOR_70,SYNTHETIC-2
PRIMARY_DIAGNOSIS_161,Hormonal therapy|Other targeting molecular therapy|Bone marrow transplant,Unknown,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 74, 'day_interval': 2220}",Adjuvant,Diagnostic,7.0,5.0,Response Assessment in Neuro-Oncology (RANO),,4.0,,TREATMENT_731,DONOR_41,SYNTHETIC-2
PRIMARY_DIAGNOSIS_162,,,"{'month_interval': 11, 'day_interval': 330}","{'month_interval': 86, 'day_interval': 2580}",Preventative,Guidance,4.0,4.0,Blazer score,Partial response,2.0,Treatment incomplete due to technical or organizational problems,TREATMENT_732,DONOR_42,SYNTHETIC-2
PRIMARY_DIAGNOSIS_163,Hormonal therapy|Chemotherapy|Surgery,Yes,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 76, 'day_interval': 2280}",Maintenance,Palliative,3.0,4.0,Physician Assessed Response Criteria,Stable disease,,Treatment incomplete because patient died,TREATMENT_733,DONOR_43,SYNTHETIC-2
PRIMARY_DIAGNOSIS_164,No treatment,No,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 68, 'day_interval': 2040}",Induction,Supportive,,4.0,,Stable disease,,Treatment incomplete because patient died,TREATMENT_734,DONOR_44,SYNTHETIC-2
PRIMARY_DIAGNOSIS_165,Radiation therapy|Photodynamic therapy|No treatment,Yes,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 81, 'day_interval': 2430}",,Preventive,1.0,3.0,Response Assessment in Neuro-Oncology (RANO),Immune uncomfirmed progressive disease (iUPD),4.0,,TREATMENT_735,DONOR_45,SYNTHETIC-2
PRIMARY_DIAGNOSIS_166,,Unknown,,"{'month_interval': 66, 'day_interval': 1980}",,,3.0,3.0,iRECIST,Progressive disease,,,TREATMENT_736,DONOR_46,SYNTHETIC-2
PRIMARY_DIAGNOSIS_167,,Yes,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 58, 'day_interval': 1740}",Adjuvant,Palliative,3.0,5.0,iRECIST,Molecular relapse (after CR MRD-),,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_737,DONOR_47,SYNTHETIC-2
PRIMARY_DIAGNOSIS_168,Photodynamic therapy|Surgery,No,"{'month_interval': 45, 'day_interval': 1350}",,Preventative,Forensic,7.0,4.0,iRECIST,Primary refractory disease,5.0,Physician decision (stopped or interrupted treatment),TREATMENT_738,DONOR_48,SYNTHETIC-2
PRIMARY_DIAGNOSIS_169,,No,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 62, 'day_interval': 1860}",Locally advanced,Guidance,3.0,4.0,AML Response Criteria,Minor response,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_739,DONOR_49,SYNTHETIC-2
PRIMARY_DIAGNOSIS_170,Chemotherapy,,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 95, 'day_interval': 2850}",Induction,Preventive,4.0,5.0,,Immune uncomfirmed progressive disease (iUPD),1.0,Treatment stopped due to acute toxicity,TREATMENT_740,DONOR_50,SYNTHETIC-2
PRIMARY_DIAGNOSIS_171,,No,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 67, 'day_interval': 2010}",Preventative,Screening,2.0,5.0,iRECIST,Complete remission without measurable residual disease (CR MRD-),5.0,Patient choice (stopped or interrupted treatment),TREATMENT_741,DONOR_51,SYNTHETIC-2
PRIMARY_DIAGNOSIS_172,Bone marrow transplant,Yes,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 77, 'day_interval': 2310}",Maintenance,Forensic,,4.0,RECIST 1.1,Partial response,,Treatment incomplete because patient died,TREATMENT_742,DONOR_52,SYNTHETIC-2
PRIMARY_DIAGNOSIS_173,Surgery|Stem cell transplant|Bone marrow transplant,Unknown,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 70, 'day_interval': 2100}",,Diagnostic,1.0,5.0,RECIST 1.1,Minor response,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_743,DONOR_53,SYNTHETIC-2
PRIMARY_DIAGNOSIS_174,Bone marrow transplant,Unknown,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 89, 'day_interval': 2670}",Conditioning,Preventive,,3.0,RECIST 1.1,,5.0,Patient choice (stopped or interrupted treatment),TREATMENT_744,DONOR_54,SYNTHETIC-2
PRIMARY_DIAGNOSIS_175,Hormonal therapy|No treatment|Surgery,Yes,"{'month_interval': 9, 'day_interval': 270}","{'month_interval': 58, 'day_interval': 1740}",Conditioning,Forensic,7.0,,Cheson CLL 2012 Oncology Response Criteria,Minor response,1.0,,TREATMENT_745,DONOR_55,SYNTHETIC-2
PRIMARY_DIAGNOSIS_176,,Yes,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 77, 'day_interval': 2310}",,,5.0,3.0,RECIST 1.1,,5.0,Treatment stopped due to acute toxicity,TREATMENT_746,DONOR_56,SYNTHETIC-2
PRIMARY_DIAGNOSIS_177,Bone marrow transplant|Surgery|Hormonal therapy,Unknown,,"{'month_interval': 66, 'day_interval': 1980}",Radiosensitization,Curative,5.0,3.0,iRECIST,Partial response,3.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_747,DONOR_57,SYNTHETIC-2
PRIMARY_DIAGNOSIS_178,Radiation therapy,No,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 63, 'day_interval': 1890}",,Curative,7.0,5.0,Response Assessment in Neuro-Oncology (RANO),Progressive disease,3.0,,TREATMENT_748,DONOR_58,SYNTHETIC-2
PRIMARY_DIAGNOSIS_179,No treatment|Hormonal therapy,No,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 100, 'day_interval': 3000}",Adjuvant,Forensic,7.0,5.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed partial response,,Other,TREATMENT_749,DONOR_59,SYNTHETIC-2
PRIMARY_DIAGNOSIS_180,,Unknown,"{'month_interval': 12, 'day_interval': 360}",,Preventative,Palliative,3.0,4.0,Blazer score,Molecular relapse (after CR MRD-),5.0,Unknown,TREATMENT_750,DONOR_60,SYNTHETIC-2
PRIMARY_DIAGNOSIS_181,Surgery,Unknown,"{'month_interval': 16, 'day_interval': 480}",,Preventative,Screening,5.0,,,Immune uncomfirmed progressive disease (iUPD),3.0,Treatment completed as prescribed,TREATMENT_751,DONOR_61,SYNTHETIC-2
PRIMARY_DIAGNOSIS_182,,No,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 100, 'day_interval': 3000}",Adjuvant,Diagnostic,4.0,3.0,RECIST 1.1,Complete remission with incomplete hematologic recovery (CRi),1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_752,DONOR_62,SYNTHETIC-2
PRIMARY_DIAGNOSIS_183,,Unknown,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 90, 'day_interval': 2700}",Locally advanced,Guidance,7.0,5.0,Response Assessment in Neuro-Oncology (RANO),,,,TREATMENT_753,DONOR_63,SYNTHETIC-2
PRIMARY_DIAGNOSIS_184,Hormonal therapy|Photodynamic therapy|Surgery,Yes,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 96, 'day_interval': 2880}",Locally advanced,Guidance,,5.0,Physician Assessed Response Criteria,Immune confirmed progressive disease (iCPD),5.0,Treatment completed as prescribed,TREATMENT_754,DONOR_64,SYNTHETIC-2
PRIMARY_DIAGNOSIS_185,Hormonal therapy,Yes,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 66, 'day_interval': 1980}",Neoadjuvant,Diagnostic,3.0,3.0,,,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_755,DONOR_65,SYNTHETIC-2
PRIMARY_DIAGNOSIS_186,,Yes,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 99, 'day_interval': 2970}",Salvage,Screening,3.0,4.0,iRECIST,Progressive disease,1.0,Patient choice (stopped or interrupted treatment),TREATMENT_756,DONOR_66,SYNTHETIC-2
PRIMARY_DIAGNOSIS_187,Surgery,Unknown,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 95, 'day_interval': 2850}",Preventative,Forensic,2.0,3.0,Response Assessment in Neuro-Oncology (RANO),,,Other,TREATMENT_757,DONOR_67,SYNTHETIC-2
PRIMARY_DIAGNOSIS_188,Chemotherapy|Surgery|Stem cell transplant,No,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 53, 'day_interval': 1590}",Radiosensitization,Curative,2.0,,,Immune uncomfirmed progressive disease (iUPD),5.0,Treatment incomplete due to technical or organizational problems,TREATMENT_758,DONOR_68,SYNTHETIC-2
PRIMARY_DIAGNOSIS_189,Surgery|Chemotherapy|No treatment,Yes,"{'month_interval': 43, 'day_interval': 1290}",,Conditioning,Screening,4.0,3.0,iRECIST,,3.0,Not applicable,TREATMENT_759,DONOR_69,SYNTHETIC-2
PRIMARY_DIAGNOSIS_190,Radiation therapy|Bone marrow transplant|Surgery,No,"{'month_interval': 4, 'day_interval': 120}","{'month_interval': 96, 'day_interval': 2880}",Radiosensitization,Screening,3.0,3.0,Blazer score,"Hematologic relapse (after CR MRD-, CR, CRi)",4.0,Treatment stopped due to acute toxicity,TREATMENT_760,DONOR_70,SYNTHETIC-2
PRIMARY_DIAGNOSIS_191,Photodynamic therapy|Surgery|Stem cell transplant,Yes,"{'month_interval': 30, 'day_interval': 900}",,Salvage,Diagnostic,6.0,5.0,Response Assessment in Neuro-Oncology (RANO),Minor response,2.0,Patient choice (stopped or interrupted treatment),TREATMENT_761,DONOR_41,SYNTHETIC-2
PRIMARY_DIAGNOSIS_192,Surgery|No treatment|Bone marrow transplant,No,"{'month_interval': 45, 'day_interval': 1350}",,Salvage,Screening,6.0,5.0,Physician Assessed Response Criteria,Physician assessed complete response,2.0,Not applicable,TREATMENT_762,DONOR_42,SYNTHETIC-2
PRIMARY_DIAGNOSIS_193,,No,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 63, 'day_interval': 1890}",,Screening,2.0,3.0,,Physician assessed stable disease,2.0,Treatment incomplete due to technical or organizational problems,TREATMENT_763,DONOR_43,SYNTHETIC-2
PRIMARY_DIAGNOSIS_194,Bone marrow transplant,No,,,Induction,Palliative,,5.0,AML Response Criteria,,3.0,,TREATMENT_764,DONOR_44,SYNTHETIC-2
PRIMARY_DIAGNOSIS_195,,,,"{'month_interval': 51, 'day_interval': 1530}",Advanced/Metastatic,Diagnostic,7.0,3.0,AML Response Criteria,Minor response,2.0,Patient choice (stopped or interrupted treatment),TREATMENT_765,DONOR_45,SYNTHETIC-2
PRIMARY_DIAGNOSIS_196,Immunotherapy,,"{'month_interval': 39, 'day_interval': 1170}","{'month_interval': 74, 'day_interval': 2220}",Induction,Diagnostic,1.0,4.0,Physician Assessed Response Criteria,,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_766,DONOR_46,SYNTHETIC-2
PRIMARY_DIAGNOSIS_197,,,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 57, 'day_interval': 1710}",Adjuvant,Forensic,1.0,4.0,Response Assessment in Neuro-Oncology (RANO),Immune uncomfirmed progressive disease (iUPD),2.0,,TREATMENT_767,DONOR_47,SYNTHETIC-2
PRIMARY_DIAGNOSIS_198,Stem cell transplant|Hormonal therapy|Bone marrow transplant,,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 95, 'day_interval': 2850}",Mobilization,Curative,4.0,4.0,RECIST 1.1,Immune uncomfirmed progressive disease (iUPD),4.0,Patient choice (stopped or interrupted treatment),TREATMENT_768,DONOR_48,SYNTHETIC-2
PRIMARY_DIAGNOSIS_199,Bone marrow transplant,Unknown,"{'month_interval': 18, 'day_interval': 540}","{'month_interval': 51, 'day_interval': 1530}",Salvage,Palliative,3.0,3.0,,Immune complete response (iCR),4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_769,DONOR_49,SYNTHETIC-2
PRIMARY_DIAGNOSIS_200,Radiation therapy,No,,"{'month_interval': 76, 'day_interval': 2280}",Maintenance,Supportive,7.0,3.0,,Immune uncomfirmed progressive disease (iUPD),4.0,Patient choice (stopped or interrupted treatment),TREATMENT_770,DONOR_50,SYNTHETIC-2
PRIMARY_DIAGNOSIS_201,Immunotherapy|Stem cell transplant,No,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 83, 'day_interval': 2490}",Maintenance,Curative,,4.0,,,5.0,Patient choice (stopped or interrupted treatment),TREATMENT_771,DONOR_51,SYNTHETIC-2
PRIMARY_DIAGNOSIS_202,Surgery,Unknown,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 66, 'day_interval': 1980}",Salvage,,4.0,5.0,Physician Assessed Response Criteria,Primary refractory disease,3.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_772,DONOR_52,SYNTHETIC-2
PRIMARY_DIAGNOSIS_203,Surgery|Radiation therapy,Unknown,,,Conditioning,Forensic,1.0,4.0,RECIST 1.1,Physician assessed partial response,4.0,Treatment stopped due to acute toxicity,TREATMENT_773,DONOR_53,SYNTHETIC-2
PRIMARY_DIAGNOSIS_204,Hormonal therapy|Surgery|Chemotherapy,No,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 62, 'day_interval': 1860}",Maintenance,,1.0,4.0,Blazer score,,5.0,Treatment stopped due to acute toxicity,TREATMENT_774,DONOR_54,SYNTHETIC-2
PRIMARY_DIAGNOSIS_205,Hormonal therapy|Other targeting molecular therapy|Surgery,Yes,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 77, 'day_interval': 2310}",Maintenance,Diagnostic,2.0,3.0,RECIST 1.1,Major response,5.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_775,DONOR_55,SYNTHETIC-2
PRIMARY_DIAGNOSIS_206,No treatment|Surgery|Radiation therapy,No,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 78, 'day_interval': 2340}",Preventative,Guidance,6.0,4.0,Cheson CLL 2012 Oncology Response Criteria,,2.0,,TREATMENT_776,DONOR_56,SYNTHETIC-2
PRIMARY_DIAGNOSIS_207,Stem cell transplant|Surgery,No,"{'month_interval': 18, 'day_interval': 540}","{'month_interval': 81, 'day_interval': 2430}",,Palliative,2.0,,,Physician assessed complete response,3.0,Not applicable,TREATMENT_777,DONOR_57,SYNTHETIC-2
PRIMARY_DIAGNOSIS_208,Hormonal therapy|Surgery,No,"{'month_interval': 10, 'day_interval': 300}","{'month_interval': 93, 'day_interval': 2790}",Adjuvant,Supportive,3.0,5.0,Physician Assessed Response Criteria,Major response,,Not applicable,TREATMENT_778,DONOR_58,SYNTHETIC-2
PRIMARY_DIAGNOSIS_209,,,,"{'month_interval': 52, 'day_interval': 1560}",Radiosensitization,Guidance,5.0,3.0,Response Assessment in Neuro-Oncology (RANO),Partial remission,2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_779,DONOR_59,SYNTHETIC-2
PRIMARY_DIAGNOSIS_210,,Unknown,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 74, 'day_interval': 2220}",Mobilization,Diagnostic,1.0,3.0,Physician Assessed Response Criteria,Partial response,4.0,Physician decision (stopped or interrupted treatment),TREATMENT_780,DONOR_60,SYNTHETIC-2
PRIMARY_DIAGNOSIS_211,,No,"{'month_interval': 50, 'day_interval': 1500}",,Maintenance,Screening,6.0,4.0,,Partial response,,Treatment stopped due to acute toxicity,TREATMENT_781,DONOR_61,SYNTHETIC-2
PRIMARY_DIAGNOSIS_212,Hormonal therapy,No,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 90, 'day_interval': 2700}",Locally advanced,Diagnostic,,,Blazer score,Minor response,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_782,DONOR_62,SYNTHETIC-2
PRIMARY_DIAGNOSIS_213,Immunotherapy|Chemotherapy|Other targeting molecular therapy,Yes,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 70, 'day_interval': 2100}",Preventative,Preventive,7.0,3.0,AML Response Criteria,Complete remission,1.0,,TREATMENT_783,DONOR_63,SYNTHETIC-2
PRIMARY_DIAGNOSIS_214,Bone marrow transplant|Photodynamic therapy,No,"{'month_interval': 7, 'day_interval': 210}",,Conditioning,Forensic,1.0,5.0,,No evidence of disease (NED),3.0,Treatment incomplete because patient died,TREATMENT_784,DONOR_64,SYNTHETIC-2
PRIMARY_DIAGNOSIS_215,Photodynamic therapy|Surgery|Chemotherapy,Yes,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 61, 'day_interval': 1830}",Adjuvant,Supportive,2.0,4.0,AML Response Criteria,,4.0,Physician decision (stopped or interrupted treatment),TREATMENT_785,DONOR_65,SYNTHETIC-2
PRIMARY_DIAGNOSIS_216,Immunotherapy,No,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 87, 'day_interval': 2610}",,Curative,3.0,3.0,iRECIST,,,,TREATMENT_786,DONOR_66,SYNTHETIC-2
PRIMARY_DIAGNOSIS_217,Chemotherapy|No treatment|Surgery,No,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 77, 'day_interval': 2310}",Conditioning,Guidance,3.0,3.0,RECIST 1.1,Morphologic leukemia-free state,3.0,Treatment completed as prescribed,TREATMENT_787,DONOR_67,SYNTHETIC-2
PRIMARY_DIAGNOSIS_218,Hormonal therapy,,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 53, 'day_interval': 1590}",Neoadjuvant,Preventive,1.0,,Cheson CLL 2012 Oncology Response Criteria,Major response,3.0,Treatment completed as prescribed,TREATMENT_788,DONOR_68,SYNTHETIC-2
PRIMARY_DIAGNOSIS_219,Photodynamic therapy|Radiation therapy|Hormonal therapy,Unknown,"{'month_interval': 7, 'day_interval': 210}",,Induction,,4.0,3.0,,"Hematologic relapse (after CR MRD-, CR, CRi)",4.0,,TREATMENT_789,DONOR_69,SYNTHETIC-2
PRIMARY_DIAGNOSIS_220,Chemotherapy|Surgery|Stem cell transplant,,,"{'month_interval': 74, 'day_interval': 2220}",Maintenance,Diagnostic,4.0,3.0,iRECIST,,2.0,Patient choice (stopped or interrupted treatment),TREATMENT_790,DONOR_70,SYNTHETIC-2
PRIMARY_DIAGNOSIS_221,Stem cell transplant,Unknown,"{'month_interval': 50, 'day_interval': 1500}",,Salvage,Curative,1.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Stable disease,4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_791,DONOR_41,SYNTHETIC-2
PRIMARY_DIAGNOSIS_222,Radiation therapy,Yes,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 69, 'day_interval': 2070}",Conditioning,,,5.0,RECIST 1.1,Complete response,,Physician decision (stopped or interrupted treatment),TREATMENT_792,DONOR_42,SYNTHETIC-2
PRIMARY_DIAGNOSIS_223,,,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 96, 'day_interval': 2880}",Advanced/Metastatic,Curative,4.0,5.0,AML Response Criteria,Major response,2.0,Treatment incomplete due to technical or organizational problems,TREATMENT_793,DONOR_43,SYNTHETIC-2
PRIMARY_DIAGNOSIS_224,Photodynamic therapy|Chemotherapy,No,"{'month_interval': 8, 'day_interval': 240}","{'month_interval': 93, 'day_interval': 2790}",Locally advanced,,7.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Immune confirmed progressive disease (iCPD),4.0,,TREATMENT_794,DONOR_44,SYNTHETIC-2
PRIMARY_DIAGNOSIS_225,,No,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 59, 'day_interval': 1770}",Advanced/Metastatic,Supportive,3.0,3.0,Response Assessment in Neuro-Oncology (RANO),Molecular relapse (after CR MRD-),1.0,Patient choice (stopped or interrupted treatment),TREATMENT_795,DONOR_45,SYNTHETIC-2
PRIMARY_DIAGNOSIS_226,Stem cell transplant,Unknown,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 60, 'day_interval': 1800}",Neoadjuvant,Guidance,3.0,5.0,,Complete remission with incomplete hematologic recovery (CRi),3.0,,TREATMENT_796,DONOR_46,SYNTHETIC-2
PRIMARY_DIAGNOSIS_227,Stem cell transplant,,"{'month_interval': 5, 'day_interval': 150}","{'month_interval': 70, 'day_interval': 2100}",Preventative,Palliative,3.0,5.0,,Complete remission,1.0,,TREATMENT_797,DONOR_47,SYNTHETIC-2
PRIMARY_DIAGNOSIS_228,Chemotherapy,No,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 53, 'day_interval': 1590}",Neoadjuvant,Guidance,7.0,4.0,RECIST 1.1,Physician assessed partial response,1.0,Treatment incomplete because patient died,TREATMENT_798,DONOR_48,SYNTHETIC-2
PRIMARY_DIAGNOSIS_229,,Unknown,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 68, 'day_interval': 2040}",,Palliative,1.0,,Cheson CLL 2012 Oncology Response Criteria,Immune uncomfirmed progressive disease (iUPD),4.0,,TREATMENT_799,DONOR_49,SYNTHETIC-2
PRIMARY_DIAGNOSIS_230,,No,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 88, 'day_interval': 2640}",Adjuvant,Guidance,7.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Primary refractory disease,1.0,Not applicable,TREATMENT_800,DONOR_50,SYNTHETIC-2
PRIMARY_DIAGNOSIS_231,Hormonal therapy|Stem cell transplant|No treatment,,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 59, 'day_interval': 1770}",Adjuvant,Guidance,2.0,5.0,Blazer score,Molecular relapse (after CR MRD-),4.0,Physician decision (stopped or interrupted treatment),TREATMENT_801,DONOR_51,SYNTHETIC-2
PRIMARY_DIAGNOSIS_232,,Unknown,,"{'month_interval': 89, 'day_interval': 2670}",Adjuvant,Palliative,2.0,3.0,iRECIST,Minor response,2.0,Not applicable,TREATMENT_802,DONOR_52,SYNTHETIC-2
PRIMARY_DIAGNOSIS_233,Radiation therapy|Bone marrow transplant,Yes,"{'month_interval': 18, 'day_interval': 540}",,Neoadjuvant,Supportive,5.0,,Cheson CLL 2012 Oncology Response Criteria,Stable disease,4.0,Treatment completed as prescribed,TREATMENT_803,DONOR_53,SYNTHETIC-2
PRIMARY_DIAGNOSIS_234,,Yes,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 74, 'day_interval': 2220}",Advanced/Metastatic,Screening,2.0,4.0,iRECIST,Complete response,5.0,Treatment incomplete because patient died,TREATMENT_804,DONOR_54,SYNTHETIC-2
PRIMARY_DIAGNOSIS_235,Radiation therapy|Immunotherapy,Unknown,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 60, 'day_interval': 1800}",Adjuvant,Supportive,5.0,4.0,Physician Assessed Response Criteria,,5.0,,TREATMENT_805,DONOR_55,SYNTHETIC-2
PRIMARY_DIAGNOSIS_236,Surgery,No,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 61, 'day_interval': 1830}",Mobilization,,7.0,3.0,,Immune stable disease (iSD),2.0,Not applicable,TREATMENT_806,DONOR_56,SYNTHETIC-2
PRIMARY_DIAGNOSIS_237,Immunotherapy|Other targeting molecular therapy|Chemotherapy,No,"{'month_interval': 11, 'day_interval': 330}",,Radiosensitization,Curative,,5.0,Cheson CLL 2012 Oncology Response Criteria,,2.0,Treatment stopped due to acute toxicity,TREATMENT_807,DONOR_57,SYNTHETIC-2
PRIMARY_DIAGNOSIS_238,Chemotherapy|Photodynamic therapy|Stem cell transplant,Unknown,"{'month_interval': 19, 'day_interval': 570}",,Maintenance,Preventive,6.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Complete remission without measurable residual disease (CR MRD-),4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_808,DONOR_58,SYNTHETIC-2
PRIMARY_DIAGNOSIS_239,Chemotherapy|Surgery,Unknown,"{'month_interval': 3, 'day_interval': 90}","{'month_interval': 83, 'day_interval': 2490}",Advanced/Metastatic,,6.0,4.0,,Minor response,3.0,Unknown,TREATMENT_809,DONOR_59,SYNTHETIC-2
PRIMARY_DIAGNOSIS_240,Photodynamic therapy,Unknown,"{'month_interval': 4, 'day_interval': 120}","{'month_interval': 86, 'day_interval': 2580}",Maintenance,,4.0,5.0,Response Assessment in Neuro-Oncology (RANO),No evidence of disease (NED),4.0,,TREATMENT_810,DONOR_60,SYNTHETIC-2
PRIMARY_DIAGNOSIS_241,Immunotherapy|Stem cell transplant|No treatment,No,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 62, 'day_interval': 1860}",Adjuvant,Guidance,3.0,4.0,Response Assessment in Neuro-Oncology (RANO),Major response,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_811,DONOR_61,SYNTHETIC-2
PRIMARY_DIAGNOSIS_242,Stem cell transplant|Hormonal therapy|Chemotherapy,Yes,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 70, 'day_interval': 2100}",,Guidance,4.0,4.0,RECIST 1.1,Complete response,3.0,Patient choice (stopped or interrupted treatment),TREATMENT_812,DONOR_62,SYNTHETIC-2
PRIMARY_DIAGNOSIS_243,Photodynamic therapy|Chemotherapy|Hormonal therapy,Yes,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 77, 'day_interval': 2310}",Radiosensitization,Diagnostic,6.0,,Blazer score,Complete remission,2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_813,DONOR_63,SYNTHETIC-2
PRIMARY_DIAGNOSIS_244,,,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 76, 'day_interval': 2280}",Salvage,,,4.0,iRECIST,Complete remission with incomplete hematologic recovery (CRi),3.0,Treatment incomplete due to technical or organizational problems,TREATMENT_814,DONOR_64,SYNTHETIC-2
PRIMARY_DIAGNOSIS_245,Photodynamic therapy|Surgery|No treatment,No,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 95, 'day_interval': 2850}",Adjuvant,Preventive,7.0,3.0,Blazer score,Partial remission,,Physician decision (stopped or interrupted treatment),TREATMENT_815,DONOR_65,SYNTHETIC-2
PRIMARY_DIAGNOSIS_246,Surgery|Chemotherapy|No treatment,Unknown,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 75, 'day_interval': 2250}",Radiosensitization,Palliative,1.0,3.0,Physician Assessed Response Criteria,,3.0,Treatment stopped due to acute toxicity,TREATMENT_816,DONOR_66,SYNTHETIC-2
PRIMARY_DIAGNOSIS_247,Chemotherapy,No,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 65, 'day_interval': 1950}",Neoadjuvant,Guidance,6.0,5.0,iRECIST,,1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_817,DONOR_67,SYNTHETIC-2
PRIMARY_DIAGNOSIS_248,Other targeting molecular therapy|Chemotherapy,Unknown,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 69, 'day_interval': 2070}",,Screening,3.0,4.0,RECIST 1.1,No evidence of disease (NED),,Treatment incomplete due to technical or organizational problems,TREATMENT_818,DONOR_68,SYNTHETIC-2
PRIMARY_DIAGNOSIS_249,No treatment|Hormonal therapy,No,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 74, 'day_interval': 2220}",Mobilization,Palliative,5.0,5.0,Physician Assessed Response Criteria,Minor response,1.0,Not applicable,TREATMENT_819,DONOR_69,SYNTHETIC-2
PRIMARY_DIAGNOSIS_250,Chemotherapy|Surgery|Radiation therapy,,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 72, 'day_interval': 2160}",Neoadjuvant,Screening,2.0,3.0,,Major response,5.0,Physician decision (stopped or interrupted treatment),TREATMENT_820,DONOR_70,SYNTHETIC-2
PRIMARY_DIAGNOSIS_161,,Unknown,"{'month_interval': 3, 'day_interval': 90}","{'month_interval': 59, 'day_interval': 1770}",Neoadjuvant,Palliative,6.0,3.0,iRECIST,Progressive disease,4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_821,DONOR_41,SYNTHETIC-2
PRIMARY_DIAGNOSIS_162,No treatment|Bone marrow transplant|Hormonal therapy,Unknown,"{'month_interval': 8, 'day_interval': 240}","{'month_interval': 94, 'day_interval': 2820}",,Screening,6.0,3.0,AML Response Criteria,Physician assessed partial response,1.0,Treatment stopped due to acute toxicity,TREATMENT_822,DONOR_42,SYNTHETIC-2
PRIMARY_DIAGNOSIS_163,,No,"{'month_interval': 10, 'day_interval': 300}",,Adjuvant,Curative,1.0,4.0,RECIST 1.1,,2.0,Physician decision (stopped or interrupted treatment),TREATMENT_823,DONOR_43,SYNTHETIC-2
PRIMARY_DIAGNOSIS_164,Bone marrow transplant|Chemotherapy,Yes,"{'month_interval': 4, 'day_interval': 120}",,Neoadjuvant,,6.0,4.0,Blazer score,Primary refractory disease,2.0,Treatment stopped due to acute toxicity,TREATMENT_824,DONOR_44,SYNTHETIC-2
PRIMARY_DIAGNOSIS_165,Immunotherapy|Radiation therapy,Yes,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 84, 'day_interval': 2520}",Neoadjuvant,Screening,2.0,4.0,Cheson CLL 2012 Oncology Response Criteria,No evidence of disease (NED),4.0,Other,TREATMENT_825,DONOR_45,SYNTHETIC-2
PRIMARY_DIAGNOSIS_166,Surgery|Radiation therapy|Hormonal therapy,No,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 96, 'day_interval': 2880}",,Preventive,7.0,3.0,Physician Assessed Response Criteria,,5.0,Treatment incomplete because patient died,TREATMENT_826,DONOR_46,SYNTHETIC-2
PRIMARY_DIAGNOSIS_167,,,,"{'month_interval': 74, 'day_interval': 2220}",Neoadjuvant,Preventive,4.0,4.0,Blazer score,Major response,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_827,DONOR_47,SYNTHETIC-2
PRIMARY_DIAGNOSIS_168,No treatment|Bone marrow transplant|Surgery,Yes,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 95, 'day_interval': 2850}",Conditioning,Diagnostic,2.0,4.0,,Primary refractory disease,1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_828,DONOR_48,SYNTHETIC-2
PRIMARY_DIAGNOSIS_169,Photodynamic therapy|Surgery|Bone marrow transplant,Unknown,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 72, 'day_interval': 2160}",Induction,Diagnostic,5.0,4.0,RECIST 1.1,Major response,4.0,Physician decision (stopped or interrupted treatment),TREATMENT_829,DONOR_49,SYNTHETIC-2
PRIMARY_DIAGNOSIS_170,Chemotherapy|No treatment,No,,"{'month_interval': 86, 'day_interval': 2580}",Mobilization,Preventive,4.0,3.0,,Progressive disease,3.0,,TREATMENT_830,DONOR_50,SYNTHETIC-2
PRIMARY_DIAGNOSIS_171,Stem cell transplant,Unknown,"{'month_interval': 4, 'day_interval': 120}","{'month_interval': 92, 'day_interval': 2760}",Radiosensitization,Forensic,4.0,,Response Assessment in Neuro-Oncology (RANO),,4.0,Treatment completed as prescribed,TREATMENT_831,DONOR_51,SYNTHETIC-2
PRIMARY_DIAGNOSIS_172,Chemotherapy|Radiation therapy|Surgery,No,"{'month_interval': 48, 'day_interval': 1440}","{'month_interval': 51, 'day_interval': 1530}",,Forensic,6.0,4.0,AML Response Criteria,Complete remission,4.0,Treatment incomplete due to technical or organizational problems,TREATMENT_832,DONOR_52,SYNTHETIC-2
PRIMARY_DIAGNOSIS_173,Other targeting molecular therapy|Surgery,Yes,"{'month_interval': 30, 'day_interval': 900}",,Preventative,Guidance,,5.0,Cheson CLL 2012 Oncology Response Criteria,Major response,4.0,Treatment stopped due to acute toxicity,TREATMENT_833,DONOR_53,SYNTHETIC-2
PRIMARY_DIAGNOSIS_174,,No,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 91, 'day_interval': 2730}",Salvage,Screening,5.0,3.0,RECIST 1.1,Minor response,2.0,Unknown,TREATMENT_834,DONOR_54,SYNTHETIC-2
PRIMARY_DIAGNOSIS_175,Stem cell transplant|No treatment|Radiation therapy,Yes,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 65, 'day_interval': 1950}",Induction,Guidance,,3.0,,Physician assessed stable disease,,Other,TREATMENT_835,DONOR_55,SYNTHETIC-2
PRIMARY_DIAGNOSIS_176,Immunotherapy,Yes,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 100, 'day_interval': 3000}",Conditioning,Supportive,6.0,5.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed complete response,2.0,Treatment incomplete due to technical or organizational problems,TREATMENT_836,DONOR_56,SYNTHETIC-2
PRIMARY_DIAGNOSIS_177,,Unknown,,"{'month_interval': 85, 'day_interval': 2550}",Conditioning,Guidance,1.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Immune partial response (iPR),5.0,Not applicable,TREATMENT_837,DONOR_57,SYNTHETIC-2
PRIMARY_DIAGNOSIS_178,Bone marrow transplant|No treatment|Immunotherapy,Yes,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 76, 'day_interval': 2280}",Mobilization,Supportive,6.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Partial response,1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_838,DONOR_58,SYNTHETIC-2
PRIMARY_DIAGNOSIS_179,Bone marrow transplant|Hormonal therapy,Yes,,"{'month_interval': 71, 'day_interval': 2130}",Mobilization,Forensic,5.0,5.0,Response Assessment in Neuro-Oncology (RANO),No evidence of disease (NED),2.0,Physician decision (stopped or interrupted treatment),TREATMENT_839,DONOR_59,SYNTHETIC-2
PRIMARY_DIAGNOSIS_180,Chemotherapy|Radiation therapy,Unknown,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 79, 'day_interval': 2370}",Advanced/Metastatic,Screening,4.0,4.0,,Complete response,2.0,,TREATMENT_840,DONOR_60,SYNTHETIC-2
PRIMARY_DIAGNOSIS_181,No treatment|Surgery,Yes,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 52, 'day_interval': 1560}",Advanced/Metastatic,Forensic,7.0,5.0,RECIST 1.1,,1.0,Unknown,TREATMENT_841,DONOR_61,SYNTHETIC-2
PRIMARY_DIAGNOSIS_182,Radiation therapy,No,"{'month_interval': 23, 'day_interval': 690}","{'month_interval': 88, 'day_interval': 2640}",,Curative,1.0,3.0,iRECIST,Partial remission,4.0,Unknown,TREATMENT_842,DONOR_62,SYNTHETIC-2
PRIMARY_DIAGNOSIS_183,,No,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 95, 'day_interval': 2850}",Neoadjuvant,,,4.0,Cheson CLL 2012 Oncology Response Criteria,Physician assessed stable disease,3.0,,TREATMENT_843,DONOR_63,SYNTHETIC-2
PRIMARY_DIAGNOSIS_184,Immunotherapy,No,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 50, 'day_interval': 1500}",Salvage,Palliative,2.0,4.0,,Immune partial response (iPR),5.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_844,DONOR_64,SYNTHETIC-2
PRIMARY_DIAGNOSIS_185,Radiation therapy,Unknown,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 64, 'day_interval': 1920}",Advanced/Metastatic,Supportive,3.0,4.0,iRECIST,Progressive disease,1.0,Treatment incomplete due to technical or organizational problems,TREATMENT_845,DONOR_65,SYNTHETIC-2
PRIMARY_DIAGNOSIS_186,Surgery|Radiation therapy|Stem cell transplant,No,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 78, 'day_interval': 2340}",Locally advanced,Palliative,3.0,3.0,iRECIST,Physician assessed partial response,3.0,Not applicable,TREATMENT_846,DONOR_66,SYNTHETIC-2
PRIMARY_DIAGNOSIS_187,,Unknown,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 75, 'day_interval': 2250}",Salvage,Guidance,,3.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed stable disease,3.0,Treatment incomplete due to technical or organizational problems,TREATMENT_847,DONOR_67,SYNTHETIC-2
PRIMARY_DIAGNOSIS_188,,Unknown,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 91, 'day_interval': 2730}",Conditioning,,,3.0,,Minor response,5.0,Not applicable,TREATMENT_848,DONOR_68,SYNTHETIC-2
PRIMARY_DIAGNOSIS_189,Radiation therapy,Unknown,,"{'month_interval': 65, 'day_interval': 1950}",Maintenance,Guidance,,5.0,AML Response Criteria,,5.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_849,DONOR_69,SYNTHETIC-2
PRIMARY_DIAGNOSIS_190,Radiation therapy,No,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 71, 'day_interval': 2130}",,Palliative,3.0,,iRECIST,Complete remission,1.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_850,DONOR_70,SYNTHETIC-2
PRIMARY_DIAGNOSIS_191,Other targeting molecular therapy,Yes,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 60, 'day_interval': 1800}",Induction,Guidance,3.0,5.0,AML Response Criteria,Immune complete response (iCR),5.0,Not applicable,TREATMENT_851,DONOR_41,SYNTHETIC-2
PRIMARY_DIAGNOSIS_192,Surgery|Bone marrow transplant|Hormonal therapy,Unknown,,"{'month_interval': 80, 'day_interval': 2400}",Adjuvant,Curative,6.0,5.0,AML Response Criteria,Immune complete response (iCR),1.0,Treatment completed as prescribed,TREATMENT_852,DONOR_42,SYNTHETIC-2
PRIMARY_DIAGNOSIS_193,Chemotherapy|Photodynamic therapy|Stem cell transplant,Yes,"{'month_interval': 41, 'day_interval': 1230}","{'month_interval': 68, 'day_interval': 2040}",Adjuvant,Diagnostic,2.0,,Response Assessment in Neuro-Oncology (RANO),Partial response,2.0,Patient choice (stopped or interrupted treatment),TREATMENT_853,DONOR_43,SYNTHETIC-2
PRIMARY_DIAGNOSIS_194,No treatment|Stem cell transplant|Hormonal therapy,Unknown,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 79, 'day_interval': 2370}",,Diagnostic,5.0,3.0,iRECIST,No evidence of disease (NED),5.0,Treatment stopped due to acute toxicity,TREATMENT_854,DONOR_44,SYNTHETIC-2
PRIMARY_DIAGNOSIS_195,Other targeting molecular therapy|Surgery,Unknown,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 60, 'day_interval': 1800}",Induction,Diagnostic,7.0,5.0,iRECIST,Partial remission,,Treatment incomplete because patient died,TREATMENT_855,DONOR_45,SYNTHETIC-2
PRIMARY_DIAGNOSIS_196,Hormonal therapy,Unknown,,,Locally advanced,Diagnostic,6.0,4.0,Response Assessment in Neuro-Oncology (RANO),,1.0,Treatment completed as prescribed,TREATMENT_856,DONOR_46,SYNTHETIC-2
PRIMARY_DIAGNOSIS_197,Immunotherapy|Other targeting molecular therapy|Hormonal therapy,Yes,,"{'month_interval': 75, 'day_interval': 2250}",Radiosensitization,Curative,5.0,4.0,iRECIST,"Hematologic relapse (after CR MRD-, CR, CRi)",,Other,TREATMENT_857,DONOR_47,SYNTHETIC-2
PRIMARY_DIAGNOSIS_198,Hormonal therapy|Other targeting molecular therapy,No,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 68, 'day_interval': 2040}",Locally advanced,Screening,6.0,3.0,RECIST 1.1,Major response,,Treatment completed as prescribed,TREATMENT_858,DONOR_48,SYNTHETIC-2
PRIMARY_DIAGNOSIS_199,No treatment|Bone marrow transplant|Stem cell transplant,Unknown,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 87, 'day_interval': 2610}",Induction,Diagnostic,6.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Complete remission,5.0,Other,TREATMENT_859,DONOR_49,SYNTHETIC-2
PRIMARY_DIAGNOSIS_200,,Yes,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 58, 'day_interval': 1740}",Preventative,Diagnostic,2.0,5.0,Response Assessment in Neuro-Oncology (RANO),Primary refractory disease,3.0,,TREATMENT_860,DONOR_50,SYNTHETIC-2
PRIMARY_DIAGNOSIS_201,Immunotherapy|Photodynamic therapy|Chemotherapy,Unknown,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 99, 'day_interval': 2970}",Maintenance,Forensic,3.0,4.0,RECIST 1.1,Immune partial response (iPR),4.0,,TREATMENT_861,DONOR_51,SYNTHETIC-2
PRIMARY_DIAGNOSIS_202,Hormonal therapy|Immunotherapy|Other targeting molecular therapy,No,"{'month_interval': 6, 'day_interval': 180}","{'month_interval': 72, 'day_interval': 2160}",Conditioning,Supportive,6.0,,AML Response Criteria,,,Not applicable,TREATMENT_862,DONOR_52,SYNTHETIC-2
PRIMARY_DIAGNOSIS_203,Chemotherapy|Bone marrow transplant,No,"{'month_interval': 20, 'day_interval': 600}","{'month_interval': 57, 'day_interval': 1710}",Preventative,Guidance,4.0,5.0,Physician Assessed Response Criteria,Primary refractory disease,4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_863,DONOR_53,SYNTHETIC-2
PRIMARY_DIAGNOSIS_204,Chemotherapy,Yes,"{'month_interval': 2, 'day_interval': 60}","{'month_interval': 98, 'day_interval': 2940}",Salvage,Forensic,1.0,4.0,Blazer score,Immune confirmed progressive disease (iCPD),2.0,Physician decision (stopped or interrupted treatment),TREATMENT_864,DONOR_54,SYNTHETIC-2
PRIMARY_DIAGNOSIS_205,Surgery|Chemotherapy,Yes,,,Conditioning,Guidance,4.0,4.0,,,,,TREATMENT_865,DONOR_55,SYNTHETIC-2
PRIMARY_DIAGNOSIS_206,No treatment|Chemotherapy|Bone marrow transplant,Yes,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 55, 'day_interval': 1650}",,Guidance,2.0,3.0,iRECIST,,4.0,,TREATMENT_866,DONOR_56,SYNTHETIC-2
PRIMARY_DIAGNOSIS_207,Immunotherapy|Stem cell transplant,No,"{'month_interval': 4, 'day_interval': 120}","{'month_interval': 79, 'day_interval': 2370}",Neoadjuvant,Forensic,3.0,5.0,Physician Assessed Response Criteria,,,Treatment stopped due to acute toxicity,TREATMENT_867,DONOR_57,SYNTHETIC-2
PRIMARY_DIAGNOSIS_208,Stem cell transplant|Hormonal therapy,Yes,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 95, 'day_interval': 2850}",Preventative,Supportive,4.0,5.0,Response Assessment in Neuro-Oncology (RANO),,2.0,,TREATMENT_868,DONOR_58,SYNTHETIC-2
PRIMARY_DIAGNOSIS_209,Photodynamic therapy,,,,Radiosensitization,Diagnostic,4.0,,Physician Assessed Response Criteria,"Hematologic relapse (after CR MRD-, CR, CRi)",,Treatment incomplete because patient died,TREATMENT_869,DONOR_59,SYNTHETIC-2
PRIMARY_DIAGNOSIS_210,,Unknown,"{'month_interval': 4, 'day_interval': 120}",,Adjuvant,,1.0,4.0,iRECIST,Partial remission,,Treatment stopped due to acute toxicity,TREATMENT_870,DONOR_60,SYNTHETIC-2
PRIMARY_DIAGNOSIS_211,,No,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 53, 'day_interval': 1590}",Conditioning,Supportive,3.0,3.0,,Partial response,,Treatment incomplete due to technical or organizational problems,TREATMENT_871,DONOR_61,SYNTHETIC-2
PRIMARY_DIAGNOSIS_212,Surgery,Yes,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 97, 'day_interval': 2910}",Preventative,,6.0,4.0,Cheson CLL 2012 Oncology Response Criteria,,1.0,Not applicable,TREATMENT_872,DONOR_62,SYNTHETIC-2
PRIMARY_DIAGNOSIS_213,Other targeting molecular therapy,Unknown,"{'month_interval': 11, 'day_interval': 330}","{'month_interval': 78, 'day_interval': 2340}",,Preventive,,3.0,Response Assessment in Neuro-Oncology (RANO),Immune complete response (iCR),4.0,Physician decision (stopped or interrupted treatment),TREATMENT_873,DONOR_63,SYNTHETIC-2
PRIMARY_DIAGNOSIS_214,No treatment|Chemotherapy,No,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 58, 'day_interval': 1740}",Adjuvant,Screening,1.0,4.0,AML Response Criteria,Partial remission,3.0,Treatment completed as prescribed,TREATMENT_874,DONOR_64,SYNTHETIC-2
PRIMARY_DIAGNOSIS_215,Surgery|Bone marrow transplant|Stem cell transplant,Yes,,"{'month_interval': 91, 'day_interval': 2730}",Conditioning,,,5.0,Physician Assessed Response Criteria,Complete response,1.0,Treatment incomplete because patient died,TREATMENT_875,DONOR_65,SYNTHETIC-2
PRIMARY_DIAGNOSIS_216,,No,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 95, 'day_interval': 2850}",Advanced/Metastatic,Curative,6.0,3.0,AML Response Criteria,,3.0,Treatment incomplete because patient died,TREATMENT_876,DONOR_66,SYNTHETIC-2
PRIMARY_DIAGNOSIS_217,Hormonal therapy|Bone marrow transplant|Surgery,No,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 58, 'day_interval': 1740}",Radiosensitization,Forensic,7.0,5.0,Physician Assessed Response Criteria,Physician assessed stable disease,3.0,Other,TREATMENT_877,DONOR_67,SYNTHETIC-2
PRIMARY_DIAGNOSIS_218,Stem cell transplant,Yes,"{'month_interval': 19, 'day_interval': 570}",,Neoadjuvant,Screening,7.0,5.0,Response Assessment in Neuro-Oncology (RANO),Primary refractory disease,3.0,,TREATMENT_878,DONOR_68,SYNTHETIC-2
PRIMARY_DIAGNOSIS_219,,No,"{'month_interval': 30, 'day_interval': 900}","{'month_interval': 53, 'day_interval': 1590}",Maintenance,Screening,5.0,,AML Response Criteria,Partial response,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_879,DONOR_69,SYNTHETIC-2
PRIMARY_DIAGNOSIS_220,,Yes,,"{'month_interval': 55, 'day_interval': 1650}",Radiosensitization,Palliative,5.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Stable disease,1.0,Not applicable,TREATMENT_880,DONOR_70,SYNTHETIC-2
PRIMARY_DIAGNOSIS_221,,No,"{'month_interval': 30, 'day_interval': 900}",,Maintenance,Palliative,,4.0,AML Response Criteria,Complete response,3.0,,TREATMENT_881,DONOR_41,SYNTHETIC-2
PRIMARY_DIAGNOSIS_222,Chemotherapy,Unknown,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 91, 'day_interval': 2730}",Conditioning,Diagnostic,1.0,4.0,RECIST 1.1,Immune partial response (iPR),5.0,Treatment incomplete because patient died,TREATMENT_882,DONOR_42,SYNTHETIC-2
PRIMARY_DIAGNOSIS_223,Hormonal therapy|Radiation therapy|Stem cell transplant,Unknown,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 78, 'day_interval': 2340}",Advanced/Metastatic,Diagnostic,4.0,5.0,,Immune complete response (iCR),5.0,Treatment incomplete because patient died,TREATMENT_883,DONOR_43,SYNTHETIC-2
PRIMARY_DIAGNOSIS_224,,Unknown,"{'month_interval': 44, 'day_interval': 1320}","{'month_interval': 80, 'day_interval': 2400}",Salvage,Palliative,4.0,5.0,RECIST 1.1,,,Treatment completed as prescribed,TREATMENT_884,DONOR_44,SYNTHETIC-2
PRIMARY_DIAGNOSIS_225,Radiation therapy|Bone marrow transplant,Unknown,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 55, 'day_interval': 1650}",Preventative,Supportive,4.0,3.0,AML Response Criteria,Immune confirmed progressive disease (iCPD),3.0,Not applicable,TREATMENT_885,DONOR_45,SYNTHETIC-2
PRIMARY_DIAGNOSIS_226,,Unknown,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 81, 'day_interval': 2430}",Advanced/Metastatic,Curative,,5.0,Response Assessment in Neuro-Oncology (RANO),Partial remission,3.0,Patient choice (stopped or interrupted treatment),TREATMENT_886,DONOR_46,SYNTHETIC-2
PRIMARY_DIAGNOSIS_227,Hormonal therapy|Other targeting molecular therapy|Radiation therapy,Yes,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 89, 'day_interval': 2670}",,Palliative,6.0,5.0,,Partial response,,Not applicable,TREATMENT_887,DONOR_47,SYNTHETIC-2
PRIMARY_DIAGNOSIS_228,Hormonal therapy|No treatment,Unknown,"{'month_interval': 4, 'day_interval': 120}","{'month_interval': 86, 'day_interval': 2580}",Radiosensitization,Supportive,4.0,3.0,,,,,TREATMENT_888,DONOR_48,SYNTHETIC-2
PRIMARY_DIAGNOSIS_229,Stem cell transplant,Unknown,"{'month_interval': 38, 'day_interval': 1140}","{'month_interval': 85, 'day_interval': 2550}",Neoadjuvant,Forensic,2.0,5.0,AML Response Criteria,Progressive disease,3.0,Treatment completed as prescribed,TREATMENT_889,DONOR_49,SYNTHETIC-2
PRIMARY_DIAGNOSIS_230,,Yes,"{'month_interval': 38, 'day_interval': 1140}",,Induction,Supportive,,4.0,Response Assessment in Neuro-Oncology (RANO),Complete remission without measurable residual disease (CR MRD-),5.0,Unknown,TREATMENT_890,DONOR_50,SYNTHETIC-2
PRIMARY_DIAGNOSIS_231,Other targeting molecular therapy,No,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 96, 'day_interval': 2880}",Radiosensitization,Screening,4.0,3.0,Cheson CLL 2012 Oncology Response Criteria,Primary refractory disease,,Treatment completed as prescribed,TREATMENT_891,DONOR_51,SYNTHETIC-2
PRIMARY_DIAGNOSIS_232,,Yes,"{'month_interval': 14, 'day_interval': 420}","{'month_interval': 91, 'day_interval': 2730}",Mobilization,Guidance,5.0,5.0,RECIST 1.1,Immune stable disease (iSD),2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_892,DONOR_52,SYNTHETIC-2
PRIMARY_DIAGNOSIS_233,Radiation therapy|Hormonal therapy|No treatment,Unknown,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 61, 'day_interval': 1830}",,Diagnostic,2.0,3.0,,Stable disease,,Treatment stopped due to acute toxicity,TREATMENT_893,DONOR_53,SYNTHETIC-2
PRIMARY_DIAGNOSIS_234,Chemotherapy|Bone marrow transplant|No treatment,,"{'month_interval': 33, 'day_interval': 990}","{'month_interval': 80, 'day_interval': 2400}",Preventative,Guidance,3.0,4.0,,Immune uncomfirmed progressive disease (iUPD),,,TREATMENT_894,DONOR_54,SYNTHETIC-2
PRIMARY_DIAGNOSIS_235,,,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 71, 'day_interval': 2130}",Adjuvant,Palliative,5.0,4.0,Response Assessment in Neuro-Oncology (RANO),,,,TREATMENT_895,DONOR_55,SYNTHETIC-2
PRIMARY_DIAGNOSIS_236,,Unknown,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 81, 'day_interval': 2430}",Induction,Supportive,7.0,5.0,Response Assessment in Neuro-Oncology (RANO),Minor response,3.0,,TREATMENT_896,DONOR_56,SYNTHETIC-2
PRIMARY_DIAGNOSIS_237,No treatment|Chemotherapy,No,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 68, 'day_interval': 2040}",Neoadjuvant,Palliative,,3.0,AML Response Criteria,Complete response,,Treatment incomplete because patient died,TREATMENT_897,DONOR_57,SYNTHETIC-2
PRIMARY_DIAGNOSIS_238,Surgery|Other targeting molecular therapy,No,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 85, 'day_interval': 2550}",Maintenance,,3.0,3.0,iRECIST,Partial remission,1.0,Treatment stopped due to acute toxicity,TREATMENT_898,DONOR_58,SYNTHETIC-2
PRIMARY_DIAGNOSIS_239,Other targeting molecular therapy,No,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 65, 'day_interval': 1950}",Advanced/Metastatic,,5.0,4.0,RECIST 1.1,Immune confirmed progressive disease (iCPD),5.0,Treatment stopped due to acute toxicity,TREATMENT_899,DONOR_59,SYNTHETIC-2
PRIMARY_DIAGNOSIS_240,Immunotherapy|Stem cell transplant|Chemotherapy,No,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 94, 'day_interval': 2820}",Induction,Curative,,4.0,RECIST 1.1,Minor response,,,TREATMENT_900,DONOR_60,SYNTHETIC-2
PRIMARY_DIAGNOSIS_241,Other targeting molecular therapy,Unknown,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 78, 'day_interval': 2340}",Salvage,Screening,7.0,3.0,,,4.0,Treatment incomplete because patient died,TREATMENT_901,DONOR_61,SYNTHETIC-2
PRIMARY_DIAGNOSIS_242,No treatment|Radiation therapy,No,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 59, 'day_interval': 1770}",Locally advanced,Diagnostic,,3.0,,,2.0,Physician decision (stopped or interrupted treatment),TREATMENT_902,DONOR_62,SYNTHETIC-2
PRIMARY_DIAGNOSIS_243,Chemotherapy|No treatment,Unknown,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 73, 'day_interval': 2190}",Neoadjuvant,Supportive,,5.0,Physician Assessed Response Criteria,Physician assessed complete response,2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_903,DONOR_63,SYNTHETIC-2
PRIMARY_DIAGNOSIS_244,No treatment|Surgery|Bone marrow transplant,Yes,"{'month_interval': 47, 'day_interval': 1410}","{'month_interval': 78, 'day_interval': 2340}",Radiosensitization,Guidance,,4.0,iRECIST,Immune uncomfirmed progressive disease (iUPD),,Other,TREATMENT_904,DONOR_64,SYNTHETIC-2
PRIMARY_DIAGNOSIS_245,Radiation therapy,,"{'month_interval': 14, 'day_interval': 420}","{'month_interval': 86, 'day_interval': 2580}",Adjuvant,Diagnostic,6.0,3.0,AML Response Criteria,Minor response,2.0,Treatment completed as prescribed,TREATMENT_905,DONOR_65,SYNTHETIC-2
PRIMARY_DIAGNOSIS_246,Immunotherapy,No,"{'month_interval': 11, 'day_interval': 330}","{'month_interval': 61, 'day_interval': 1830}",Induction,,1.0,3.0,Physician Assessed Response Criteria,Complete response,2.0,Patient choice (stopped or interrupted treatment),TREATMENT_906,DONOR_66,SYNTHETIC-2
PRIMARY_DIAGNOSIS_247,Other targeting molecular therapy,Yes,,"{'month_interval': 63, 'day_interval': 1890}",Induction,Supportive,,3.0,Physician Assessed Response Criteria,,2.0,Not applicable,TREATMENT_907,DONOR_67,SYNTHETIC-2
PRIMARY_DIAGNOSIS_248,,No,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 66, 'day_interval': 1980}",Induction,Forensic,5.0,,AML Response Criteria,Progressive disease,2.0,Other,TREATMENT_908,DONOR_68,SYNTHETIC-2
PRIMARY_DIAGNOSIS_249,,Yes,"{'month_interval': 9, 'day_interval': 270}","{'month_interval': 85, 'day_interval': 2550}",Maintenance,Curative,7.0,5.0,RECIST 1.1,Molecular relapse (after CR MRD-),1.0,Unknown,TREATMENT_909,DONOR_69,SYNTHETIC-2
PRIMARY_DIAGNOSIS_250,Bone marrow transplant|Chemotherapy|Other targeting molecular therapy,No,"{'month_interval': 6, 'day_interval': 180}",,Induction,,4.0,4.0,Blazer score,Complete response,2.0,Unknown,TREATMENT_910,DONOR_70,SYNTHETIC-2
PRIMARY_DIAGNOSIS_251,Bone marrow transplant|Immunotherapy|Photodynamic therapy,Yes,"{'month_interval': 2, 'day_interval': 60}",,Radiosensitization,Guidance,3.0,,Cheson CLL 2012 Oncology Response Criteria,,2.0,Treatment stopped due to acute toxicity,TREATMENT_911,DONOR_71,SYNTHETIC-3
PRIMARY_DIAGNOSIS_252,,Unknown,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 55, 'day_interval': 1650}",Preventative,,,4.0,Cheson CLL 2012 Oncology Response Criteria,Physician assessed stable disease,4.0,Not applicable,TREATMENT_912,DONOR_72,SYNTHETIC-3
PRIMARY_DIAGNOSIS_253,,Unknown,,"{'month_interval': 93, 'day_interval': 2790}",,Supportive,4.0,4.0,Physician Assessed Response Criteria,Primary refractory disease,5.0,Other,TREATMENT_913,DONOR_73,SYNTHETIC-3
PRIMARY_DIAGNOSIS_254,,No,"{'month_interval': 39, 'day_interval': 1170}","{'month_interval': 88, 'day_interval': 2640}",Salvage,Preventive,3.0,,Response Assessment in Neuro-Oncology (RANO),Partial remission,1.0,,TREATMENT_914,DONOR_74,SYNTHETIC-3
PRIMARY_DIAGNOSIS_255,Stem cell transplant|Chemotherapy,,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 56, 'day_interval': 1680}",Locally advanced,Supportive,,4.0,Response Assessment in Neuro-Oncology (RANO),Stable disease,5.0,Not applicable,TREATMENT_915,DONOR_75,SYNTHETIC-3
PRIMARY_DIAGNOSIS_256,Photodynamic therapy,No,"{'month_interval': 28, 'day_interval': 840}","{'month_interval': 82, 'day_interval': 2460}",Mobilization,Forensic,1.0,3.0,Cheson CLL 2012 Oncology Response Criteria,,4.0,,TREATMENT_916,DONOR_76,SYNTHETIC-3
PRIMARY_DIAGNOSIS_257,Immunotherapy,No,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 82, 'day_interval': 2460}",Induction,Forensic,1.0,5.0,Physician Assessed Response Criteria,,,Physician decision (stopped or interrupted treatment),TREATMENT_917,DONOR_77,SYNTHETIC-3
PRIMARY_DIAGNOSIS_258,Stem cell transplant|Surgery,Yes,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 89, 'day_interval': 2670}",Neoadjuvant,Guidance,2.0,3.0,Physician Assessed Response Criteria,Immune confirmed progressive disease (iCPD),5.0,Treatment completed as prescribed,TREATMENT_918,DONOR_78,SYNTHETIC-3
PRIMARY_DIAGNOSIS_259,Radiation therapy,No,"{'month_interval': 18, 'day_interval': 540}","{'month_interval': 65, 'day_interval': 1950}",Locally advanced,Forensic,5.0,5.0,Physician Assessed Response Criteria,Complete remission,5.0,Treatment completed as prescribed,TREATMENT_919,DONOR_79,SYNTHETIC-3
PRIMARY_DIAGNOSIS_260,Surgery|Bone marrow transplant,No,,"{'month_interval': 53, 'day_interval': 1590}",Maintenance,,,5.0,iRECIST,Physician assessed complete response,5.0,Treatment completed as prescribed,TREATMENT_920,DONOR_80,SYNTHETIC-3
PRIMARY_DIAGNOSIS_261,No treatment|Other targeting molecular therapy|Stem cell transplant,Unknown,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 100, 'day_interval': 3000}",Salvage,Diagnostic,5.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Physician assessed stable disease,1.0,,TREATMENT_921,DONOR_81,SYNTHETIC-3
PRIMARY_DIAGNOSIS_262,Stem cell transplant|Surgery|Other targeting molecular therapy,Unknown,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 67, 'day_interval': 2010}",Radiosensitization,Preventive,5.0,5.0,Blazer score,Physician assessed complete response,4.0,,TREATMENT_922,DONOR_82,SYNTHETIC-3
PRIMARY_DIAGNOSIS_263,,Unknown,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 90, 'day_interval': 2700}",Adjuvant,Curative,5.0,4.0,Response Assessment in Neuro-Oncology (RANO),Immune uncomfirmed progressive disease (iUPD),5.0,Physician decision (stopped or interrupted treatment),TREATMENT_923,DONOR_83,SYNTHETIC-3
PRIMARY_DIAGNOSIS_264,Hormonal therapy|Bone marrow transplant|Radiation therapy,No,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 91, 'day_interval': 2730}",,,4.0,,AML Response Criteria,Progressive disease,1.0,Physician decision (stopped or interrupted treatment),TREATMENT_924,DONOR_84,SYNTHETIC-3
PRIMARY_DIAGNOSIS_265,Immunotherapy,Unknown,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 51, 'day_interval': 1530}",Neoadjuvant,Palliative,4.0,3.0,RECIST 1.1,Molecular relapse (after CR MRD-),2.0,Not applicable,TREATMENT_925,DONOR_85,SYNTHETIC-3
PRIMARY_DIAGNOSIS_266,Hormonal therapy,Yes,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 90, 'day_interval': 2700}",Neoadjuvant,,6.0,3.0,RECIST 1.1,Morphologic leukemia-free state,5.0,Unknown,TREATMENT_926,DONOR_86,SYNTHETIC-3
PRIMARY_DIAGNOSIS_267,Photodynamic therapy|No treatment|Hormonal therapy,Yes,"{'month_interval': 4, 'day_interval': 120}","{'month_interval': 92, 'day_interval': 2760}",Locally advanced,Forensic,2.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Stable disease,3.0,,TREATMENT_927,DONOR_87,SYNTHETIC-3
PRIMARY_DIAGNOSIS_268,Stem cell transplant|Surgery,No,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 73, 'day_interval': 2190}",Mobilization,Supportive,3.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Immune confirmed progressive disease (iCPD),1.0,,TREATMENT_928,DONOR_88,SYNTHETIC-3
PRIMARY_DIAGNOSIS_269,Bone marrow transplant|Photodynamic therapy,,"{'month_interval': 45, 'day_interval': 1350}","{'month_interval': 94, 'day_interval': 2820}",Maintenance,Palliative,2.0,5.0,AML Response Criteria,,,Treatment incomplete due to technical or organizational problems,TREATMENT_929,DONOR_89,SYNTHETIC-3
PRIMARY_DIAGNOSIS_270,Stem cell transplant|Immunotherapy|Other targeting molecular therapy,Unknown,"{'month_interval': 41, 'day_interval': 1230}","{'month_interval': 87, 'day_interval': 2610}",Adjuvant,Diagnostic,1.0,,iRECIST,Complete remission,3.0,Not applicable,TREATMENT_930,DONOR_90,SYNTHETIC-3
PRIMARY_DIAGNOSIS_271,Other targeting molecular therapy,No,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 97, 'day_interval': 2910}",Neoadjuvant,Supportive,5.0,,Blazer score,Physician assessed complete response,3.0,Patient choice (stopped or interrupted treatment),TREATMENT_931,DONOR_71,SYNTHETIC-3
PRIMARY_DIAGNOSIS_272,No treatment,,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 59, 'day_interval': 1770}",,,6.0,3.0,RECIST 1.1,,3.0,,TREATMENT_932,DONOR_72,SYNTHETIC-3
PRIMARY_DIAGNOSIS_273,Hormonal therapy,Yes,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 93, 'day_interval': 2790}",Conditioning,Screening,1.0,5.0,Physician Assessed Response Criteria,,3.0,Treatment incomplete because patient died,TREATMENT_933,DONOR_73,SYNTHETIC-3
PRIMARY_DIAGNOSIS_274,Radiation therapy|Photodynamic therapy,Yes,"{'month_interval': 37, 'day_interval': 1110}",,Preventative,Palliative,6.0,,AML Response Criteria,,4.0,Treatment completed as prescribed,TREATMENT_934,DONOR_74,SYNTHETIC-3
PRIMARY_DIAGNOSIS_275,Stem cell transplant|Bone marrow transplant,Yes,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 89, 'day_interval': 2670}",Induction,Preventive,6.0,5.0,RECIST 1.1,Complete remission with incomplete hematologic recovery (CRi),4.0,Treatment completed as prescribed,TREATMENT_935,DONOR_75,SYNTHETIC-3
PRIMARY_DIAGNOSIS_276,Bone marrow transplant|Radiation therapy|No treatment,Unknown,"{'month_interval': 17, 'day_interval': 510}",,Induction,,,3.0,RECIST 1.1,,3.0,Treatment completed as prescribed,TREATMENT_936,DONOR_76,SYNTHETIC-3
PRIMARY_DIAGNOSIS_277,Chemotherapy|Bone marrow transplant|Surgery,No,,"{'month_interval': 55, 'day_interval': 1650}",Neoadjuvant,Preventive,,,Physician Assessed Response Criteria,No evidence of disease (NED),4.0,Physician decision (stopped or interrupted treatment),TREATMENT_937,DONOR_77,SYNTHETIC-3
PRIMARY_DIAGNOSIS_278,Radiation therapy|Other targeting molecular therapy,Unknown,"{'month_interval': 9, 'day_interval': 270}",,Mobilization,,6.0,3.0,RECIST 1.1,Morphologic leukemia-free state,,Unknown,TREATMENT_938,DONOR_78,SYNTHETIC-3
PRIMARY_DIAGNOSIS_279,Hormonal therapy,No,"{'month_interval': 3, 'day_interval': 90}","{'month_interval': 60, 'day_interval': 1800}",,,4.0,4.0,Cheson CLL 2012 Oncology Response Criteria,Molecular relapse (after CR MRD-),5.0,Treatment stopped due to acute toxicity,TREATMENT_939,DONOR_79,SYNTHETIC-3
PRIMARY_DIAGNOSIS_280,Chemotherapy,Unknown,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 91, 'day_interval': 2730}",Adjuvant,Guidance,4.0,5.0,iRECIST,Physician assessed complete response,,Not applicable,TREATMENT_940,DONOR_80,SYNTHETIC-3
PRIMARY_DIAGNOSIS_281,Bone marrow transplant,Yes,,,Preventative,Supportive,6.0,,Blazer score,Complete response,,Physician decision (stopped or interrupted treatment),TREATMENT_941,DONOR_81,SYNTHETIC-3
PRIMARY_DIAGNOSIS_282,,No,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 92, 'day_interval': 2760}",Neoadjuvant,Curative,5.0,3.0,,Morphologic leukemia-free state,4.0,Unknown,TREATMENT_942,DONOR_82,SYNTHETIC-3
PRIMARY_DIAGNOSIS_283,Photodynamic therapy|Stem cell transplant,Yes,"{'month_interval': 4, 'day_interval': 120}","{'month_interval': 94, 'day_interval': 2820}",Conditioning,,4.0,5.0,iRECIST,No evidence of disease (NED),3.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_943,DONOR_83,SYNTHETIC-3
PRIMARY_DIAGNOSIS_284,,,"{'month_interval': 48, 'day_interval': 1440}","{'month_interval': 94, 'day_interval': 2820}",,Preventive,3.0,5.0,Cheson CLL 2012 Oncology Response Criteria,Immune complete response (iCR),,Patient choice (stopped or interrupted treatment),TREATMENT_944,DONOR_84,SYNTHETIC-3
PRIMARY_DIAGNOSIS_285,,Unknown,"{'month_interval': 31, 'day_interval': 930}","{'month_interval': 73, 'day_interval': 2190}",Induction,Preventive,2.0,3.0,RECIST 1.1,Complete response,2.0,,TREATMENT_945,DONOR_85,SYNTHETIC-3
PRIMARY_DIAGNOSIS_286,Chemotherapy,No,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 85, 'day_interval': 2550}",Neoadjuvant,Palliative,1.0,4.0,,,,Treatment stopped due to acute toxicity,TREATMENT_946,DONOR_86,SYNTHETIC-3
PRIMARY_DIAGNOSIS_287,Immunotherapy|Bone marrow transplant,No,"{'month_interval': 40, 'day_interval': 1200}","{'month_interval': 65, 'day_interval': 1950}",Maintenance,Diagnostic,7.0,5.0,AML Response Criteria,Immune partial response (iPR),5.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_947,DONOR_87,SYNTHETIC-3
PRIMARY_DIAGNOSIS_288,Stem cell transplant|Chemotherapy|Radiation therapy,Yes,,"{'month_interval': 72, 'day_interval': 2160}",Locally advanced,Palliative,4.0,,Physician Assessed Response Criteria,Morphologic leukemia-free state,5.0,Not applicable,TREATMENT_948,DONOR_88,SYNTHETIC-3
PRIMARY_DIAGNOSIS_289,,Unknown,,"{'month_interval': 63, 'day_interval': 1890}",,Guidance,3.0,3.0,Blazer score,Complete remission without measurable residual disease (CR MRD-),,Not applicable,TREATMENT_949,DONOR_89,SYNTHETIC-3
PRIMARY_DIAGNOSIS_290,Other targeting molecular therapy|Surgery,Unknown,,"{'month_interval': 74, 'day_interval': 2220}",Salvage,Screening,2.0,,Cheson CLL 2012 Oncology Response Criteria,Immune stable disease (iSD),4.0,Unknown,TREATMENT_950,DONOR_90,SYNTHETIC-3
PRIMARY_DIAGNOSIS_251,,Yes,"{'month_interval': 16, 'day_interval': 480}","{'month_interval': 82, 'day_interval': 2460}",,,6.0,4.0,iRECIST,Stable disease,,Treatment completed as prescribed,TREATMENT_951,DONOR_71,SYNTHETIC-3
PRIMARY_DIAGNOSIS_252,Photodynamic therapy|Chemotherapy,No,"{'month_interval': 23, 'day_interval': 690}","{'month_interval': 88, 'day_interval': 2640}",Salvage,Curative,1.0,5.0,Blazer score,Morphologic leukemia-free state,3.0,Treatment stopped due to acute toxicity,TREATMENT_952,DONOR_72,SYNTHETIC-3
PRIMARY_DIAGNOSIS_253,No treatment,No,"{'month_interval': 37, 'day_interval': 1110}","{'month_interval': 57, 'day_interval': 1710}",Radiosensitization,,3.0,,,,5.0,Treatment stopped due to acute toxicity,TREATMENT_953,DONOR_73,SYNTHETIC-3
PRIMARY_DIAGNOSIS_254,Stem cell transplant,Yes,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 79, 'day_interval': 2370}",Salvage,Screening,4.0,,AML Response Criteria,Stable disease,4.0,,TREATMENT_954,DONOR_74,SYNTHETIC-3
PRIMARY_DIAGNOSIS_255,Photodynamic therapy,No,"{'month_interval': 27, 'day_interval': 810}","{'month_interval': 68, 'day_interval': 2040}",Conditioning,,7.0,5.0,Physician Assessed Response Criteria,Complete response,,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_955,DONOR_75,SYNTHETIC-3
PRIMARY_DIAGNOSIS_256,Other targeting molecular therapy,,"{'month_interval': 44, 'day_interval': 1320}","{'month_interval': 74, 'day_interval': 2220}",Conditioning,Palliative,1.0,3.0,RECIST 1.1,,3.0,Treatment incomplete due to technical or organizational problems,TREATMENT_956,DONOR_76,SYNTHETIC-3
PRIMARY_DIAGNOSIS_257,Stem cell transplant|Radiation therapy,No,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 86, 'day_interval': 2580}",Advanced/Metastatic,,3.0,5.0,iRECIST,No evidence of disease (NED),4.0,Treatment completed as prescribed,TREATMENT_957,DONOR_77,SYNTHETIC-3
PRIMARY_DIAGNOSIS_258,Bone marrow transplant|No treatment,,"{'month_interval': 4, 'day_interval': 120}",,Mobilization,Diagnostic,7.0,4.0,,Morphologic leukemia-free state,,,TREATMENT_958,DONOR_78,SYNTHETIC-3
PRIMARY_DIAGNOSIS_259,Photodynamic therapy|Chemotherapy,Unknown,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 62, 'day_interval': 1860}",Locally advanced,Preventive,1.0,,Response Assessment in Neuro-Oncology (RANO),Immune confirmed progressive disease (iCPD),3.0,,TREATMENT_959,DONOR_79,SYNTHETIC-3
PRIMARY_DIAGNOSIS_260,,No,"{'month_interval': 46, 'day_interval': 1380}","{'month_interval': 59, 'day_interval': 1770}",Induction,Screening,7.0,4.0,Cheson CLL 2012 Oncology Response Criteria,,5.0,,TREATMENT_960,DONOR_80,SYNTHETIC-3
PRIMARY_DIAGNOSIS_261,Surgery|Immunotherapy,Unknown,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 85, 'day_interval': 2550}",Neoadjuvant,Supportive,7.0,5.0,iRECIST,Partial remission,4.0,Treatment incomplete because patient died,TREATMENT_961,DONOR_81,SYNTHETIC-3
PRIMARY_DIAGNOSIS_262,Immunotherapy|Bone marrow transplant,Unknown,"{'month_interval': 50, 'day_interval': 1500}","{'month_interval': 94, 'day_interval': 2820}",Advanced/Metastatic,Diagnostic,3.0,4.0,Physician Assessed Response Criteria,Stable disease,2.0,Other,TREATMENT_962,DONOR_82,SYNTHETIC-3
PRIMARY_DIAGNOSIS_263,,No,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 91, 'day_interval': 2730}",,Palliative,6.0,,Response Assessment in Neuro-Oncology (RANO),,5.0,Treatment incomplete due to technical or organizational problems,TREATMENT_963,DONOR_83,SYNTHETIC-3
PRIMARY_DIAGNOSIS_264,Stem cell transplant,Unknown,"{'month_interval': 5, 'day_interval': 150}",,Preventative,Guidance,7.0,5.0,AML Response Criteria,Morphologic leukemia-free state,2.0,Patient choice (stopped or interrupted treatment),TREATMENT_964,DONOR_84,SYNTHETIC-3
PRIMARY_DIAGNOSIS_265,Bone marrow transplant|Immunotherapy|Radiation therapy,Yes,"{'month_interval': 34, 'day_interval': 1020}","{'month_interval': 90, 'day_interval': 2700}",,Screening,1.0,3.0,AML Response Criteria,Immune complete response (iCR),2.0,Treatment stopped due to acute toxicity,TREATMENT_965,DONOR_85,SYNTHETIC-3
PRIMARY_DIAGNOSIS_266,Radiation therapy,Yes,"{'month_interval': 13, 'day_interval': 390}","{'month_interval': 91, 'day_interval': 2730}",Conditioning,Palliative,,5.0,,Immune partial response (iPR),5.0,Treatment incomplete because patient died,TREATMENT_966,DONOR_86,SYNTHETIC-3
PRIMARY_DIAGNOSIS_267,Hormonal therapy,Unknown,"{'month_interval': 26, 'day_interval': 780}","{'month_interval': 96, 'day_interval': 2880}",Salvage,Diagnostic,2.0,5.0,Blazer score,Complete response,5.0,Treatment completed as prescribed,TREATMENT_967,DONOR_87,SYNTHETIC-3
PRIMARY_DIAGNOSIS_268,Immunotherapy,No,"{'month_interval': 29, 'day_interval': 870}","{'month_interval': 80, 'day_interval': 2400}",Mobilization,,1.0,4.0,Blazer score,,4.0,Unknown,TREATMENT_968,DONOR_88,SYNTHETIC-3
PRIMARY_DIAGNOSIS_269,Photodynamic therapy,,,"{'month_interval': 67, 'day_interval': 2010}",Mobilization,Curative,,3.0,Blazer score,No evidence of disease (NED),,Other,TREATMENT_969,DONOR_89,SYNTHETIC-3
PRIMARY_DIAGNOSIS_270,Bone marrow transplant,Yes,"{'month_interval': 36, 'day_interval': 1080}","{'month_interval': 64, 'day_interval': 1920}",,Supportive,4.0,3.0,,No evidence of disease (NED),3.0,Treatment incomplete due to technical or organizational problems,TREATMENT_970,DONOR_90,SYNTHETIC-3
PRIMARY_DIAGNOSIS_271,,No,"{'month_interval': 24, 'day_interval': 720}","{'month_interval': 82, 'day_interval': 2460}",Maintenance,Guidance,,4.0,Response Assessment in Neuro-Oncology (RANO),Physician assessed stable disease,,Patient choice (stopped or interrupted treatment),TREATMENT_971,DONOR_71,SYNTHETIC-3
PRIMARY_DIAGNOSIS_272,Bone marrow transplant|Radiation therapy|Immunotherapy,No,"{'month_interval': 12, 'day_interval': 360}","{'month_interval': 61, 'day_interval': 1830}",Induction,,3.0,3.0,AML Response Criteria,Major response,1.0,Other,TREATMENT_972,DONOR_72,SYNTHETIC-3
PRIMARY_DIAGNOSIS_273,,Unknown,"{'month_interval': 9, 'day_interval': 270}",,Maintenance,Palliative,,4.0,RECIST 1.1,,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_973,DONOR_73,SYNTHETIC-3
PRIMARY_DIAGNOSIS_274,,Unknown,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 53, 'day_interval': 1590}",Preventative,,,5.0,RECIST 1.1,Major response,3.0,Physician decision (stopped or interrupted treatment),TREATMENT_974,DONOR_74,SYNTHETIC-3
PRIMARY_DIAGNOSIS_275,,Yes,"{'month_interval': 22, 'day_interval': 660}","{'month_interval': 96, 'day_interval': 2880}",,,3.0,5.0,iRECIST,Partial remission,2.0,,TREATMENT_975,DONOR_75,SYNTHETIC-3
PRIMARY_DIAGNOSIS_276,,No,,"{'month_interval': 84, 'day_interval': 2520}",Maintenance,Curative,4.0,,Physician Assessed Response Criteria,,2.0,,TREATMENT_976,DONOR_76,SYNTHETIC-3
PRIMARY_DIAGNOSIS_277,Chemotherapy|Immunotherapy,Yes,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 59, 'day_interval': 1770}",Conditioning,Supportive,7.0,4.0,RECIST 1.1,,,Unknown,TREATMENT_977,DONOR_77,SYNTHETIC-3
PRIMARY_DIAGNOSIS_278,,Yes,"{'month_interval': 7, 'day_interval': 210}","{'month_interval': 80, 'day_interval': 2400}",Salvage,,1.0,4.0,Physician Assessed Response Criteria,No evidence of disease (NED),4.0,,TREATMENT_978,DONOR_78,SYNTHETIC-3
PRIMARY_DIAGNOSIS_279,No treatment,Yes,"{'month_interval': 23, 'day_interval': 690}","{'month_interval': 65, 'day_interval': 1950}",Adjuvant,Supportive,5.0,4.0,Physician Assessed Response Criteria,Stable disease,2.0,Physician decision (stopped or interrupted treatment),TREATMENT_979,DONOR_79,SYNTHETIC-3
PRIMARY_DIAGNOSIS_280,Immunotherapy|Other targeting molecular therapy|Bone marrow transplant,Yes,"{'month_interval': 43, 'day_interval': 1290}","{'month_interval': 95, 'day_interval': 2850}",Mobilization,Forensic,,3.0,AML Response Criteria,Molecular relapse (after CR MRD-),1.0,Not applicable,TREATMENT_980,DONOR_80,SYNTHETIC-3
PRIMARY_DIAGNOSIS_281,,,"{'month_interval': 38, 'day_interval': 1140}",,Adjuvant,Supportive,5.0,4.0,,"Hematologic relapse (after CR MRD-, CR, CRi)",,,TREATMENT_981,DONOR_81,SYNTHETIC-3
PRIMARY_DIAGNOSIS_282,Bone marrow transplant,Unknown,"{'month_interval': 25, 'day_interval': 750}","{'month_interval': 57, 'day_interval': 1710}",,Curative,6.0,5.0,iRECIST,Immune uncomfirmed progressive disease (iUPD),2.0,,TREATMENT_982,DONOR_82,SYNTHETIC-3
PRIMARY_DIAGNOSIS_283,Other targeting molecular therapy,Yes,"{'month_interval': 15, 'day_interval': 450}","{'month_interval': 84, 'day_interval': 2520}",,Forensic,4.0,4.0,Physician Assessed Response Criteria,Partial remission,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_983,DONOR_83,SYNTHETIC-3
PRIMARY_DIAGNOSIS_284,Chemotherapy,Unknown,"{'month_interval': 23, 'day_interval': 690}","{'month_interval': 54, 'day_interval': 1620}",,Forensic,4.0,5.0,Blazer score,Stable disease,3.0,Treatment completed as prescribed,TREATMENT_984,DONOR_84,SYNTHETIC-3
PRIMARY_DIAGNOSIS_285,Photodynamic therapy|Chemotherapy|Stem cell transplant,Unknown,"{'month_interval': 35, 'day_interval': 1050}","{'month_interval': 83, 'day_interval': 2490}",,,,3.0,iRECIST,,,,TREATMENT_985,DONOR_85,SYNTHETIC-3
PRIMARY_DIAGNOSIS_286,No treatment|Radiation therapy,No,"{'month_interval': 32, 'day_interval': 960}","{'month_interval': 82, 'day_interval': 2460}",Conditioning,Curative,3.0,5.0,AML Response Criteria,Minor response,,Patient choice (stopped or interrupted treatment),TREATMENT_986,DONOR_86,SYNTHETIC-3
PRIMARY_DIAGNOSIS_287,Bone marrow transplant|Photodynamic therapy,Unknown,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 99, 'day_interval': 2970}",Maintenance,Screening,,3.0,iRECIST,Complete remission with incomplete hematologic recovery (CRi),5.0,,TREATMENT_987,DONOR_87,SYNTHETIC-3
PRIMARY_DIAGNOSIS_288,Chemotherapy|Immunotherapy|Other targeting molecular therapy,Unknown,"{'month_interval': 8, 'day_interval': 240}","{'month_interval': 56, 'day_interval': 1680}",Adjuvant,Palliative,2.0,,Physician Assessed Response Criteria,Primary refractory disease,,,TREATMENT_988,DONOR_88,SYNTHETIC-3
PRIMARY_DIAGNOSIS_289,Other targeting molecular therapy,Yes,"{'month_interval': 18, 'day_interval': 540}","{'month_interval': 68, 'day_interval': 2040}",Radiosensitization,Forensic,2.0,,iRECIST,,4.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_989,DONOR_89,SYNTHETIC-3
PRIMARY_DIAGNOSIS_290,Chemotherapy|Bone marrow transplant|Stem cell transplant,Unknown,"{'month_interval': 29, 'day_interval': 870}",,Mobilization,Diagnostic,4.0,3.0,Physician Assessed Response Criteria,Physician assessed partial response,4.0,Patient choice (stopped or interrupted treatment),TREATMENT_990,DONOR_90,SYNTHETIC-3
PRIMARY_DIAGNOSIS_291,Bone marrow transplant|Radiation therapy,Yes,,"{'month_interval': 69, 'day_interval': 2070}",Neoadjuvant,Diagnostic,5.0,5.0,Blazer score,Partial response,5.0,,TREATMENT_991,DONOR_91,SYNTHETIC-4
PRIMARY_DIAGNOSIS_292,Immunotherapy|Radiation therapy,No,"{'month_interval': 9, 'day_interval': 270}",,Adjuvant,Guidance,4.0,5.0,,,1.0,Not applicable,TREATMENT_992,DONOR_92,SYNTHETIC-4
PRIMARY_DIAGNOSIS_293,Photodynamic therapy|Bone marrow transplant,,"{'month_interval': 19, 'day_interval': 570}","{'month_interval': 53, 'day_interval': 1590}",Locally advanced,Curative,,4.0,iRECIST,Immune stable disease (iSD),3.0,Treatment completed as prescribed,TREATMENT_993,DONOR_93,SYNTHETIC-4
PRIMARY_DIAGNOSIS_294,No treatment|Photodynamic therapy,Unknown,"{'month_interval': 1, 'day_interval': 30}","{'month_interval': 88, 'day_interval': 2640}",Salvage,Screening,3.0,5.0,Physician Assessed Response Criteria,Stable disease,2.0,Treatment incomplete due to technical or organizational problems,TREATMENT_994,DONOR_94,SYNTHETIC-4
PRIMARY_DIAGNOSIS_295,Radiation therapy,Yes,"{'month_interval': 49, 'day_interval': 1470}","{'month_interval': 97, 'day_interval': 2910}",Adjuvant,Supportive,5.0,4.0,,Physician assessed stable disease,,,TREATMENT_995,DONOR_95,SYNTHETIC-4
PRIMARY_DIAGNOSIS_296,,Yes,"{'month_interval': 21, 'day_interval': 630}","{'month_interval': 59, 'day_interval': 1770}",Locally advanced,Curative,,,,,2.0,,TREATMENT_996,DONOR_96,SYNTHETIC-4
PRIMARY_DIAGNOSIS_297,Bone marrow transplant|Photodynamic therapy,No,"{'month_interval': 17, 'day_interval': 510}","{'month_interval': 63, 'day_interval': 1890}",Conditioning,,2.0,4.0,Response Assessment in Neuro-Oncology (RANO),Immune uncomfirmed progressive disease (iUPD),1.0,Treatment incomplete because patient died,TREATMENT_997,DONOR_97,SYNTHETIC-4
PRIMARY_DIAGNOSIS_298,Surgery,Unknown,"{'month_interval': 42, 'day_interval': 1260}","{'month_interval': 52, 'day_interval': 1560}",Advanced/Metastatic,Palliative,4.0,3.0,,,2.0,Treatment stopped due to lack of efficacy (disease progression),TREATMENT_998,DONOR_98,SYNTHETIC-4
PRIMARY_DIAGNOSIS_299,Chemotherapy|Bone marrow transplant|Radiation therapy,No,,"{'month_interval': 57, 'day_interval': 1710}",Locally advanced,,,3.0,RECIST 1.1,,1.0,Treatment completed as prescribed,TREATMENT_999,DONOR_99,SYNTHETIC-4
PRIMARY_DIAGNOSIS_300,Radiation therapy|Bone marrow transplant|Other targeting molecular therapy,No,"{'month_interval': 41, 'day_interval': 1230}","{'month_interval': 87, 'day_interval': 2610}",,Screening,7.0,4.0,AML Response Criteria,Immune complete response (iCR),5.0,Treatment incomplete because patient died,TREATMENT_1000,DONOR_100,SYNTHETIC-4
